<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="review-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Free Radic Biol Med</journal-id>
      <journal-title-group>
        <journal-title>Free Radical Biology &amp; Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0891-5849</issn>
      <issn pub-type="epub">1873-4596</issn>
      <publisher>
        <publisher-name>Elsevier Science</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3049876</article-id>
      <article-id pub-id-type="pmid">21236334</article-id>
      <article-id pub-id-type="publisher-id">FRB10492</article-id>
      <article-id pub-id-type="doi">10.1016/j.freeradbiomed.2011.01.003</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Redox signaling in cardiac myocytes</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Santos</surname>
            <given-names>Celio X.C.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Anilkumar</surname>
            <given-names>Narayana</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Min</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brewer</surname>
            <given-names>Alison C.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shah</surname>
            <given-names>Ajay M.</given-names>
          </name>
          <email>ajay.shah@kcl.ac.uk</email>
          <xref rid="cr0005" ref-type="corresp">⁎</xref>
        </contrib>
      </contrib-group>
      <aff id="af0005">Cardiovascular Division, King's College London British Heart Foundation Centre, London SE5 9PJ, UK</aff>
      <author-notes>
        <corresp id="cr0005"><label>⁎</label>Corresponding author. Fax: +44 20 7346 4771. <email>ajay.shah@kcl.ac.uk</email></corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>01</day>
        <month>4</month>
        <year>2011</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <pub-date pub-type="ppub">
        <day>01</day>
        <month>4</month>
        <year>2011</year>
      </pub-date>
      <volume>50</volume>
      <issue>7</issue>
      <fpage>777</fpage>
      <lpage>793</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>10</month>
          <year>2010</year>
        </date>
        <date date-type="rev-recd">
          <day>5</day>
          <month>1</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>5</day>
          <month>1</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2011 Elsevier Inc.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <copyright-holder>Elsevier Inc.</copyright-holder>
        <license>
          <license-p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>The heart has complex mechanisms that facilitate the maintenance of an oxygen supply–demand balance necessary for its contractile function in response to physiological fluctuations in workload as well as in response to chronic stresses such as hypoxia, ischemia, and overload. Redox-sensitive signaling pathways are centrally involved in many of these homeostatic and stress-response mechanisms. Here, we review the main redox-regulated pathways that are involved in cardiac myocyte excitation–contraction coupling, differentiation, hypertrophy, and stress responses. We discuss specific sources of endogenously generated reactive oxygen species (e.g., mitochondria and NADPH oxidases of the Nox family), the particular pathways and processes that they affect, the role of modulators such as thioredoxin, and the specific molecular mechanisms that are involved—where this knowledge is available. A better understanding of this complex regulatory system may allow the development of more specific therapeutic strategies for heart diseases.</p>
      </abstract>
      <kwd-group>
        <title>Abbreviations</title>
        <kwd>AIF, apoptosis-inducing factor</kwd>
        <kwd>ARC, apoptosis repressor with caspase recruitment domain</kwd>
        <kwd>CamKII, calmodulin kinase II</kwd>
        <kwd>CTGF, connective tissue growth factor</kwd>
        <kwd>EB, embryoid body</kwd>
        <kwd>ECC, excitation–contraction coupling</kwd>
        <kwd>ER, endoplasmic reticulum</kwd>
        <kwd>ES, embryonic stem</kwd>
        <kwd>ETC, electron transport chain</kwd>
        <kwd>G6PDH, glucose-6-phosphate dehydrogenase</kwd>
        <kwd>GPCR, G-protein-coupled receptor</kwd>
        <kwd>HDAC, histone deacetylase</kwd>
        <kwd>Hif, hypoxia-inducible factor</kwd>
        <kwd>MAO-A, monoamine oxidase-A</kwd>
        <kwd>MI, myocardial infarction</kwd>
        <kwd>MMP, matrix metalloproteinase</kwd>
        <kwd>MPTP, mitochondrial permeability transition pore</kwd>
        <kwd>mtDNA, mitochondrial DNA</kwd>
        <kwd>NCX, Na/Ca exchanger</kwd>
        <kwd>NOS, nitric oxide synthase</kwd>
        <kwd>PHD, prolyl hydroxylase dioxygenase</kwd>
        <kwd>PKA, protein kinase A</kwd>
        <kwd>PKC, protein kinase C</kwd>
        <kwd>PKG, protein kinase G</kwd>
        <kwd>ROS, reactive oxygen species</kwd>
        <kwd>RyR, ryanodine receptor</kwd>
        <kwd>SERCA, sarcoplasmic reticulum calcium ATPase</kwd>
        <kwd>SR, sarcoplasmic reticulum</kwd>
        <kwd>Trx1, thioredoxin1</kwd>
        <kwd>TNFα, tumor necrosis factor-α</kwd>
        <kwd>VEGF, vascular endothelial growth factor</kwd>
      </kwd-group>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Cardiac myocyte</kwd>
        <kwd>Reactive oxygen species</kwd>
        <kwd>Redox signaling</kwd>
        <kwd>Hypertrophy</kwd>
        <kwd>Heart failure</kwd>
        <kwd>NADPH oxidase</kwd>
        <kwd>Mitochondria</kwd>
        <kwd>Free radicals</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="s0005">
      <title>Introduction</title>
      <p>The heart as a contractile pump has the highest O<sub>2</sub> consumption among all body organs and can increase consumption eightfold or more under maximal workload conditions. Complex mechanisms have evolved to facilitate the maintenance of a balance between myocardial O<sub>2</sub> supply and O<sub>2</sub> consumption during physiological fluctuations in contractile function and workload, during growth and differentiation, and under pathological stresses such as hypoxia, ischemia, pressure, and volume overload. These mechanisms induce changes in cardiomyocyte structure and/or function through coordinated changes in gene and protein expression and/or the activities of various proteins. Redox mechanisms are centrally involved in the signaling pathways underlying many of these homeostatic mechanisms, both via the direct effects of O<sub>2</sub> levels in the cardiomyocyte and through the effects of reactive oxygen species (ROS)<sup>1</sup> (<xref rid="f0005" ref-type="fig">Fig. 1</xref>). From a clinical perspective, much attention has focused on the concept that oxidative stress may be a driver of cardiac disease progression (e.g., heart failure) but clinical interventions with antioxidants have had little or no impact on heart disease risk and progression. Among the reasons for the failure of such interventions, we may include the fact that an isolated focus on oxidative stress as detrimental is far too simplistic and neglects the wider role of ROS, redox balance (and perhaps O<sub>2</sub> itself) in integrated cellular signaling and heart metabolism. Here, we review current knowledge on the involvement of ROS as well as O<sub>2</sub> in modulating key signaling pathways and physiological and pathophysiological processes in cardiac myocytes. Although we focus on the cardiomyocyte, functional communication and cross talk among the various cardiac cell types (i.e., cardiomyocytes, fibroblasts, endothelial cells, vessels) are also critical for normal heart function and responses to stress <xref rid="bb0005 bb0010" ref-type="bibr">[1,2]</xref>.</p>
    </sec>
    <sec id="s0010">
      <title>General considerations on redox signaling in cardiomyocytes</title>
      <p>The propagation of electrons through coupled transfer partners is a key aspect of basic O<sub>2</sub>-dependent eukaryotic cell processes such as oxidative phosphorylation, protein folding in the endoplasmic reticulum, the enzymatic activities of many oxygenases, and the generation of reductive power (e.g., NADP<sup>+</sup>/NADPH; FAD/FADH<sub>2</sub>) during metabolism. In redox <italic>signaling</italic> involving O<sub>2</sub> or O<sub>2</sub>-derived reactive species (ROS), the transmission and amplification of signals generally involves posttranslational redox protein modifications. ROS in cardiomyocytes are generated by various sources among which the most important are mitochondria, NADPH oxidases of the Nox family, and nitric oxide synthases (NOSs) (<xref rid="f0005" ref-type="fig">Fig. 1</xref>). The quantity of ROS generation by these various sources may increase severalfold under different cellular contexts (e.g., disease) or upon specific stimulation (e.g., for certain NADPH oxidases). Both one-electron oxidants (e.g., the free radicals O<sub>2</sub><sup>•−</sup> and NO) and two-electron oxidants (e.g., the nonradicals H<sub>2</sub>O<sub>2</sub> and ONOO<sup>−</sup>) are generated, the effects of which are influenced not only by their sites and level of production but also by cell compartment-specific antioxidant pools and by interplay between one- and two-electron species to form more powerful oxidants such as <sup>•</sup>OH <xref rid="bb0015 bb0020" ref-type="bibr">[3,4]</xref>. The physiological and pathological roles of <sup>•</sup>NO generated in cardiac myocytes have been covered in recent reviews <xref rid="bb0025 bb0030 bb0035" ref-type="bibr">[5–7]</xref> and are not considered in detail in this article. It should be noted, however, that the inactivation of NO by O<sub>2</sub><sup>•−</sup> may lead to modulation of signaling pathways both as a consequence of ONOO<sup>−</sup> generation and because of the decrease in NO bioavailability <xref rid="bb0040" ref-type="bibr">[8]</xref>.</p>
      <p>Even low concentrations of moieties such as <sup>•</sup>OH (subnanomolar) may cause severe oxidation of macromolecules and organelles and lead to maladaptive cardiac dysfunction, whereas less oxidative ROS (such as O<sub>2</sub><sup>•−</sup>, NO, and H<sub>2</sub>O<sub>2</sub>) are commonly involved in cellular signaling that may have an impact on both adaptive and maladaptive cardiac responses <xref rid="bb0045" ref-type="bibr">[9]</xref> (<xref rid="f0005" ref-type="fig">Fig. 1</xref>). The concept that oxidative stress resulting from an imbalance between increased ROS generation and inadequate endogenous antioxidant pools contributes to heart failure is well established and this may contribute to the activation of maladaptive signaling cascades, e.g., those leading to impaired calcium (Ca) handling—a fundamental feature of most forms of advanced heart disease. Much less attention has been paid to the idea of cell compartment-specific or “localized” redox signaling, which may have quite distinct and more restricted effects. Moreover, an imbalance between ROS and antioxidants in the opposite direction, i.e., leading to so-called reductive stress, has recently also been suggested to be detrimental in certain cardiac conditions <xref rid="bb0050" ref-type="bibr">[10]</xref>. Such varying effects on cell signaling can be considered within an overall scheme in which O<sub>2</sub> and local compartment-specific generation of ROS modulate signaling pathways that can potentially drive adaptive or maladaptive stress responses. Ultimately, the balance between such pathways determines whether the heart adapts or fails in different pathological settings (e.g., cardiac overload or ischemia).</p>
      <p>Posttranslational redox modifications to myocardial proteins (such as cysteine and methionine thiol oxidation, proline and arginine hydroxylation, and tyrosine nitration) may affect the conformation, stability, and activity of diverse receptors, ion transporters (pumps/exchangers/channels), kinases, phosphatases, caspases, translocators (GTPases), transcription factors, and structural/contractile proteins. Perhaps the most susceptible redox targets of “signaling” ROS such as H<sub>2</sub>O<sub>2</sub> are protein cysteine thiols, the oxidation of which may result in reversible intra- or intermolecular disulfide formation or other thiol modifications such as nitrosylation and glutathiolation <xref rid="bb0020 bb0055" ref-type="bibr">[4,11]</xref>. The activities of proteins such as the phosphatases PTP1B and PTEN, caspase-3, and STAT3 are well known to be modulated by such thiol redox switching between reduced and oxidized states <xref rid="bb0060" ref-type="bibr">[12]</xref>. In the heart, examples of redox-modulated protein activities that may be particularly important for cardiomyocyte function include protein kinase A (PKA) <xref rid="bb0065" ref-type="bibr">[13]</xref>, protein kinase G (PKG) <xref rid="bb0070" ref-type="bibr">[14]</xref>, the ryanodine receptor (RyR) <xref rid="bb0075" ref-type="bibr">[15]</xref>, the small G protein Ras <xref rid="bb0080" ref-type="bibr">[16]</xref>, class II histone deacetylases (HDACs) <xref rid="bb0085" ref-type="bibr">[17]</xref>, and the metabolic enzyme glyceraldehyde-3-phosphate dehydrogenase <xref rid="bb0090 bb0095" ref-type="bibr">[18,19]</xref>. The balance between oxidized and reduced forms of such signaling proteins is influenced by both local ROS generation and reductants such as glutathione that can reduce a wide range of oxidized proteins. A more specific modulator of redox switching of key signaling proteins in the heart is the protein thioredoxin 1 (Trx1), which catalyzes the reduction of cysteine disulfides and nitrosothiols in selected proteins (e.g., Ras, apoptosis signal regulating kinase-1 (ASK1), and class II HDACs during cardiac hypertrophy) after specific protein–protein interactions <xref rid="bb0100 bb0105" ref-type="bibr">[20,21]</xref>. Indeed, transgenic mice overexpressing Trx1 specifically in the heart had reduced cardiac hypertrophy after overload stress compared to wild-type mice <xref rid="bb0110" ref-type="bibr">[22]</xref>. Recent proteomic analyses from tissues of mice with cardiac-specific overexpression of Trx1 revealed increased levels of proteins associated with the creatine–phosphocreatine shuttle, the mitochondrial permeability transition pore (MPTP) complex, and the contractile apparatus, suggesting that Trx1 may be involved in the coordination of a wide array of cellular functions for maintaining proper cardiac energy dynamics and facilitating contractile function <xref rid="bb0115" ref-type="bibr">[23]</xref>.</p>
      <p>Irreversible acute protein oxidation may also modulate signaling, secondary to the proteasomal degradation of the oxidized protein. The best example of this is probably the proline and arginine hydroxylation of the transcription factor hypoxia-inducible factor 1α (Hif1α; see later). More commonly, severe irreversible protein oxidation correlates with the formation of insoluble protease-resistant protein aggregates <xref rid="bb0120" ref-type="bibr">[24]</xref>. Indeed, both aged and failing hearts show increased levels of irreversibly oxidized protein amino acids, e.g., 3-nitrotyrosine <xref rid="bb0125" ref-type="bibr">[25]</xref>. The correlation between protein oxidation and aggregate formation is, however, complex. Increased reductive power was also found to promote the accumulation of protein aggregates in hearts expressing a mutant αB-crystallin, a chaperone that stabilizes cytoskeletal desmin filaments <xref rid="bb0050" ref-type="bibr">[10]</xref>. These results suggest that a fine balance between redox state and metabolism is more important than oxidative stress per se and that an imbalance in either the oxidative or the reductive direction could be detrimental.</p>
    </sec>
    <sec id="s0015">
      <title>Role of heart metabolism</title>
      <p>The heart in metazoan organisms exemplifies the major importance of oxygen metabolism for efficient high-energy processes (in particular, contractile function) on the one hand, and the use of oxygen and ROS for modulating complex intracellular signaling cascades on the other. The intracellular organelle content and distribution play a key role in the metabolism and integrated signaling network of cardiomyocytes <xref rid="bb0130 bb0135" ref-type="bibr">[26,27]</xref>. Mitochondria occupy 30% of cardiomyocyte volume and are organized in ordered rows regularly spaced between myofilaments, closely related to the sarcoplasmic reticulum (SR), and also clustered around the nucleus. Such an organization facilitates the functional interplay between mitochondrial ATP production, SR-regulated Ca homeostasis and myofilament-dependent contraction <xref rid="bb0140 bb0145 bb0150" ref-type="bibr">[28–30]</xref>. This architecture also favors efficient high energy output through the matching of local ATP generation and consumption.</p>
      <p>In contrast to organs such as brain, which depend mainly on glucose metabolism, the adult mammalian heart normally uses lipids as the major fuel, and mitochondria supply over 90% of the total ATP through β-oxidation of plasma fatty acids <xref rid="bb0155" ref-type="bibr">[31]</xref>. During hypoxia, under ischemia or settings of increased cardiac workload, there is a substantial increase in glycolytic ATP generation, which may be cardioprotective during ischemia–reperfusion by ensuring an adequate ATP supply for membrane and SR ion pumps <xref rid="bb0155 bb0160" ref-type="bibr">[31,32]</xref>. Such a metabolic shift is accompanied by changes in levels and activities of numerous proteins involved in glucose metabolism, among which a major increase in the expression and activity of glucose-6-phosphate dehydrogenase (G6PDH; the rate-limiting enzyme in the pentose phosphate pathway) contributes to the generation of NADPH. Recent studies indicate that a metabolic shift to glycolysis has important implications for redox status in the heart. NADPH is critical for the maintenance of antioxidant defense through the regeneration of reduced pools of glutathione, and G6PDH activity was shown to be of major importance for the maintenance of redox status, Ca homeostasis, and contractile function in cardiomyocytes subjected to oxidative stress <xref rid="bb0165" ref-type="bibr">[33]</xref>. Similarly, the hearts of mice lacking G6PDH have reduced glutathione (GSH) levels and demonstrate impaired contractile function after ischemia–reperfusion <xref rid="bb0170" ref-type="bibr">[34]</xref>. On the other hand, it has been suggested that increased NADPH levels may fuel NADPH oxidase-derived ROS generation in failing hearts, and this could be partially reversed by a G6PDH inhibitor, 6-aminonicotinamide <xref rid="bb0175" ref-type="bibr">[35]</xref>. In this regard, the relative importance of NADPH levels for antioxidant balance secondary to the regeneration of glutathione and thioredoxin versus possible promotion of NADPH-dependent ROS generation (e.g., via NADPH oxidases) remains to be established. The intracellular locations of the various types of NADPH-dependent processes and their integration with cell signaling pathways may also be important. Adding further complexity, an increased activity of the G6PDH–NADPH pathway has also been shown to contribute to detrimental “reductive stress” associated with increased levels of GSH in a transgenic mouse model of cardiomyopathy caused by a mutation in αB-crystallin <xref rid="bb0050" ref-type="bibr">[10]</xref>. In this case, the use of a G6PDH blocker could partially rescue such detrimental effects <xref rid="bb0050" ref-type="bibr">[10]</xref>. Therefore, it may be that an appropriate G6PDH/NADPH/GSH balance is more important than absolute levels of glutathione.</p>
    </sec>
    <sec id="s0020">
      <title>Sources of ROS in cardiomyocytes</title>
      <sec id="s0025">
        <title>Mitochondrial electron transport chain-derived ROS</title>
        <p>Mitochondria have long been recognized as one of the most important sources of cellular ROS, which can increase severalfold depending upon the context <xref rid="bb0180 bb0185" ref-type="bibr">[36,37]</xref>. ROS are thought to be generated mainly at complexes I and III of the electron transport chain (ETC) through “leakage” during respiration <xref rid="bb0180 bb0185" ref-type="bibr">[36,37]</xref>. It is important to remember that mitochondrial ROS levels are influenced not only by the ROS generation rate but also by ROS-scavenging systems. In this regard, there is close linkage and cross talk between the redox couples involved in substrate oxidation and the ETC (i.e., NADH/NAD<sup>+</sup>) and those involved in antioxidant defense through NADPH-regenerating reactions that maintain reduced pools of glutathione, glutaredoxin, and thioredoxin, i.e., NADPH/NADP<sup>+</sup> <xref rid="bb0190" ref-type="bibr">[38]</xref>. The precise relationship between electron transport chain flux, ROS generation, and the mitochondrial membrane potential and the mechanisms underlying increases in mitochondrial ROS remain controversial <xref rid="bb0190" ref-type="bibr">[38]</xref>. It has been suggested that in settings in which the mitochondrial redox potential is significantly reduced (e.g., hypoxia), low electron flow is accompanied by increased ROS generation. On the other hand, ROS levels may also be higher in settings in which the mitochondrial redox potential is highly oxidized, e.g., during increased workload in failing hearts. In this case, the increase in ROS is related more to a depletion of the antioxidant capacity as a result of decreased NADPH levels than an increase in ROS production per se <xref rid="bb0190" ref-type="bibr">[38]</xref>. Recently, it was demonstrated that the latter mechanism may be modulated by changes in ionic homeostasis in failing hearts. Kohlhaas et al. <xref rid="bb0195" ref-type="bibr">[39]</xref> found that an elevated intracellular [Na<sup>+</sup>], which leads to a reduction in mitochondrial Ca, caused a decrease in NADPH levels during increased workload and a consequent increase in ROS levels. The reduction in NADPH was attributed to a decreased activity of Ca-dependent Krebs-cycle dehydrogenases and presumably led to reduced regeneration of antioxidant pools.</p>
        <p>Mitochondrial ROS generation may have beneficial or detrimental effects. For example, ROS generation during cardiac ischemic preconditioning may be beneficial, as discussed later in this article. In contrast, increased mitochondrial ROS generation in failing hearts <xref rid="bb0200" ref-type="bibr">[40]</xref> may induce damage to mitochondrial DNA (mtDNA), e.g., after myocardial infarction (MI) <xref rid="bb0205" ref-type="bibr">[41]</xref> or in the hypertrophied heart <xref rid="bb0210" ref-type="bibr">[42]</xref>. mtDNA is thought to be more susceptible to oxidative damage than nuclear DNA because of the proximity of ROS generation and the lack of protective histone. Mitochondrial ROS generation during ischemia–reperfusion can also trigger the MPT and lead to a burst of further ROS release—a phenomenon termed mitochondrial ROS-induced ROS release <xref rid="bb0215" ref-type="bibr">[43]</xref>. This is not only capable of depolarizing individual mitochondria but also can propagate among long chains of mitochondria and perhaps cells, thus amplifying cell injury <xref rid="bb0215 bb0220" ref-type="bibr">[43,44]</xref>. Interestingly, recent studies have suggested that a transient opening of the MPTP in quiescent unstressed cells can functionally couple to ETC-dependent ROS production and lead to so-called “superoxide flashes” <xref rid="bb0225" ref-type="bibr">[45]</xref>. Although such flashes were especially evident during reoxygenation after anoxia in cardiomyocytes, the authors also suggested that basally produced superoxide flashes could potentially be involved in modulating local signaling <xref rid="bb0225" ref-type="bibr">[45]</xref>.</p>
        <p>Significant evidence for a pathological role of increased mitochondrial ROS in heart disease comes from studies in gene-modified mice in which mitochondrial antioxidant levels have been perturbed. Mice with deletion of mitochondrial thioredoxin reductase 2 are embryonically lethal because of impaired hematopoiesis and impaired cardiac function <xref rid="bb0230" ref-type="bibr">[46]</xref>, whereas mice with complete deletion of mitochondrial Mn superoxide dismutase develop severe fatal dilated cardiomyopathy <xref rid="bb0235" ref-type="bibr">[47]</xref>. In contrast, transgenic mice overexpressing mitochondrial peroxiredoxin III <xref rid="bb0240" ref-type="bibr">[48]</xref> or glutathione peroxidase <xref rid="bb0245" ref-type="bibr">[49]</xref> demonstrate a significant attenuation of adverse left ventricular remodeling post-MI. Similarly, mice with a mitochondrial-targeted overexpression of catalase demonstrate a prolonged life span with improved cardiac function <xref rid="bb0250" ref-type="bibr">[50]</xref> and an attenuation of cardiac aging <xref rid="bb0255" ref-type="bibr">[51]</xref>.</p>
      </sec>
      <sec id="s0030">
        <title>NADPH oxidase-derived ROS</title>
        <p>The Nox family NADPH oxidases generate ROS (O<sub>2</sub><sup>•−</sup> and H<sub>2</sub>O<sub>2</sub>) through electron transfer from NADPH to molecular O<sub>2</sub>. Each of the seven oxidase family members is based on a distinct catalytic subunit (i.e., Nox1–5 and Duox1 and 2) and has differing requirements for additional protein subunits <xref rid="bb0260 bb0265 bb0270 bb0275 bb0280 bb0285" ref-type="bibr">[52–57]</xref>. The prototypic member of the Nox family, Nox2 oxidase (aka gp91<sup>phox</sup> oxidase) is best known for its role in neutrophil phagocytosis and the fact that genetic defects in the enzyme result in chronic granulomatous disease, a condition in which affected children suffer from recurrent severe fungal and bacterial infections due to defective phagocyte function <xref rid="bb0260 bb0265" ref-type="bibr">[52,53]</xref>. However, Nox2 is also expressed in many other cell types and Nox family oxidases as a whole are very widely expressed in a tissue-specific manner. Detailed reviews on the structure, function, and roles of these fascinating enzymes have been published recently <xref rid="bb0260 bb0265 bb0270 bb0275" ref-type="bibr">[52–55]</xref>. Apart from the roles of some of the Nox's (e.g., phagocyte Nox2 and epithelial Duox's) in host defense, a large number of studies have demonstrated that these enzymes generate ROS that are involved in redox signaling <xref rid="bb0045 bb0275 bb0280 bb0285" ref-type="bibr">[9,55–57]</xref>. In many cases, Nox-dependent redox signaling involves the regulated and spatially restricted production of low levels of ROS in the vicinity of target proteins, and such effects have been implicated in signaling pathways that regulate processes such as cell differentiation, proliferation, survival, senescence, and migration <xref rid="bb0045 bb0275 bb0280 bb0285" ref-type="bibr">[9,55–57]</xref>.</p>
        <p>The two Nox isoforms for which there are good data on expression and functional effects in cardiac myocytes are Nox2 <xref rid="bb0290 bb0295 bb0300 bb0305" ref-type="bibr">[58–61]</xref> and Nox4 <xref rid="bb0310 bb0315 bb0320 bb0325" ref-type="bibr">[62–65]</xref> (<xref rid="f0010" ref-type="fig">Fig. 2</xref>). Each of these isoforms exists as a heterodimer with a lower molecular weight p22<sup>phox</sup> subunit and is predicted to be membrane-bound but there are several major differences between the isoforms. Nox2 is normally quiescent and is acutely activated by stimuli such as G-protein-coupled receptor (GPCR) agonists (e.g., angiotensin II, endothelin-1), growth factors, and cytokines in a tightly regulated process in which cytosolic subunits (p47<sup>phox</sup>, p67<sup>phox</sup>, p40<sup>phox</sup>, and Rac1) associate with the Nox2–p22<sup>phox</sup> heterodimer to initiate enzyme activity <xref rid="bb0260 bb0265 bb0270" ref-type="bibr">[52–54]</xref>. In contrast, Nox4 does not have a requirement for additional regulatory subunits, has constitutive low-level activity, and seems to be regulated largely by changes in abundance <xref rid="bb0260 bb0265 bb0270 bb0275" ref-type="bibr">[52–55]</xref>. Therefore, Nox4 may be regarded as an inducible isoform. Additionally, recent independent studies from several groups suggest that, in contrast to Nox2, Nox4 may generate predominantly H<sub>2</sub>O<sub>2</sub> rather than O<sub>2</sub><sup>•−</sup> <xref rid="bb0325 bb0330 bb0335 bb0340 bb0345" ref-type="bibr">[65–69]</xref>, although it should be noted that some papers have reported O<sub>2</sub><sup>•−</sup> generation <xref rid="bb0350" ref-type="bibr">[70]</xref>, possibly related to experimental conditions and methodological issues. Finally, it is clear that the intracellular locations of the two isoforms in cardiomyocytes are distinct. There is a broad consensus that activated Nox2 is found predominantly on the plasma membrane, whereas Nox4 is found intracellularly <xref rid="bb0045 bb0275 bb0280 bb0285 bb0300 bb0330 bb0335 bb0340" ref-type="bibr">[9,55–57,60,66–68]</xref>. Several groups, including our own, have found Nox4 to be in an endoplasmic reticulum (ER)-related perinuclear location <xref rid="bb0325" ref-type="bibr">[65]</xref> but others reported that it may also be present in the mitochondria <xref rid="bb0320" ref-type="bibr">[64]</xref>.</p>
        <p>Nox2 may be activated by several different cardiac stresses and an increasing body of data suggests important pathophysiological roles for this isoform in cardiac disease <xref rid="bb0045" ref-type="bibr">[9]</xref>. Previous work from our laboratory and others has shown that Nox2 contributes to the development of angiotensin II-induced left ventricular hypertrophy; to contractile dysfunction, interstitial fibrosis, and apoptosis in the pressure-overloaded or remodeling heart; and to ischemic preconditioning <xref rid="bb0045 bb0295 bb0310 bb0355" ref-type="bibr">[9,59,62,71]</xref>. Although the detailed mechanisms responsible for these effects still remain to be defined, it is clear that Nox-derived ROS modulate several signaling pathways in cardiomyocytes, as are discussed further later (<xref rid="f0010" ref-type="fig">Fig. 2</xref>). Much less has been known about the role of Nox4 in the heart until recently, apart from it being suggested to be involved in cardiomyogenesis <xref rid="bb0315 bb0360" ref-type="bibr">[63,72]</xref>. An emerging literature from studies in other tissues suggests that Nox4 expression increases during stresses such as hypoxia <xref rid="bb0365" ref-type="bibr">[73]</xref>, ER stress <xref rid="bb0370 bb0375" ref-type="bibr">[74,75]</xref>, and mitochondrial dysfunction <xref rid="bb0380 bb0385" ref-type="bibr">[76,77]</xref>, and we have recently found that myocardial Nox4 expression also increases during hypoxia, myocardial ischemia, or in vivo pressure overload <xref rid="bb0310 bb0325 bb0355" ref-type="bibr">[62,65,71]</xref>. Furthermore, our studies demonstrate an unanticipated protective role of this isoform during the cardiac response to chronic pressure overload <xref rid="bb0325" ref-type="bibr">[65]</xref>, as discussed further later (<xref rid="f0010" ref-type="fig">Fig. 2</xref>).</p>
      </sec>
      <sec id="s0035">
        <title>Uncoupled NO synthases</title>
        <p>Cardiomyocytes constitutively express both neuronal and endothelial NOS isoforms (nNOS and eNOS, respectively), whereas inducible NOS (iNOS) may be expressed in various pathological situations. NO generated by nNOS and eNOS has important physiological effects on myocardial contractile function <xref rid="bb0025 bb0030" ref-type="bibr">[5,6]</xref>. Although we do not discuss NO-mediated signaling in detail in this review, it should be noted that NO-dependent nitrosylation of cysteine residues in proteins may modulate signal transduction cascades in a manner analogous to the effects of cysteine oxidation <xref rid="bb0390" ref-type="bibr">[78]</xref>. NOSs, however, can also become “uncoupled” and generate O<sub>2</sub><sup>•−</sup> in settings in which there is a deficiency of the essential NOS cofactor tetrahydrobiopterin (BH<sub>4</sub>) <xref rid="bb0395" ref-type="bibr">[79]</xref>. Because BH<sub>4</sub> is degraded by ROS, including those derived from Nox's <xref rid="bb0400" ref-type="bibr">[80]</xref>, ROS production by uncoupled NOSs can act as an amplifying mechanism for both the deleterious and the signaling effects of ROS. The concomitant production of NO and O<sub>2</sub><sup>•−</sup> is generally associated with nitroxidative stress and protein nitration via ONOO<sup>−</sup> or heme peroxidase-dependent nitration <xref rid="bb0015 bb0125" ref-type="bibr">[3,25]</xref>. 3-Nitrotyrosine provides a useful marker for NO-associated stress in various diseases <xref rid="bb0405" ref-type="bibr">[81]</xref> and increased levels are found in failing hearts, notably in proteins such as myofibrillar creatine kinase, α-actinin, and sarcoplasmic reticulum Ca<sup>2+</sup> ATPase <xref rid="bb0125" ref-type="bibr">[25]</xref>.</p>
      </sec>
      <sec id="s0040">
        <title>Other sources of ROS</title>
        <p>Xanthine oxidoreductase exists in two forms, xanthine dehydrogenase and xanthine oxidase (XO), which are interconvertible <xref rid="bb0410" ref-type="bibr">[82]</xref>. Only XO generates ROS, producing more O<sub>2</sub><sup>•−</sup> or H<sub>2</sub>O<sub>2</sub> depending on the environmental conditions, e.g., substantially more H<sub>2</sub>O<sub>2</sub> than O<sub>2</sub><sup>•−</sup> during hypoxia <xref rid="bb0415" ref-type="bibr">[83]</xref>. Upregulation of XO is reported in experimental models of heart failure and in human end-stage failing myocardium and its inhibition is reported to enhance mechanical efficiency and improve cardiac remodeling <xref rid="bb0420 bb0425" ref-type="bibr">[84,85]</xref>. Interestingly, the activity of XO is also reported to be linked to that of nNOS such that XO-derived ROS production is enhanced when nNOS is deficient <xref rid="bb0425 bb0430" ref-type="bibr">[85,86]</xref>.</p>
        <p>Apart from the ETC, there may be other sources of ROS in mitochondria, for example, enzyme systems such as 2-oxoglutarate, pyruvate dehydrogenase, and flavoprotein acyl-CoA dehydrogenase <xref rid="bb0180 bb0435" ref-type="bibr">[36,87]</xref>. Recently, mitochondrial monoamine oxidase-A (MAO-A) enzymes were reported to be important ROS sources through the catabolism of prohypertrophic neurotransmitters such as norepinephrine and serotonin, resulting in the generation of H<sub>2</sub>O<sub>2</sub>. In mice with pressure overload-induced heart failure, either an MAO-A inhibitor, clorgyline, or a dominant-negative MAO-A reduced oxidative stress, inhibited contractile dysfunction, and inhibited matrix metalloproteinase and caspase-3 activation <xref rid="bb0440" ref-type="bibr">[88]</xref>.</p>
      </sec>
    </sec>
    <sec id="s0045">
      <title>Cardiomyocyte differentiation and proliferation</title>
      <p>Adult cardiomyocytes are terminally differentiated cells with absent or extremely limited proliferative capacity and therefore differentiation and proliferation are processes that are pertinent mainly to the developing heart. The molecular mechanisms that underlie early cardiomyocyte differentiation have largely been studied in vitro, often in cultured embryonic stem (ES) cell systems. ES cells can be induced to differentiate in vitro into embryoid bodies (EBs) comprising many different cell types, including cardiomyocytes, which can be seen to “beat” in culture. An increase in the proportion of beating cardiomyocytes in such cultures is commonly taken as a measure of increased cardiotypic differentiation but it should be noted that an increase in proliferative capacity of a cardiac progenitor resulting in increased numbers of cardiomyocytes would have a similar effect.</p>
      <p>The overall cellular and compartment-specific redox balance is a critical regulator of differentiation and proliferation in many cell types <xref rid="bb0445 bb0450" ref-type="bibr">[89,90]</xref>, including cardiomyocytes <xref rid="bb0455 bb0460 bb0465" ref-type="bibr">[91–93]</xref>. Both mechanical strain and electrical stimulation, which increase the levels of intracellular ROS, also increase the proportion of beating cardiomyocytes within an EB population <xref rid="bb0360 bb0470 bb0475" ref-type="bibr">[72,94,95]</xref>. By contrast, agents that scavenge or reduce ROS levels (e.g., Trolox, pyrrolidine dithiocarbamate, catalase, and <italic>N</italic>-acetylcysteine) impair cardiomyocyte formation in EBs <xref rid="bb0315 bb0470" ref-type="bibr">[63,94]</xref>. Intriguingly, however, the incubation of ES cells with H<sub>2</sub>O<sub>2</sub> either enhances or impairs the cardiomyogenic program, dependent upon the concentration and timing during differentiation—suggesting both a dose-dependency and a cellular competency in the response to ROS <xref rid="bb0315 bb0460 bb0480" ref-type="bibr">[63,92,96]</xref>.</p>
      <p>It has been suggested that an important source of the ROS involved in cardiomyogenesis is Nox4 NADPH oxidase, which is abundantly expressed in ES cells. Li et al. <xref rid="bb0315" ref-type="bibr">[63]</xref> showed that small interfering RNA (siRNA)-mediated downregulation of Nox4 reduced the potential of ES cells to express cardiac-specific markers and form beating EBs, an effect that was reversed by a pulse of low-dose exogenous H<sub>2</sub>O<sub>2</sub>. The activation of phosphatidylinositol 3-kinase seems to be required upstream of ROS generation <xref rid="bb0455 bb0485" ref-type="bibr">[91,97]</xref> and the activation of PPARα has also been implicated <xref rid="bb0490" ref-type="bibr">[98]</xref>. Nox2 is also expressed in ES cells but the overexpression of a dominant-negative Rac mutant that inhibits Nox2 activation did not alter the ability to form beating EBs <xref rid="bb0480" ref-type="bibr">[96]</xref>, suggesting that Nox2- and Nox4-derived ROS are functionally distinct during early cardiomyogenesis. In <italic>Xenopus laevis</italic> embryos, the mitochondrial respiratory chain was found to play an essential role in heart formation through Ca-dependent activation of the transcription factor NFAT <xref rid="bb0495" ref-type="bibr">[99]</xref>. In that study, embryos in which either of two subunits of the respiratory chain, GRIM-19 or NDUFS3, was knocked down showed severe defects in heart formation that could be rescued by a constitutively active form of mouse NFATc4. Although the signaling pathway between mitochondria and NFAT was not established in detail, other studies have shown that mitochondrial respiration and aerobic energy production are dispensable during very early cardiomyocyte differentiation <xref rid="bb0500" ref-type="bibr">[100]</xref>, suggesting that other mitochondrial respiratory chain-dependent mechanisms such as ROS production may be involved.</p>
      <p>The molecular mechanisms involved in redox regulation of cardiomyocyte differentiation remain poorly understood and deserve further study. In cardiotrophin-1-treated EBs, a ROS-dependent activation of Jak-2, STAT3, and ERK1/2 and the nuclear translocation of NF-κB were reported <xref rid="bb0485" ref-type="bibr">[97]</xref>. Also, siRNA-mediated downregulation of Nox4 inhibited the activation of p38MAPK in ES cells during cardiotypic differentiation <xref rid="bb0315" ref-type="bibr">[63]</xref>. Moreover, the specific inhibition of p38MAPK signaling resulted in reduced cardiomyogenesis and abnormal myofibrillogenesis of cardiac-committed cells together with an impaired nuclear translocation of the cardiac-restricted transcription factor MEF2C. In addition to changes in ROS production, alterations in antioxidant balance may also be involved in regulating cardiomyocyte differentiation and proliferation. For example, in adult cardiac stem cells, the redox effector protein-1 seems to regulate ROS-dependent increases in cardiac differentiation markers <xref rid="bb0465" ref-type="bibr">[93]</xref>.</p>
    </sec>
    <sec id="s0050">
      <title>Excitation–contraction coupling</title>
      <p>The process of excitation–contraction coupling (ECC) is essential for cardiomyocyte contractile activity and becomes dysregulated in cardiac conditions such as heart failure <xref rid="bb0505" ref-type="bibr">[101]</xref>. During ECC, depolarization of the sarcolemmal membrane results in the opening of voltage-gated L-type Ca channels and subsequent Ca-induced Ca release from the SR through the opening of RyR Ca-release channels (<xref rid="f0015" ref-type="fig">Fig. 3</xref>). The binding of Ca to troponin C initiates actomyosin cross-bridge cycling and contraction. During relaxation, Ca is actively taken back into the SR via the SR Ca ATPase (SERCA). In addition, other sarcolemmal ion pumps and exchangers (e.g., the Na/Ca exchanger) and ion fluxes between the cytoplasm and the mitochondria also contribute to Ca homeostasis. The control of SR Ca release and uptake is regulated by a specialized molecular machinery comprising the RyR and SERCA as well as several accessory proteins, including phospholamban, FKBP12.6, calsequestrin, triadin, and junctin. Appropriate regulation of Ca cycling is essential for normal contractile function and is a major site of potential pathologic failure, contributing not only to contractile dysfunction but also to arrhythmia, energetic dysfunction, and mitochondrial ROS production <xref rid="bb0505 bb0510 bb0515 bb0520" ref-type="bibr">[101–104]</xref>. Redox signaling involving the oxidative modification of target proteins can affect several components of the cardiomyocyte ECC machinery <xref rid="bb0525 bb0530 bb0535" ref-type="bibr">[105–107]</xref> (<xref rid="f0015" ref-type="fig">Fig. 3</xref>).</p>
      <sec id="s0055">
        <title>Redox modulation of RyR</title>
        <p>The cardiac RyR (RyR2) has around 90 cysteine residues per subunit of which approximately 20 are in a reduced state and potential targets for various redox modifications, including S-nitrosylation, S-glutathionylation, and disulfide crosslinking <xref rid="bb0075" ref-type="bibr">[15]</xref>. Many in vitro studies and experiments in synthetic lipid bilayers have convincingly demonstrated that moieties such as NO, H<sub>2</sub>O<sub>2</sub>, nitroxyl (HNO), and hydroxyl radicals induce redox-dependent alterations in RyR activity <xref rid="bb0530 bb0535 bb0540 bb0545" ref-type="bibr">[106–109]</xref>. The functional consequences of such modification are likely to depend upon the nature, concentration, and exposure time of the oxidizing agent; the type of chemical modification; and the specific cysteine residues that are affected. In skeletal muscle RyR (RyR1), it has been shown that although some cysteines are nonspecific targets for various redox agents, others are exclusively S-nitrosylated (Cys1040, Cys1303) or S-glutathionylated (Cys1591, Cys3193) <xref rid="bb0550" ref-type="bibr">[110]</xref>. In general, the RyR2 open probability and therefore SR Ca release is increased by oxidizing conditions, whereas reducing reagents such as dithiothreitol reverse these effects <xref rid="bb0530 bb0550 bb0555" ref-type="bibr">[106,110,111]</xref>. However, prolonged exposure to high doses of oxidizing agents may cause irreversible and detrimental RyR activation <xref rid="bb0555 bb0560" ref-type="bibr">[111,112]</xref>.</p>
        <p>Although redox modification of RyR activity is well established, its physiological relevance and role in relation to endogenously generated oxidants remains incompletely understood. Significant evidence suggests that RyR2 may be modulated by NO derived from both eNOS (under conditions of myocardial stretch) and nNOS <xref rid="bb0530 bb0565" ref-type="bibr">[106,113]</xref>. Indeed, nNOS coimmunoprecipitates with RyR2 in the heart <xref rid="bb0570" ref-type="bibr">[114]</xref> and eNOS, which is normally found in sarcolemmal caveolae, can translocate to the SR in failing hearts <xref rid="bb0575 bb0580" ref-type="bibr">[115,116]</xref>. The effects of NO may depend upon the level of PKA activation <xref rid="bb0565" ref-type="bibr">[113]</xref>. It has not yet been definitively established, however, whether these effects of NO involve redox modification of RyR2. Additional redox-sensitive modulation may arise from the inactivation of NO by endogenously generated O<sub>2</sub><sup>•−</sup>. For example, nNOS is reported to colocalize with xanthine oxidase in the heart so that interaction between xanthine oxidase-derived ROS and nNOS-derived NO may be relevant <xref rid="bb0430 bb0585" ref-type="bibr">[86,117]</xref>. In addition, cardiac SR is reported to have NADH oxidase activity, which influences SR Ca release, although the nature of the oxidase was not established in that study <xref rid="bb0590" ref-type="bibr">[118]</xref>. Hidalgo and colleagues reported the presence of a Nox2 oxidase (which utilizes NADPH rather than NADH) in cardiac and skeletal muscle SR and found a stimulation of RyR Ca release via S-glutathionylation <xref rid="bb0595 bb0600" ref-type="bibr">[119,120]</xref>, in the former case in response to tachycardia. The functional effect of a transient increase in RyR open probability in the physiological setting has been suggested to be an augmentation of contractile force by increasing Ca transient amplitude, but it is also argued that isolated transient RyR2 activation will have no sustained effect on the Ca transient or contraction, at least in isolated cells <xref rid="bb0605" ref-type="bibr">[121]</xref>. Recently, the positive inotropic effects of nitroxyl donors (or HNO, the one-electron reduction product of NO) in the form of Angeli's salt were reported to involve redox-dependent enhancement of both RyR Ca release and SR Ca uptake <xref rid="bb0610" ref-type="bibr">[122]</xref>—exemplifying the concept that effects additional to RyR Ca release may be required to induce changes in contractile function.</p>
        <p>Growing evidence suggests that redox modification of RyR2 may contribute to abnormal Ca handling in disease states. RyR2 dysfunction with an increase in diastolic Ca leak from the SR may reduce SR Ca content and the Ca transient and thereby contribute to a reduced contractile force in the failing heart as well as an increased likelihood of arrhythmia <xref rid="bb0615 bb0620" ref-type="bibr">[123,124]</xref>. Proposed mechanisms underlying such abnormal RyR2 behavior include a hyperphosphorylation of RyR2 by PKA <xref rid="bb0615" ref-type="bibr">[123]</xref> or calmodulin kinase II (CamKII) <xref rid="bb0625" ref-type="bibr">[125]</xref>, or redox modification of RyR2 <xref rid="bb0630 bb0635" ref-type="bibr">[126,127]</xref>. Interestingly, myocardial CamKII activation has been found to be enhanced by ROS independent of Ca (discussed further under myocyte apoptosis) <xref rid="bb0640" ref-type="bibr">[128]</xref>, raising the possibility that multiple redox mechanisms could contribute to RyR2 dysfunction. Recently, it was also suggested that diastolic Ca leak and impaired contraction in cardiomyocytes from rats with spontaneous hypertensive heart failure was attributable not only to increased RyR2 oxidation by xanthine oxidase-derived O<sub>2</sub><sup>•−</sup> but also to a reduced RyR2 nitrosylation due to less bioavailable NO <xref rid="bb0645" ref-type="bibr">[129]</xref>. Several studies in experimental models of heart failure have provided support for a redox-dependent mechanism for RyR2 dysregulation, including canine tachypacing models <xref rid="bb0650 bb0655" ref-type="bibr">[130,131]</xref>, sudden cardiac death models <xref rid="bb0660" ref-type="bibr">[132]</xref>, and a model of muscular dystrophy <xref rid="bb0665" ref-type="bibr">[133]</xref>.</p>
      </sec>
      <sec id="s0060">
        <title>Redox modulation of SERCA</title>
        <p>It has been known for many years that SERCA may be posttranslationally modified by cysteine oxidation or tyrosine nitration, and several of the specific residues that can be oxidatively modified have been mapped by mass spectrometry studies in noncardiomyocyte systems <xref rid="bb0670 bb0675 bb0680 bb0685" ref-type="bibr">[134–137]</xref>. These include nitration of Tyr294 and Tyr295 <xref rid="bb0680" ref-type="bibr">[136]</xref>, S-glutathiolation of Cys669 and Cys674 <xref rid="bb0675" ref-type="bibr">[135]</xref>, and the oxidation of several other cysteine residues <xref rid="bb0685" ref-type="bibr">[137]</xref>. It is suggested that low levels of ROS may reversibly increase SERCA activity, whereas higher levels may cause inactivation as a result of irreversible oxidative modifications <xref rid="bb0670 bb0685" ref-type="bibr">[134,137]</xref>. In skeletal muscle, the age-dependent decrease in SERCA activity was suggested to be related to such oxidation of cysteine residues <xref rid="bb0685" ref-type="bibr">[137]</xref>. In vascular smooth muscle, SERCA2b (the dominant isoform in this tissue) has been shown to be redox-activated via a peroxynitrite-mediated reversible S-glutathiolation at Cys674, resulting in a reduced intracellular Ca level and vasorelaxation <xref rid="bb0675" ref-type="bibr">[135]</xref>. This mechanism was suggested to play an important role in NO-dependent cyclic GMP-independent vasorelaxation. Furthermore, the irreversible oxidation of this residue rendered SERCA unresponsive to NO-dependent regulation. In platelets, there is evidence for the modification of SERCA activity by H<sub>2</sub>O<sub>2</sub> <xref rid="bb0690" ref-type="bibr">[138]</xref>.</p>
        <p>Although the above studies strongly support redox regulation of SERCA as a biologically important mechanism, information on the redox regulation of the major SERCA isoform expressed in cardiac myocytes—i.e., SERCA2a—and the functional consequences of such modification is still quite limited. Tocchetti et al. <xref rid="bb0610" ref-type="bibr">[122]</xref> reported that the positive inotropic effects of HNO involved an increase in SR Ca uptake, and Lancel et al. <xref rid="bb0695" ref-type="bibr">[139]</xref> subsequently demonstrated that the mechanism of this effect is an HNO-mediated reversible S-glutathiolation of Cys674. The same authors have recently reported that contractile dysfunction in transgenic mice overexpressing G<sub>αq</sub> subunits (an established model of heart failure that involves increased GPCR signaling) is attributable, at least in part, to a ROS-dependent increase in SERCA2a oxidation <xref rid="bb0700" ref-type="bibr">[140]</xref>. Irreversible oxidative modifications comprising sulfonylation at Cys674 and nitration at Tyr294/295 together with a reduction in maximal SERCA activity were identified, which contributed to marked abnormalities of myocyte Ca transients and contractile function. Crossbreeding the G<sub>αq</sub> transgenic mice with animals that had a cardiomyocyte-specific overexpression of catalase reduced both Cys674 sulfonylation and Tyr294/295 nitration, restored SERCA activity, and improved myocyte Ca transients and contraction—suggesting that H<sub>2</sub>O<sub>2</sub> was involved in these effects. The reduced cardiomyocyte Ca transients in the setting of H<sub>2</sub>O<sub>2</sub>-induced oxidative stress may involve a decrease in SERCA activity as well as an increase in Na/Ca exchanger activity, which together lead to a reduced SR Ca content <xref rid="bb0700" ref-type="bibr">[140]</xref>. Oxidation of cardiomyocyte SERCA2a associated with a reduction in Ca uptake was also reported in a rodent model of obesity associated with contractile dysfunction <xref rid="bb0705" ref-type="bibr">[141]</xref>. In that study, the authors found similar effects when cardiomyocytes were treated with angiotensin II and proposed that activation of Nox2 may be involved. In the setting of myocardial ischemia–reperfusion, it has been suggested that activation of the polyol pathway (comprising aldose reductase and sorbitol dehydrogenase) contributes to irreversible SERCA2a and RyR oxidation as a result of increased peroxynitrite formation <xref rid="bb0710" ref-type="bibr">[142]</xref>. The treatment of isolated rat hearts subjected to ischemia–reperfusion with polyol pathway inhibitors reduced SERCA Cys674–SO<sub>3</sub>H (sulfonic) formation and ameliorated postischemic contractile dysfunction. A similar mechanism of contractile dysfunction was also suggested in the setting of hyperglycemia <xref rid="bb0715" ref-type="bibr">[143]</xref>.</p>
      </sec>
      <sec id="s0065">
        <title>Redox modulation of myofilament proteins</title>
        <p>Direct inhibitory effects of ROS on myofilament function have been recognized for many years although the precise mechanisms that are involved remain unclear <xref rid="bb0720 bb0725" ref-type="bibr">[144,145]</xref>. Potential sources of such ROS include xanthine oxidase <xref rid="bb0730 bb0735" ref-type="bibr">[146,147]</xref>. Recently, the passive stiffness of cardiac muscle, which depends to a significant extent on the giant elastic protein titin, was shown to be redox-modulated through disulfide bridge formation in the cardiac-specific N2-B-unique extensible segment <xref rid="bb0740" ref-type="bibr">[148]</xref>. Elevated oxidation increased titin-based stiffness in isolated human heart myofibrils, an effect that could be reversed by thioredoxin.</p>
        <p>In addition to direct mechanisms, ROS may indirectly modulate myofilament function through effects on key protein kinases that induce posttranslational phosphorylation of various myofilament proteins such as troponin I and myosin-binding protein C. Type 1 PKA is centrally involved in the positive inotropic actions of β-adrenergic stimulation through effects on the L-type Ca channel, SERCA2a, troponin I, and myosin-binding protein C. Brennan et al. <xref rid="bb0065" ref-type="bibr">[13]</xref> found that ROS-induced formation of an interprotein disulfide bond between its two regulatory RI subunits leads to a subcellular translocation and activation of the kinase. The activated PKA localizes to myofilaments through interaction with the α-myosin heavy chain (which serves as a PKA anchor protein) and phosphorylates troponin I and myosin-binding protein C, leading to an increase in contractile shortening that is independent of β-adrenergic stimulation and cAMP elevation. PKG also modulates contractile function through the phosphorylation of troponin I <xref rid="bb0745" ref-type="bibr">[149]</xref> and it has been found that oxidants activate PKG1α through the formation of an interprotein disulfide linking its two subunits <xref rid="bb0070" ref-type="bibr">[14]</xref>. The latter mechanism was found to contribute to NO-independent vasorelaxation <xref rid="bb0070" ref-type="bibr">[14]</xref> but whether redox activation of PKG1α has physiological effects in cardiac myocytes remains to be established. Redox-dependent protein kinase C (PKC) activation was reported to increase the phosphorylation of troponin I and myosin-binding protein C in cardiac myocytes and thereby to increase the Ca sensitivity of force production <xref rid="bb0750" ref-type="bibr">[150]</xref>.</p>
      </sec>
      <sec id="s0070">
        <title>Other ECC targets</title>
        <p>Redox modifications may also affect L-type Ca channels, the plasmalemmal Ca ATPase, the Na/Ca exchanger, and other ion channels <xref rid="bb0530 bb0755" ref-type="bibr">[106,151]</xref>. The pore-forming α<sub>1C</sub> subunit of the L-type Ca channel contains &gt; 10 cysteine residues, and a modulation of channel activity by thiol oxidizing agents is reported <xref rid="bb0755" ref-type="bibr">[151]</xref>. In isolated cardiomyocytes, endothelin-1 reportedly increases the open probability of L-type Ca channels through a mechanism that involves Nox2 oxidase activation <xref rid="bb0760" ref-type="bibr">[152]</xref>. 20-Hydroxyeicosatetraenoic acid, an eicosanoid that is increased during ischemia–reperfusion, also activated L-type Ca current via a Nox2/PKC-dependent mechanism <xref rid="bb0765" ref-type="bibr">[153]</xref>. The Na/Ca exchanger comprises nine transmembrane domains and intramolecular disulfide bonds between cysteine residues in different domains are thought be functionally important <xref rid="bb0770" ref-type="bibr">[154]</xref>. Na/Ca exchanger activity is reported to be significantly increased by ROS <xref rid="bb0775 bb0780 bb0785" ref-type="bibr">[155–157]</xref> but the source of these ROS remains unclear. Angiotensin II-induced NADPH oxidase activation is reported to reduce membrane K<sup>+</sup> currents in streptozotocin-induced diabetes in rats <xref rid="bb0790" ref-type="bibr">[158]</xref> and swelling-activated Cl<sup>−</sup> current in rabbit ventricular myocytes <xref rid="bb0795" ref-type="bibr">[159]</xref>. Nox2-derived ROS may also modulate the expression of ion channels, for example, an increase in the L-type Ca channel α<sub>1C</sub> subunits <xref rid="bb0800" ref-type="bibr">[160]</xref>, a decrease in Scn5a Na<sup>+</sup> channel mRNA abundance <xref rid="bb0805" ref-type="bibr">[161]</xref>, and the destabilization of cardiac Kv4.3 channel mRNA <xref rid="bb0810" ref-type="bibr">[162]</xref>.</p>
      </sec>
    </sec>
    <sec id="s0075">
      <title>Myocardial hypoxia and ischemia–reperfusion</title>
      <p>A reduction in oxygen supply (hypoxia) critically affects heart function and is a major driver of pathophysiology in various acute and chronic disease settings, e.g., ischemic heart disease, MI, ischemia–reperfusion, and pressure overload hypertrophy. Prolonged hypoxia or ischemia beyond a critical threshold results in cell death by necrosis and/or apoptosis due to the lack of O<sub>2</sub>, disruption of Ca and pH homeostasis, mitochondrial injury, increased ROS generation, and oxidative DNA damage. Reperfusion (or reoxygenation) is essential for cardiomyocyte survival but is itself associated with significant cell damage that is mediated at least in part via ROS-dependent mechanisms <xref rid="bb0815" ref-type="bibr">[163]</xref>. As discussed earlier, mitochondrial ROS generation and the opening of the MPTP are thought to be causally involved in acute reperfusion-associated damage <xref rid="bb0820" ref-type="bibr">[164]</xref>.</p>
      <sec id="s0080">
        <title>Adaptation to hypoxia</title>
        <p>Cardiac myocytes are generally relatively resistant to moderate hypoxia <xref rid="bb0825" ref-type="bibr">[165]</xref>. This is largely related to hypoxia-induced activation of a broad range of adaptive pathways, a process in which the redox-sensitive transcription factor Hif plays a central role <xref rid="bb0830 bb0835 bb0840 bb0845" ref-type="bibr">[166–169]</xref>. Hif1-dependent transcription requires the dimerization of Hif1α (or Hif2α) with Hif1β (also called aryl hydrocarbon receptor nuclear translocator) and the recruitment of coactivators such as CBP/p300. The primary regulator of Hif1 transcriptional activity is the level of Hif1 or 2α, which is very low under normoxic conditions but becomes elevated during hypoxia or in response to certain other stimuli—notably those that generate ROS. In the presence of oxygen, prolyl hydroxylase dioxygenase family enzymes (PHD1–3) hydroxylate Hif-α at conserved proline residues (i.e., Pro402 and Pro564) in a process that requires nonheme Fe(II), ascorbate, and 2-oxoglutarate <xref rid="bb0840 bb0850" ref-type="bibr">[168,170]</xref>. Hydroxylated Hif-α binds to the von Hippel-Lindau (vHL)–E3 ligase and is targeted for rapid proteasomal degradation. PHD activity is substantially inhibited during hypoxia, leading to increased Hif-α levels and an increase in the transcription of a multitude of Hif-regulated genes—including genes involved in regulating O<sub>2</sub> delivery and consumption, glycolysis, glucose metabolism, mitochondrial function, cell survival, antioxidant defense, angiogenesis, and many others. During sustained chronic hypoxia, PHD levels themselves are also upregulated and act as a brake on sustained Hif activation, which is thought to be detrimental <xref rid="bb0855" ref-type="bibr">[171]</xref>.</p>
        <p>In addition to the direct effects of a reduction in O<sub>2</sub> levels, an increase in ROS also results in Hif activation through other mechanisms that increase Hif1α levels. The transcription of both Hif1α and Hif2α is redox-sensitive <xref rid="bb0830 bb0835" ref-type="bibr">[166,167]</xref>, whereas Hif1α translation may also be subject to redox regulation via changes in the activity of mTOR <xref rid="bb0860" ref-type="bibr">[172]</xref>. In addition, PHD activity is inhibited by ROS, potentially through oxidation of the nonheme iron and/or reduction in ascorbate levels <xref rid="bb0865" ref-type="bibr">[173]</xref>. It is worth noting that NO also has similar effects on Hif1α <xref rid="bb0870" ref-type="bibr">[174]</xref>. During hypoxia, both mitochondrial ROS <xref rid="bb0875 bb0880" ref-type="bibr">[175,176]</xref> and those derived from NADPH oxidases—in particular, Nox4 <xref rid="bb0325 bb0885" ref-type="bibr">[65,177]</xref>—may contribute to Hif activation. Nox4 levels increase in response to hypoxia in fibroblasts <xref rid="bb0365" ref-type="bibr">[73]</xref> and cardiomyocytes <xref rid="bb0325" ref-type="bibr">[65]</xref>, and we have recently reported that a major mechanism underlying cardiomyocyte Hif activation during hypoxia is a Nox4-dependent increase in Hif1α levels secondary to reduced Hif1α hydroxylation at both Pro402 and Pro564 residues <xref rid="bb0325" ref-type="bibr">[65]</xref>.</p>
        <p>The activation of Hif-regulated genes is likely to contribute to protection during and/or after ischemia through several mechanisms such as an increase in glycolytic capacity, enhanced antioxidant defense, activation of cell survival pathways, and an increase in angiogenesis. Indeed, increased levels of Hif1α and Hif-regulated genes such as heme oxygenase-1 (HO-1), iNOS, and VEGF are found in the peri-infarct zone after MI <xref rid="bb0890 bb0895" ref-type="bibr">[178,179]</xref>. Mice with a cardiomyocyte-specific deletion of Hif1α demonstrate a reduction in vascularization, contractility, and high-energy phosphate content that is attributable to the altered expression of genes involved in angiogenesis, calcium handling, and glucose metabolism, indicating a major role for Hif1α in coordinating energy availability and utilization in the heart <xref rid="bb0900" ref-type="bibr">[180]</xref>. Transgenic overexpression of HIF1α in the myocardium of mice reduces infarct size and improves cardiac function 4 weeks after MI in association with evidence of increased capillary density in the peri-infarct region <xref rid="bb0905" ref-type="bibr">[181]</xref>. Similarly, the siRNA-mediated silencing of PHD expression in murine hearts in vivo was found to increase HIF1α protein stabilization and to decrease infarct size and cardiac dysfunction after ischemia–reperfusion <xref rid="bb0910" ref-type="bibr">[182]</xref>. These effects seemed to involve Hif1-induced increases in iNOS (which has been shown to be cardioprotective in several studies) because they were lost in iNOS<sup>−/−</sup> mice <xref rid="bb0915" ref-type="bibr">[183]</xref>. Other studies have implicated increases in HO-1 as a downstream mediator of Hif1-dependent reduction in cardiac ischemia–reperfusion injury <xref rid="bb0920" ref-type="bibr">[184]</xref>. Hif1 activation may also have favorable effects in nonischemic cardiac pathology, such as pressure-overload hypertrophy, which is discussed in a later section. Although the data described above indicate that short-term Hif1 activation is protective after MI, it should be noted that several studies suggest that chronic sustained activation of the Hif1 pathway in ischemic myocardium may be maladaptive. For example, mice with a cardiac-specific deletion of vHL <xref rid="bb0925" ref-type="bibr">[185]</xref>, a genetic deletion of PHD2/3 <xref rid="bb0930 bb0935" ref-type="bibr">[186,187]</xref>, or overexpression of an O<sub>2</sub>-insensitive form of Hif1α <xref rid="bb0940" ref-type="bibr">[188]</xref> all develop severe cardiomyopathy.</p>
      </sec>
      <sec id="s0085">
        <title>Ischemic preconditioning</title>
        <p>Transient episodes of myocardial ischemia are protective against cell injury and death caused by subsequent prolonged ischemia, a phenomenon known as ischemic preconditioning <xref rid="bb0945 bb0950" ref-type="bibr">[189,190]</xref>. In addition to ischemia per se, such cardioprotection can be evoked by a wide variety of stimuli, notably many GPCR agonists. The pathways underlying this potent phenomenon still remain incompletely understood but inhibition of the MPT is considered an important terminal mechanism. Many studies have suggested that redox signaling during the initial preconditioning period may be involved in the eventual cardioprotective effect, at least for some stimuli that evoke preconditioning <xref rid="bb0955 bb0960 bb0965 bb0970" ref-type="bibr">[191–194]</xref>. These signaling ROS can be derived from mitochondria (related to slight mitochondrial swelling and an increase in respiration) <xref rid="bb0965" ref-type="bibr">[193]</xref> or from Nox2 NADPH oxidase <xref rid="bb0975 bb0980" ref-type="bibr">[195,196]</xref> and are thought to act through the redox activation of PKC, although it is possible that other kinases involved in preconditioning could also be redox-activated. Several studies have suggested that the signaling pathways activated by diverse preconditioning stimuli converge on glycogen synthase kinase-3β (GSK-3β), the phosphorylation and inactivation of which inhibits the MPTP, although the precise molecular target(s) of GSK-3β remains to be established <xref rid="bb0965 bb0985" ref-type="bibr">[193,197]</xref>. However, some studies have argued against a central role for GSK-3β inhibition in preconditioning (e.g., <xref rid="bb0990 bb0995 bb1000" ref-type="bibr">[198–200]</xref>).</p>
        <p>Preconditioning triggers not only induce immediate protection against ischemia–reperfusion injury but also provide delayed protection 24 hours or more after the initial trigger—termed delayed or late preconditioning. Several Hif-dependent genes are implicated in late ischemic preconditioning, for example, iNOS <xref rid="bb1005" ref-type="bibr">[201]</xref>, cyclooxygenase-2 <xref rid="bb1010" ref-type="bibr">[202]</xref>, and HO-1 <xref rid="bb1015" ref-type="bibr">[203]</xref>, suggesting that redox signaling may be involved. The protective effect may, in part, involve an upregulation of antioxidants such as HO-1 and other proteins <xref rid="bb1015" ref-type="bibr">[203]</xref>.</p>
      </sec>
    </sec>
    <sec id="s0090">
      <title>Cardiac hypertrophy</title>
      <p>Chronic increases in cardiac workload result in heart hypertrophy, a situation in which there is a significant increase in cardiomyocyte size that contributes to increased chamber mass and wall thickness. In “physiological” hypertrophy, e.g., with chronic endurance exercise or pregnancy, the increase in size is an adaptation to the increased workload and is associated with the maintenance of normal contractile function and the absence of long-term ill effects. In contrast, persistent “pathological” hypertrophy, e.g., with chronic hypertension or after MI, is associated with a progressive energetic deficit, contractile dysfunction, and eventual heart failure. As well as changes at the cardiomyocyte level, pathological hypertrophy is characterized by significant rarefaction of myocardial capillaries and major changes in the extracellular matrix that lead to fibrosis and ventricular dilatation. Specific signaling pathways are thought to drive adaptive versus maladaptive programs of gene and protein expression that contribute to these abnormalities and the balance between these may determine whether the heart fails <xref rid="bb1020 bb1025 bb1030" ref-type="bibr">[204–206]</xref>. Abnormalities in myocyte ECC and tissue hypoxia (both discussed earlier) and the occurrence of myocyte apoptosis (discussed later) are important contributors to the development of heart failure. In this section, we focus on ROS-modulated pathways that promote cardiomyocyte hypertrophy as well as those that are protective in this setting (<xref rid="f0010" ref-type="fig">Fig. 2</xref>).</p>
      <sec id="s0095">
        <title>Hypertrophic pathways modulated by endogenous ROS</title>
        <p>Numerous experimental studies have reported that exogenous ROS can modulate many signaling pathways known to be involved in cardiomyocyte hypertrophy, such as the activation of ERK1/2, JNK, p38MAPK, Akt, PKCs, and NF-κB <xref rid="bb1035" ref-type="bibr">[207]</xref>. Here we focus on studies that have addressed the involvement of endogenous ROS in hypertrophic signaling pathways, identified the sources of such ROS, and/or provided information on molecular mechanisms involved in such redox signaling.</p>
        <p>Cardiomyocyte hypertrophy induced by GPCR agonists such as angiotensin II, α-adrenoceptor agonists, and endothelin-1 has been shown to involve endogenous ROS generation and the activation of ERK1/2 and NF-κB <xref rid="bb1040 bb1045 bb1050" ref-type="bibr">[208–210]</xref>. In the case of α-adrenoceptor stimulation, it was demonstrated that the Trx1-sensitive oxidation of specific cysteine thiols on the small G protein Ras is a key molecular mechanism that induces activation of the Ras–Raf–MEK1/2–ERK1/2 signaling pathway leading to cardiomyocyte hypertrophy <xref rid="bb1055" ref-type="bibr">[211]</xref>. Another molecular mechanism that has been elegantly dissected is the Trx1-sensitive oxidation of class II HDACs <xref rid="bb0085" ref-type="bibr">[17]</xref>, which are master negative regulators of cardiac hypertrophy that inhibit the transcription of MEF2-dependent genes <xref rid="bb1020 bb1030" ref-type="bibr">[204,206]</xref>. It was found that Trx1 forms a multiprotein complex with HDAC4 and a heat shock protein, DnaJb5, in cardiomyocytes. During α-adrenoceptor-induced cardiomyocyte hypertrophy, specific cysteine residues in HDAC4 (Cys667, Cys669) and DnaJb5 (Cys274, Cys276) were oxidized to form intramolecular disulfide bonds, leading to the phosphorylation-independent nuclear export of HDAC4 and the induction of hypertrophy <xref rid="bb0085" ref-type="bibr">[17]</xref>.</p>
        <p>Redox-dependent activation of the MAPKKK ASK1 has been implicated upstream of NF-κB activation in GPCR-induced hypertrophy <xref rid="bb1050" ref-type="bibr">[210]</xref>. Tumor necrosis factor-α (TNFα)-induced cardiomyocyte hypertrophy was also reported to involve ROS-dependent activation of NF-κB <xref rid="bb1060" ref-type="bibr">[212]</xref>. These investigators subsequently showed that Ca-dependent activation of Pyk leads to Rac1 activation <xref rid="bb1065" ref-type="bibr">[213]</xref>, which is itself upstream of ASK1 and NF-κB activation <xref rid="bb1070" ref-type="bibr">[214]</xref>, raising the possibility that cardiomyocyte Nox2 (which requires Rac1 for its activation) may the ROS source. Indeed, Nox2 has been confirmed to be involved in cultured cardiomyocyte hypertrophy induced by angiotensin II <xref rid="bb1075 bb1080" ref-type="bibr">[215,216]</xref> and endothelin-1 <xref rid="bb1085" ref-type="bibr">[217]</xref>, and Hingtgen et al. <xref rid="bb1080" ref-type="bibr">[216]</xref> provided evidence that Akt activation may also be involved. Further strong evidence for an involvement of Nox2 in angiotensin II-induced cardiac hypertrophy comes from in vivo studies in gene-modified mice. We found that hypertrophy induced by chronic angiotensin II infusion was significantly inhibited in Nox2-null mice independent of changes in blood pressure, in conjunction with a failure to increase myocardial NADPH oxidase activity <xref rid="bb0295" ref-type="bibr">[59]</xref>. Satoh et al. <xref rid="bb1090" ref-type="bibr">[218]</xref> reported that angiotensin II-induced in vivo cardiac hypertrophy was similarly inhibited in mice with a cardiomyocyte-specific deletion of Rac1 in conjunction with a reduction in Nox2 activation. Angiotensin II-induced in vivo cardiac hypertrophy was also inhibited in ASK1-null mice <xref rid="bb1095" ref-type="bibr">[219]</xref>.</p>
        <p>Redox signaling is also implicated in pressure-overload-induced cardiac hypertrophy <xref rid="bb1100" ref-type="bibr">[220]</xref>. Mechanical strain may be at least one prohypertrophic stimulus during pressure overload and it has been shown that mechanical stress-induced cardiomyocyte hypertrophy may involve Rac1–ROS-dependent pathways that activate ERK1/2 <xref rid="bb1105" ref-type="bibr">[221]</xref> and p38MAPK <xref rid="bb1110" ref-type="bibr">[222]</xref>, consistent with the involvement of Nox2. ROS-dependent S-glutathiolation of Ras at Cys118 and consequent activation of the Raf–MEK–ERK pathway were involved in mechanical strain-induced hypertrophy <xref rid="bb1115" ref-type="bibr">[223]</xref>, similar to findings in GPCR-induced hypertrophy <xref rid="bb1055" ref-type="bibr">[211]</xref>. The expression and activation of Nox2 do in fact increase during chronic pressure overload <xref rid="bb0290 bb1120 bb1125" ref-type="bibr">[58,224,225]</xref>, and increases in Nox2 expression and activity have also been demonstrated in myocardial samples from failing human hearts <xref rid="bb0300 bb1130 bb1135" ref-type="bibr">[60,226,227]</xref>. Mice with a cardiomyocyte-specific deletion of Rac1 were protected against pressure-overload hypertrophy <xref rid="bb1090" ref-type="bibr">[218]</xref> and Nox2-null mice developed less contractile dysfunction than wild-type littermates when subjected to chronic pressure overload <xref rid="bb1140" ref-type="bibr">[228]</xref>, supporting a prohypertrophic role of Nox2. However, the extent of hypertrophy in Nox2-null mice was similar to that in wild-type littermates <xref rid="bb0310 bb1145 bb1150" ref-type="bibr">[62,229,230]</xref>, suggesting that although Nox2 can exert prohypertrophic effects during chronic pressure overload other pathways may compensate in its absence.</p>
      </sec>
      <sec id="s0100">
        <title>Redox-sensitive protective pathways activated during cardiac hypertrophy</title>
        <p>We have recently identified a potent Nox4-dependent protective pathway that is activated during chronic pressure overload <xref rid="bb0325" ref-type="bibr">[65]</xref>. Earlier studies had shown that although the level of Nox4 is low in the healthy adult heart, its expression increases significantly during pressure overload or after myocardial ischemia <xref rid="bb0310 bb0355" ref-type="bibr">[62,71]</xref>. It was therefore speculated that Nox4 might compensate for Nox2 in the setting of pressure overload hypertrophy. As discussed under Sources of ROS in cardiomyocytes, however, the two Nox isoforms exhibit significant differences in regulation, activation, subcellular location, and nature of ROS generation. Nox4, unlike Nox2, does not require agonist stimulation and is regulated mainly by its expression level <xref rid="bb0330 bb0335" ref-type="bibr">[66,67]</xref>. It is found in an intracellular perinuclear location <xref rid="bb0325" ref-type="bibr">[65]</xref> in contrast to activated Nox2, which is located at the cardiomyocyte sarcolemmal membrane <xref rid="bb0300" ref-type="bibr">[60]</xref>. Furthermore, Nox4 seems to generate predominantly H<sub>2</sub>O<sub>2</sub> rather than O<sub>2</sub><sup><bold>•</bold>−</sup>, in contrast to Nox2 <xref rid="bb0325 bb0330 bb0335 bb0340 bb0345" ref-type="bibr">[65–69]</xref>. To investigate the role of Nox4 during pressure overload, we generated mouse models with a deletion of Nox4 or a cardiomyocyte-targeted increase in Nox4 expression. Neither model developed significant changes in cardiac hypertrophy or function in the absence of stress, and there were no changes in myocardial Nox2 levels <xref rid="bb0325" ref-type="bibr">[65]</xref>. In response to chronic pressure overload, however, Nox4-null mice developed significantly greater cardiac hypertrophy and contractile dysfunction than control animals, whereas Nox4-transgenic mice exhibited protection against pressure-overload-induced hypertrophy and failure. Investigation of the mechanisms underlying the protective effect of Nox4 revealed that it facilitated the preservation of myocardial capillary density during pressure overload by augmenting stress-induced cardiomyocyte Hif1 activation and the release of VEGF, resulting in increased paracrine angiogenic activity <xref rid="bb0325" ref-type="bibr">[65]</xref>. The main mechanism by which Nox4 regulated cardiomyocyte Hif1 activation was through inhibition of Hif prolyl hydroxylase activity and a subsequent increase in Hif1α protein levels. These data extend the findings from recent studies showing that the extent of myocardial capillarization is a key determinant of functional cardiac compensation during chronic pressure overload <xref rid="bb1155 bb1160" ref-type="bibr">[231,232]</xref>, with Hif1 being a major driver of this process <xref rid="bb1165" ref-type="bibr">[233]</xref>. An insufficient increase in capillary number relative to the increase in cardiomyocyte size during hypertrophy may promote pathological remodeling of the heart with increased hypertrophy, fibrosis, cardiac dilatation, and contractile failure. Whether other Nox4-dependent antihypertrophic pathways are also involved in its beneficial effects requires further investigation. The above data on Nox4 taken together with previous studies on Nox2 indicate that the two isoforms contrast markedly in their effects during pressure-overload-induced cardiac hypertrophy, with Nox2 being detrimental and Nox4 beneficial (<xref rid="f0010" ref-type="fig">Fig. 2</xref>). It should be noted that a recent study using different mouse models of Nox4 deletion and overexpression suggested that Nox4 contributed to detrimental O<sub>2</sub><sup>•−</sup> production, which enhanced heart failure in response to pressure overload, although no effects on cardiac hypertrophy were found in that study and Hif1 activation was not studied <xref rid="bb0350" ref-type="bibr">[70]</xref>. The reasons for this discrepancy remain to be elucidated but the finding of substantial Nox4-dependent O<sub>2</sub><sup>•−</sup> production in this study is at odds with recent data from several independent laboratories that Nox4 generates predominantly H<sub>2</sub>O<sub>2</sub> rather than O<sub>2</sub><sup>•−</sup> <xref rid="bb0325 bb0330 bb0335 bb0340 bb0345 bb1170 bb1175" ref-type="bibr">[65–69,234,235]</xref>. It should also be noted that persistent Hif1 activation in the setting of pathological cardiac hypertrophy could be detrimental by promoting maladaptive metabolic changes in glycolytic and lipid anabolic pathways <xref rid="bb1180" ref-type="bibr">[236]</xref>.</p>
      </sec>
    </sec>
    <sec id="s0105">
      <title>Myocyte apoptosis</title>
      <p>Cardiomyocyte apoptosis is recognized to be important in both ischemia–reperfusion injury and the transition from compensated cardiac hypertrophy to heart failure, at least in part through redox-dependent mechanisms <xref rid="bb1185 bb1190" ref-type="bibr">[237,238]</xref>. The signaling pathways that regulate apoptosis in cardiomyocytes have been reviewed in detail <xref rid="bb1185 bb1190" ref-type="bibr">[237,238]</xref> In brief, apoptosis may be activated by extrinsic or intrinsic pathways. The extrinsic pathway is stimulated by factors such as TNFα that cause the formation of a death-inducing signaling complex, which leads to the activation of a cascade of caspases and eventual caspase-3-mediated proteolysis of intracellular proteins and oligonucleosomal DNA cleavage. The intrinsic apoptotic pathway uses mitochondria to evoke cell death through the opening of the MPTP or the permeabilization of the outer membrane, resulting in the release of cytochrome <italic>c</italic> and other proteins (e.g., apoptosis-inducing factor, AIF) into the cytoplasm. Cytochrome <italic>c</italic> facilitates the formation of an apoptosome complex with apoptotic protease activating factor-1, dATP, and caspase-9 and leads to caspase-3 activation. Bcl-2 family proteins are key regulators of mitochondrial membrane integrity in apoptosis and comprise proapoptotic (e.g., Bax, Bak) and antiapoptotic proteins (e.g., Bcl-2, Bcl-xL) that are transcriptionally and posttranslationally regulated. BH3-only proteins are additional death effectors that can activate proapoptotic or inactivate antiapoptotic Bcl-2 family members.</p>
      <p>The importance of oxidative stress in cardiomyocyte apoptosis is illustrated by the finding that the overexpression of various antioxidant proteins, including catalase <xref rid="bb1105" ref-type="bibr">[221]</xref>, glutathione peroxidase 1 <xref rid="bb0245" ref-type="bibr">[49]</xref>, metallothionein <xref rid="bb1195" ref-type="bibr">[239]</xref>, mitochondrial glutaredoxin-2 <xref rid="bb1200" ref-type="bibr">[240]</xref>, and peroxiredoxin II <xref rid="bb1205" ref-type="bibr">[241]</xref>, reduces apoptosis and improves contractile dysfunction after ischemia–reperfusion injury in mice in vivo. Oxidative stress activates the intrinsic apoptotic pathway in cardiomyocytes (e.g., during ischemia–reperfusion) through multiple mechanisms, such as the induction of MPTP opening, DNA damage-induced activation of the p53 transcription factor, translocation of Bax and Bad to the mitochondria, and caspase activation <xref rid="bb1185 bb1190 bb1210" ref-type="bibr">[237,238,242]</xref>. An alternative mode of oxidative stress-induced activation of the intrinsic apoptotic pathway may involve induction of the ER stress response, leading to caspase-12 activation and/or Ca-dependent opening of the MPTP <xref rid="bb1190" ref-type="bibr">[238]</xref>. During oxidative stress, p53 induces the E3 ubiquitin ligase, MDM2, which promotes the ubiquitination and proteasomal degradation of a key antiapoptotic regulator, ARC (apoptosis repressor with caspase recruitment domain), which is known to interact with Bax and inhibit apoptosis involving the mitochondrial pathway <xref rid="bb1215" ref-type="bibr">[243]</xref>. This seems to be an important pathogenic mechanism based on the findings that overexpression of ARC inhibits oxidant-induced apoptosis in isolated myocytes <xref rid="bb1220" ref-type="bibr">[244]</xref> and that ARC knockout mice develop larger infarcts after ischemia–reperfusion and more rapidly develop pressure-overload-induced heart failure <xref rid="bb1225" ref-type="bibr">[245]</xref>. However, it should be noted that MDM2 may have complex effects because it also promotes the degradation of p53 itself, which may be cardioprotective <xref rid="bb1230" ref-type="bibr">[246]</xref>. AIF also provides protection against oxidative stress-induced apoptosis in cardiomyocytes, and AIF-deficient mice show increased apoptosis and faster progression to heart failure when subjected to chronic pressure overload <xref rid="bb1235" ref-type="bibr">[247]</xref>.</p>
      <p>GPCR signaling induced by catecholamines, angiotensin II, prostaglandin F<sub>2α</sub>, or endothelin-1, which induces cardiomyocyte hypertrophy, may also induce apoptosis at higher intensities of GPCR activation. One mechanism that has been quite well characterized is a G<sub>αq</sub>-mediated PKC-dependent transcriptional upregulation of the Bcl-2 family member Nix, which activates the mitochondrial death pathway <xref rid="bb1240" ref-type="bibr">[248]</xref>. PKC activation is potentially redox-sensitive but whether this is involved in the upregulation of Nix remains to be established. Cardiomyocyte apoptosis induced by 5-HT was shown to involve MAO-A-dependent ROS generation, which led to upregulation of Bax and downregulation of Bcl-2 and subsequent mitochondrial release of cytochrome <italic>c</italic> <xref rid="bb1245" ref-type="bibr">[249]</xref>. Other pathways linking GPCR activation and the induction of apoptosis may involve the activation of kinases such as ASK1, JNK, and p38MAPK <xref rid="bb1250" ref-type="bibr">[250]</xref>. In adult rat cardiomyocytes, β-adrenoceptor-induced apoptosis was shown to involve ROS-dependent activation of JNK, which in turn activated the mitochondrial death pathway and cytochrome <italic>c</italic> release <xref rid="bb1255" ref-type="bibr">[251]</xref>. ASK1 may be redox-activated upstream of p38MAPK and JNK to induce cardiomyocyte apoptosis, and ASK1 activity and ASK1-dependent apoptosis are inhibited by Trx1 and Trx2 <xref rid="bb1260" ref-type="bibr">[252]</xref>.</p>
      <p>A novel redox mechanism involved in angiotensin II-induced cardiomyocyte apoptosis has recently been identified as the Ca-independent activation of CamKII as a result of the oxidation of methionine residues 281 and 282 in the regulatory domain of the kinase <xref rid="bb0640" ref-type="bibr">[128]</xref>. In vivo oxidative activation of CamKII in the hearts of mice infused with angiotensin II was accompanied by increased apoptosis, which was inhibited in mice overexpressing an inhibitory peptide against CamKII (AC3-I). The authors also provided evidence that the ROS responsible for CamKII activation and apoptotic death via the mitochondrial pathway were derived from Nox2 oxidase activation (<xref rid="f0010" ref-type="fig">Fig. 2</xref>), because the effects were abolished in mice lacking p47<sup>phox</sup> (which is essential for Nox2 activity) <xref rid="bb0640" ref-type="bibr">[128]</xref>. The methionine oxidation of CamKII is reversible by methionine sulfoxide reductase A (MsrA) and mice deficient in MsrA were found to exhibit exaggerated CamKII oxidation, cardiomyocyte apoptosis, cardiac dysfunction, and mortality after myocardial infarction <xref rid="bb0640" ref-type="bibr">[128]</xref>. Interestingly, however, isoproterenol induced activation of CamKII, and induction of apoptosis did not involve ROS. Palomeque et al. <xref rid="bb1265" ref-type="bibr">[253]</xref> also reported a similar angiotensin II-induced ROS-dependent cardiomyocyte apoptotic pathway involving CamKII activation and found that p38MAPK activation was downstream of CamKII in the proapoptotic pathway.</p>
      <p>It should be noted that recent studies in various noncardiomyocyte settings have reported that Nox4-derived ROS may <italic>inhibit</italic> apoptosis, e.g., in pulmonary fibroblasts <xref rid="bb0365" ref-type="bibr">[73]</xref>, human glioma cells <xref rid="bb1270" ref-type="bibr">[254]</xref>, pancreatic carcinoma cells <xref rid="bb1275 bb1280 bb1285" ref-type="bibr">[255–257]</xref>, and hepatocytes <xref rid="bb1290" ref-type="bibr">[258]</xref>. The mechanisms involved in Nox4-dependent antiapoptotic effects may include the activation of kinases such as Akt <xref rid="bb1285" ref-type="bibr">[257]</xref> and Jak-2 <xref rid="bb1295" ref-type="bibr">[259]</xref>. Whether such ROS-dependent antiapoptotic effects are relevant in cardiomyocytes remains to be established.</p>
    </sec>
    <sec id="s0110">
      <title>Conclusions</title>
      <p>In this article, we have reviewed the main redox-regulated physiological and pathological pathways that are involved in cardiac myocyte ECC, growth, differentiation, hypertrophy, survival, and responses to stresses such as hypoxia, ischemia, and chronically increased workload. The sources of the endogenously generated ROS that are involved in modulating these various pathways are gradually being identified and it is increasingly evident that in many cases, regulatory pathways are source-specific. A number of molecular mechanisms through which ROS modulate specific pathways in cardiomyocytes have been defined (e.g., the redox activation of RyR, PKA, and Ras, or the posttranslational modification of HDAC4) but many others remain to be elucidated. In addition to such direct posttranslational protein modifications mediated by ROS, redox protein recycling systems such as Trx1 and glutaredoxin and the metabolic processes that influence redox status (e.g., through the regeneration of antioxidant pools) are of major importance. The latter are especially sensitive to the cardiomyocyte O<sub>2</sub> supply, and the interrelationship between the direct effects of O<sub>2</sub> levels and ROS-dependent regulation is also a key aspect of redox signaling in the cardiomyocyte. The data reviewed in this article clearly show that redox signaling is integral to the maintenance of cardiomyocyte homeostasis and is centrally involved in the integrated cellular signaling machinery that underlies cardiac responses to stress. Future work in the field needs to better address several key aspects that include (a) cardiomyocyte compartment-specific redox regulation and signaling in various settings, (b) mechanisms that regulate and integrate intercompartmental signaling, (c) the integration of specific ROS generation with antioxidant balance and metabolic processes (which may be especially important in myocytes), (d) the detrimental and/or protective roles of specific ROS generators, and (e) the identification of key molecular mechanisms that could be therapeutically targeted. A better understanding of this complex regulatory system may allow the development of more specific therapeutic strategies for heart diseases.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bb0005">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brutsaert</surname>
              <given-names>D.L.</given-names>
            </name>
          </person-group>
          <article-title>Cardiac endothelial–myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity</article-title>
          <source>Physiol. Rev.</source>
          <volume>83</volume>
          <year>2003</year>
          <fpage>59</fpage>
          <lpage>115</lpage>
          <pub-id pub-id-type="pmid">12506127</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0010">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kakkar</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>R.T.</given-names>
            </name>
          </person-group>
          <article-title>Intramyocardial fibroblast myocyte communication</article-title>
          <source>Circ. Res.</source>
          <volume>106</volume>
          <year>2010</year>
          <fpage>47</fpage>
          <lpage>57</lpage>
          <pub-id pub-id-type="pmid">20056945</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0015">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Augusto</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Bonini</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Amanso</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Linares</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>De Menezes</surname>
              <given-names>S.L.</given-names>
            </name>
          </person-group>
          <article-title>Nitrogen dioxide and carbonate radical anion: two emerging radicals in biology</article-title>
          <source>Free Radic. Biol. Med.</source>
          <volume>32</volume>
          <year>2002</year>
          <fpage>841</fpage>
          <lpage>859</lpage>
          <pub-id pub-id-type="pmid">11978486</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0020">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Winterbourn</surname>
              <given-names>C.C.</given-names>
            </name>
          </person-group>
          <article-title>Reconciling the chemistry and biology of reactive oxygen species</article-title>
          <source>Nat. Chem. Biol.</source>
          <volume>4</volume>
          <year>2008</year>
          <fpage>278</fpage>
          <lpage>286</lpage>
          <pub-id pub-id-type="pmid">18421291</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0025">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Massion</surname>
              <given-names>P.B.</given-names>
            </name>
            <name>
              <surname>Balligand</surname>
              <given-names>J.L.</given-names>
            </name>
          </person-group>
          <article-title>Relevance of nitric oxide for myocardial remodeling</article-title>
          <source>Curr. Heart Fail. Rep.</source>
          <volume>4</volume>
          <year>2007</year>
          <fpage>18</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="pmid">17386181</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0030">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seddon</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Casadei</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Cardiomyocytes as effectors of nitric oxide signalling</article-title>
          <source>Cardiovasc. Res.</source>
          <volume>75</volume>
          <year>2007</year>
          <fpage>315</fpage>
          <lpage>326</lpage>
          <pub-id pub-id-type="pmid">17568574</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0035">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kass</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Takimoto</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Nagayama</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Champion</surname>
              <given-names>H.C.</given-names>
            </name>
          </person-group>
          <article-title>Phosphodiesterase regulation of nitric oxide signaling</article-title>
          <source>Cardiovasc. Res.</source>
          <volume>75</volume>
          <year>2007</year>
          <fpage>303</fpage>
          <lpage>314</lpage>
          <pub-id pub-id-type="pmid">17467673</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0040">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pacher</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Beckman</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Liaudet</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Nitric oxide and peroxynitrite in health and disease</article-title>
          <source>Physiol. Rev.</source>
          <volume>87</volume>
          <year>2007</year>
          <fpage>315</fpage>
          <lpage>324</lpage>
          <pub-id pub-id-type="pmid">17237348</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0045">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cave</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Brewer</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Narayanapanicker</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ray</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Grieve</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>NADPH oxidases in cardiovascular health and disease</article-title>
          <source>Antioxid. Redox Signaling</source>
          <volume>8</volume>
          <year>2006</year>
          <fpage>691</fpage>
          <lpage>728</lpage>
        </element-citation>
      </ref>
      <ref id="bb0050">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rajasekaran</surname>
              <given-names>N.S.</given-names>
            </name>
            <name>
              <surname>Connell</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Christians</surname>
              <given-names>E.S.</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>L.J.</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>R.P.</given-names>
            </name>
            <name>
              <surname>Orosz</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>X.Q.</given-names>
            </name>
            <name>
              <surname>Stevenson</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Peshock</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Leopold</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Barry</surname>
              <given-names>W.H.</given-names>
            </name>
            <name>
              <surname>Loscalzo</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Odelberg</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Benjamin</surname>
              <given-names>I.J.</given-names>
            </name>
          </person-group>
          <article-title>Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice</article-title>
          <source>Cell</source>
          <volume>130</volume>
          <year>2007</year>
          <fpage>427</fpage>
          <lpage>439</lpage>
          <pub-id pub-id-type="pmid">17693254</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0055">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eaton</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Protein thiol oxidation in health and disease: techniques for measuring disulfides and related modifications in complex protein mixtures</article-title>
          <source>Free Radic. Biol. Med.</source>
          <volume>40</volume>
          <year>2006</year>
          <fpage>1889</fpage>
          <lpage>1899</lpage>
          <pub-id pub-id-type="pmid">16716890</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0060">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Forman</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Maiorino</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ursini</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Signaling functions of reactive oxygen species</article-title>
          <source>Biochemistry</source>
          <volume>49</volume>
          <year>2010</year>
          <fpage>835</fpage>
          <lpage>842</lpage>
          <pub-id pub-id-type="pmid">20050630</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0065">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brennan</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Bardswell</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Burgoyne</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Fuller</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Schröder</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Wait</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Begum</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kentish</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Eaton</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Oxidant-induced activation of type I protein kinase A is mediated by RI subunit interprotein disulfide bond formation</article-title>
          <source>J. Biol. Chem.</source>
          <volume>281</volume>
          <year>2006</year>
          <fpage>21827</fpage>
          <lpage>21836</lpage>
          <pub-id pub-id-type="pmid">16754666</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0070">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burgoyne</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Madhani</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cuello</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Charles</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Brennan</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Schröder</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Browning</surname>
              <given-names>D.D.</given-names>
            </name>
            <name>
              <surname>Eaton</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Cysteine redox sensor in PKGIa enables oxidant-induced activation</article-title>
          <source>Science</source>
          <volume>317</volume>
          <year>2007</year>
          <fpage>1393</fpage>
          <lpage>1397</lpage>
          <pub-id pub-id-type="pmid">17717153</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0075">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Eu</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Meissner</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Stamler</surname>
              <given-names>J.S.</given-names>
            </name>
          </person-group>
          <article-title>Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation</article-title>
          <source>Science</source>
          <volume>279</volume>
          <year>1998</year>
          <fpage>234</fpage>
          <lpage>237</lpage>
          <pub-id pub-id-type="pmid">9422697</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0080">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuster</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Siwik</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Pimentel</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Colucci</surname>
              <given-names>W.S.</given-names>
            </name>
          </person-group>
          <article-title>Role of reversible, thioredoxin-sensitive oxidative protein modifications in cardiac myocytes</article-title>
          <source>Antioxid. Redox Signaling</source>
          <volume>8</volume>
          <year>2006</year>
          <fpage>2153</fpage>
          <lpage>2159</lpage>
        </element-citation>
      </ref>
      <ref id="bb0085">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ago</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Zhai</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Molkentin</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Vatner</surname>
              <given-names>S.F.</given-names>
            </name>
            <name>
              <surname>Sadoshima</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy</article-title>
          <source>Cell</source>
          <volume>133</volume>
          <year>2008</year>
          <fpage>978</fpage>
          <lpage>993</lpage>
          <pub-id pub-id-type="pmid">18555775</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0090">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eaton</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Byers</surname>
              <given-names>H.L.</given-names>
            </name>
            <name>
              <surname>Leeds</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Ward</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Shattock</surname>
              <given-names>M.J.</given-names>
            </name>
          </person-group>
          <article-title>Detection, quantitation, purification, and identification of cardiac proteins S-thiolated during ischemia and reperfusion</article-title>
          <source>J. Biol. Chem.</source>
          <volume>277</volume>
          <year>2002</year>
          <fpage>9806</fpage>
          <lpage>98011</lpage>
          <pub-id pub-id-type="pmid">11777920</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0095">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eaton</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Hearse</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Shattock</surname>
              <given-names>M.J.</given-names>
            </name>
          </person-group>
          <article-title>Glyceraldehyde phosphate dehydrogenase oxidation during cardiac ischemia and reperfusion</article-title>
          <source>J. Mol. Cell. Cardiol.</source>
          <volume>34</volume>
          <year>2002</year>
          <fpage>1549</fpage>
          <lpage>1560</lpage>
          <pub-id pub-id-type="pmid">12431453</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0100">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berndt</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Lillig</surname>
              <given-names>C.H.</given-names>
            </name>
            <name>
              <surname>Holmgren</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system</article-title>
          <source>Am. J. Physiol.</source>
          <volume>292</volume>
          <year>2007</year>
          <fpage>H1227</fpage>
          <lpage>H1236</lpage>
        </element-citation>
      </ref>
      <ref id="bb0105">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oka</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ago</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kitazono</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Zablocki</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Sadoshima</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>The role of redox modulation of class II histone deacetylases in mediating pathological cardiac hypertrophy</article-title>
          <source>J. Mol. Med.</source>
          <volume>87</volume>
          <year>2009</year>
          <fpage>785</fpage>
          <lpage>791</lpage>
          <pub-id pub-id-type="pmid">19424677</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0110">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamamoto</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Holle</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Wagner</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Vatner</surname>
              <given-names>S.F.</given-names>
            </name>
            <name>
              <surname>Sadoshima</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy</article-title>
          <source>J. Clin. Invest.</source>
          <volume>112</volume>
          <year>2003</year>
          <fpage>1395</fpage>
          <lpage>1406</lpage>
          <pub-id pub-id-type="pmid">14597765</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0115">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ago</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Zhai</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Sadoshima</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Elucidation of thioredoxin target protein networks in mouse</article-title>
          <source>Mol. Cell. Proteomics</source>
          <volume>8</volume>
          <year>2009</year>
          <fpage>1674</fpage>
          <lpage>1687</lpage>
          <pub-id pub-id-type="pmid">19416943</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0120">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kiffin</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Bandyopadhyay</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Cuervo</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>Oxidative stress and autophagy</article-title>
          <source>Antioxid. Redox Signaling</source>
          <volume>8</volume>
          <year>2006</year>
          <fpage>152</fpage>
          <lpage>162</lpage>
        </element-citation>
      </ref>
      <ref id="bb0125">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peluffo</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Radi</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Biochemistry of protein tyrosine nitration in cardiovascular pathology</article-title>
          <source>Cardiovasc. Res.</source>
          <volume>75</volume>
          <year>2007</year>
          <fpage>291</fpage>
          <lpage>302</lpage>
          <pub-id pub-id-type="pmid">17544386</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0130">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weiss</surname>
              <given-names>J.N.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Qu</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>Systems biology approaches to metabolic and cardiovascular disorders: network perspectives of cardiovascular metabolism</article-title>
          <source>J. Lipid Res.</source>
          <volume>47</volume>
          <year>2006</year>
          <fpage>2355</fpage>
          <lpage>2366</lpage>
          <pub-id pub-id-type="pmid">16946414</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0135">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hayashi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Martone</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Thor</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Doi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Holst</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Ellisman</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Hoshijima</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Three-dimensional electron microscopy reveals new details of membrane systems for Ca<sup>2+</sup> signaling in the heart</article-title>
          <source>J. Cell Sci.</source>
          <volume>122</volume>
          <year>2009</year>
          <fpage>1005</fpage>
          <lpage>1013</lpage>
          <pub-id pub-id-type="pmid">19295127</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0140">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pizzo</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Pozzan</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondria–endoplasmic reticulum choreography: structure and signaling dynamics</article-title>
          <source>Trends Cell Biol.</source>
          <volume>17</volume>
          <year>2007</year>
          <fpage>511</fpage>
          <lpage>517</lpage>
          <pub-id pub-id-type="pmid">17851078</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0145">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rizzuto</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Pinton</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Carrington</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Fay</surname>
              <given-names>F.S.</given-names>
            </name>
            <name>
              <surname>Fogarty</surname>
              <given-names>K.E.</given-names>
            </name>
            <name>
              <surname>Lifshitz</surname>
              <given-names>L.M.</given-names>
            </name>
            <name>
              <surname>Tuft</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Pozzan</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca<sup>2+</sup> responses</article-title>
          <source>Science</source>
          <volume>280</volume>
          <year>1998</year>
          <fpage>1763</fpage>
          <lpage>1766</lpage>
          <pub-id pub-id-type="pmid">9624056</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0150">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kornmann</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Currie</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>S.R.</given-names>
            </name>
            <name>
              <surname>Schuldiner</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Nunnari</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Weissman</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Walter</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>An ER–mitochondria tethering complex revealed by a synthetic biology screen</article-title>
          <source>Science</source>
          <volume>325</volume>
          <year>2009</year>
          <fpage>477</fpage>
          <lpage>481</lpage>
          <pub-id pub-id-type="pmid">19556461</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0155">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Opie</surname>
              <given-names>L.H.</given-names>
            </name>
            <name>
              <surname>Sack</surname>
              <given-names>M.N.</given-names>
            </name>
          </person-group>
          <article-title>Metabolic plasticity and the promotion of cardiac protection in ischemia and ischemic preconditioning</article-title>
          <source>J. Mol. Cell. Cardiol.</source>
          <volume>34</volume>
          <year>2002</year>
          <fpage>1077</fpage>
          <lpage>1089</lpage>
          <pub-id pub-id-type="pmid">12392880</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0160">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bolukoglu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Goodwin</surname>
              <given-names>G.W.</given-names>
            </name>
            <name>
              <surname>Guthrie</surname>
              <given-names>P.H.</given-names>
            </name>
            <name>
              <surname>Carmical</surname>
              <given-names>S.G.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>T.M.</given-names>
            </name>
            <name>
              <surname>Taegtmeyer</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Metabolic fate of glucose in reversible low-flow ischemia of the isolated working rat heart</article-title>
          <source>Am. J. Physiol.</source>
          <volume>270</volume>
          <year>1996</year>
          <fpage>H817</fpage>
          <lpage>H826</lpage>
          <pub-id pub-id-type="pmid">8780175</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0165">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jain</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Brenner</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Cui</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Pimentel</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Koh</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Sawyer</surname>
              <given-names>D.B.</given-names>
            </name>
            <name>
              <surname>Leopold</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Handy</surname>
              <given-names>D.E.</given-names>
            </name>
            <name>
              <surname>Loscalzo</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Apstein</surname>
              <given-names>C.S.</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Glucose-6-phosphate dehydrogenase modulates cytosolic redox status and contractile phenotype in adult cardiomyocytes</article-title>
          <source>Circ. Res.</source>
          <volume>93</volume>
          <year>2003</year>
          <fpage>e9</fpage>
          <lpage>e16</lpage>
          <pub-id pub-id-type="pmid">12829617</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0170">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jain</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cui</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Brenner</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Handy</surname>
              <given-names>D.E.</given-names>
            </name>
            <name>
              <surname>Leopold</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Loscalzo</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Apstein</surname>
              <given-names>C.S.</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Increased myocardial dysfunction after ischemia–reperfusion in mice lacking glucose-6-phosphate dehydrogenase</article-title>
          <source>Circulation</source>
          <volume>109</volume>
          <year>2004</year>
          <fpage>898</fpage>
          <lpage>903</lpage>
          <pub-id pub-id-type="pmid">14757696</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0175">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gupte</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Gupte</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Lionetti</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Labinskyy</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Floyd</surname>
              <given-names>B.C.</given-names>
            </name>
            <name>
              <surname>Ojaimi</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Bellomo</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wolin</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Recchia</surname>
              <given-names>F.A.</given-names>
            </name>
          </person-group>
          <article-title>Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart</article-title>
          <source>J. Mol. Cell. Cardiol.</source>
          <volume>41</volume>
          <year>2006</year>
          <fpage>340</fpage>
          <lpage>349</lpage>
          <pub-id pub-id-type="pmid">16828794</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0180">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kowaltowski</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>de Souza-Pinto</surname>
              <given-names>N.C.</given-names>
            </name>
            <name>
              <surname>Castilho</surname>
              <given-names>R.F.</given-names>
            </name>
            <name>
              <surname>Vercesi</surname>
              <given-names>A.E.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondria and reactive oxygen species</article-title>
          <source>Free Radic. Biol. Med.</source>
          <volume>47</volume>
          <year>2009</year>
          <fpage>333</fpage>
          <lpage>343</lpage>
          <pub-id pub-id-type="pmid">19427899</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0185">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murphy</surname>
              <given-names>M.P.</given-names>
            </name>
          </person-group>
          <article-title>How mitochondria produce reactive oxygen species</article-title>
          <source>Biochem. J.</source>
          <volume>417</volume>
          <year>2009</year>
          <fpage>1</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">19061483</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0190">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aon</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Cortassa</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>O'Rourke</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Redox-optimized ROS balance: a unifying hypothesis</article-title>
          <source>Biochim. Biophys. Acta</source>
          <volume>1797</volume>
          <year>2010</year>
          <fpage>865</fpage>
          <lpage>877</lpage>
          <pub-id pub-id-type="pmid">20175987</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0195">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kohlhaas</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Knopp</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Zeller</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ong</surname>
              <given-names>M.F.</given-names>
            </name>
            <name>
              <surname>Böhm</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>O'Rourke</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Maack</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Elevated cytosolic Na<sup>+</sup> increases mitochondrial formation of reactive oxygen species in failing cardiac myocytes</article-title>
          <source>Circulation</source>
          <volume>121</volume>
          <year>2010</year>
          <fpage>1606</fpage>
          <lpage>1613</lpage>
          <pub-id pub-id-type="pmid">20351235</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0200">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ide</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Tsutsui</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kinugawa</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Utsumi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Hattori</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Uchida</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Arimura</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Egashira</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Takeshita</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium</article-title>
          <source>Circ. Res.</source>
          <volume>85</volume>
          <year>1999</year>
          <fpage>357</fpage>
          <lpage>363</lpage>
          <pub-id pub-id-type="pmid">10455064</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0205">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ide</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Tsutsui</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hayashidani</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Suematsu</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Utsumi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hamasaki</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Takeshita</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction</article-title>
          <source>Circ. Res.</source>
          <volume>88</volume>
          <year>2001</year>
          <fpage>529</fpage>
          <lpage>535</lpage>
          <pub-id pub-id-type="pmid">11249877</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0210">
        <label>42</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marín-García</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Goldenthal</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Moe</surname>
              <given-names>G.W.</given-names>
            </name>
          </person-group>
          <article-title>Abnormal cardiac and skeletal muscle mitochondrial function in pacing-induced cardiac failure</article-title>
          <source>Cardiovasc. Res.</source>
          <volume>52</volume>
          <year>2001</year>
          <fpage>103</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="pmid">11557238</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0215">
        <label>43</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zorov</surname>
              <given-names>D.B.</given-names>
            </name>
            <name>
              <surname>Filburn</surname>
              <given-names>C.R.</given-names>
            </name>
            <name>
              <surname>Klotz</surname>
              <given-names>L.O.</given-names>
            </name>
            <name>
              <surname>Zweier</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Sollott</surname>
              <given-names>S.J.</given-names>
            </name>
          </person-group>
          <article-title>Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes</article-title>
          <source>J. Exp. Med.</source>
          <volume>192</volume>
          <year>2000</year>
          <fpage>1001</fpage>
          <lpage>1014</lpage>
          <pub-id pub-id-type="pmid">11015441</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0220">
        <label>44</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aon</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Cortassa</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Marbán</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>O'Rourke</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Synchronized whole cell oscillations in mitochondrial metabolism triggered by a local release of reactive oxygen species in cardiac myocytes</article-title>
          <source>J. Biol. Chem.</source>
          <volume>278</volume>
          <year>2003</year>
          <fpage>44735</fpage>
          <lpage>44744</lpage>
          <pub-id pub-id-type="pmid">12930841</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0225">
        <label>45</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Fang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Groom</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Mattson</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Kao</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Lakatta</surname>
              <given-names>E.G.</given-names>
            </name>
            <name>
              <surname>Sheu</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Ouyang</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Dirksen</surname>
              <given-names>R.T.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Superoxide flashes in single mitochondria</article-title>
          <source>Cell</source>
          <volume>134</volume>
          <year>2008</year>
          <fpage>279</fpage>
          <lpage>290</lpage>
          <pub-id pub-id-type="pmid">18662543</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0230">
        <label>46</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Conrad</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Jakupoglu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Moreno</surname>
              <given-names>S.G.</given-names>
            </name>
            <name>
              <surname>Lippl</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Banjac</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Beck</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hatzopoulos</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Just</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Sinowatz</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Schmahl</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Chien</surname>
              <given-names>K.R.</given-names>
            </name>
            <name>
              <surname>Wurst</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Bornkamm</surname>
              <given-names>G.W.</given-names>
            </name>
            <name>
              <surname>Brielmeier</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function</article-title>
          <source>Mol. Cell. Biol.</source>
          <volume>24</volume>
          <year>2004</year>
          <fpage>9414</fpage>
          <lpage>9423</lpage>
          <pub-id pub-id-type="pmid">15485910</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0235">
        <label>47</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>T.T.</given-names>
            </name>
            <name>
              <surname>Carlson</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Melov</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ursell</surname>
              <given-names>P.C.</given-names>
            </name>
            <name>
              <surname>Olson</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Noble</surname>
              <given-names>L.J.</given-names>
            </name>
            <name>
              <surname>Yoshimura</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>P.H.</given-names>
            </name>
            <name>
              <surname>Wallace</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Epstein</surname>
              <given-names>C.J.</given-names>
            </name>
          </person-group>
          <article-title>Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase</article-title>
          <source>Nat. Genet.</source>
          <volume>11</volume>
          <year>1995</year>
          <fpage>376</fpage>
          <lpage>381</lpage>
          <pub-id pub-id-type="pmid">7493016</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0240">
        <label>48</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsushima</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ide</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Yamato</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Matsusaka</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hattori</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Ikeuchi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kubota</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Sunagawa</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hasegawa</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kurihara</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Oikawa</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kinugawa</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tsutsui</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice</article-title>
          <source>Circulation</source>
          <volume>113</volume>
          <year>2006</year>
          <fpage>1779</fpage>
          <lpage>1786</lpage>
          <pub-id pub-id-type="pmid">16585391</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0245">
        <label>49</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shiomi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Tsutsui</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Matsusaka</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Murakami</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hayashidani</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ikeuchi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kubota</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Utsumi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Takeshita</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice</article-title>
          <source>Circulation</source>
          <volume>109</volume>
          <year>2004</year>
          <fpage>544</fpage>
          <lpage>549</lpage>
          <pub-id pub-id-type="pmid">14744974</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0250">
        <label>50</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schriner</surname>
              <given-names>S.E.</given-names>
            </name>
            <name>
              <surname>Linford</surname>
              <given-names>N.J.</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Treuting</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Ogburn</surname>
              <given-names>C.E.</given-names>
            </name>
            <name>
              <surname>Emond</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Coskun</surname>
              <given-names>P.E.</given-names>
            </name>
            <name>
              <surname>Ladiges</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Van Remmen</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Wallace</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Rabinovitch</surname>
              <given-names>P.S.</given-names>
            </name>
          </person-group>
          <article-title>Extension of murine life span by overexpression of catalase targeted to mitochondria</article-title>
          <source>Science</source>
          <volume>308</volume>
          <year>2005</year>
          <fpage>1909</fpage>
          <lpage>1911</lpage>
          <pub-id pub-id-type="pmid">15879174</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0255">
        <label>51</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dai</surname>
              <given-names>D.F.</given-names>
            </name>
            <name>
              <surname>Santana</surname>
              <given-names>L.F.</given-names>
            </name>
            <name>
              <surname>Vermulst</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tomazela</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Emond</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>MacCoss</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Gollahon</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Loeb</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Ladiges</surname>
              <given-names>W.C.</given-names>
            </name>
            <name>
              <surname>Rabinovitch</surname>
              <given-names>P.S.</given-names>
            </name>
          </person-group>
          <article-title>Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging</article-title>
          <source>Circulation</source>
          <volume>119</volume>
          <year>2009</year>
          <fpage>2789</fpage>
          <lpage>2797</lpage>
          <pub-id pub-id-type="pmid">19451351</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0260">
        <label>52</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lambeth</surname>
              <given-names>J.D.N.O.X.</given-names>
            </name>
          </person-group>
          <article-title>enzymes and the biology of reactive oxygen</article-title>
          <source>Nat. Rev. Immunol.</source>
          <volume>4</volume>
          <year>2004</year>
          <fpage>181</fpage>
          <lpage>189</lpage>
          <pub-id pub-id-type="pmid">15039755</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0265">
        <label>53</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van der Vliet</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>NADPH oxidases in lung biology and pathology: host defense enzymes, and more</article-title>
          <source>Free Radic. Biol. Med.</source>
          <volume>44</volume>
          <year>2008</year>
          <fpage>938</fpage>
          <lpage>955</lpage>
          <pub-id pub-id-type="pmid">18164271</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0270">
        <label>54</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bedard</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Krause</surname>
              <given-names>K.H.</given-names>
            </name>
          </person-group>
          <article-title>The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology</article-title>
          <source>Physiol. Rev.</source>
          <volume>87</volume>
          <year>2007</year>
          <fpage>245</fpage>
          <lpage>313</lpage>
          <pub-id pub-id-type="pmid">17237347</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0275">
        <label>55</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brandes</surname>
              <given-names>R.P.</given-names>
            </name>
            <name>
              <surname>Weissmann</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Schröder</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>NADPH oxidases in cardiovascular disease</article-title>
          <source>Free Radic. Biol. Med.</source>
          <volume>49</volume>
          <year>2010</year>
          <fpage>687</fpage>
          <lpage>706</lpage>
          <pub-id pub-id-type="pmid">20444433</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0280">
        <label>56</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>D.I.</given-names>
            </name>
            <name>
              <surname>Griendling</surname>
              <given-names>K.K.</given-names>
            </name>
          </person-group>
          <article-title>Nox proteins in signal transduction</article-title>
          <source>Free Radic. Biol. Med.</source>
          <volume>47</volume>
          <year>2009</year>
          <fpage>1239</fpage>
          <lpage>1253</lpage>
          <pub-id pub-id-type="pmid">19628035</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0285">
        <label>57</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ushio-Fukai</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Compartmentalization of redox signaling through NADPH oxidase-derived ROS</article-title>
          <source>Antioxid. Redox Signaling</source>
          <volume>11</volume>
          <year>2009</year>
          <fpage>1289</fpage>
          <lpage>1299</lpage>
        </element-citation>
      </ref>
      <ref id="bb0290">
        <label>58</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Gall</surname>
              <given-names>N.P.</given-names>
            </name>
            <name>
              <surname>Grieve</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>Activation of NADPH oxidase during progression of cardiac hypertrophy to failure</article-title>
          <source>Hypertension</source>
          <volume>40</volume>
          <year>2002</year>
          <fpage>477</fpage>
          <lpage>484</lpage>
          <pub-id pub-id-type="pmid">12364350</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0295">
        <label>59</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bendall</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Cave</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Heymes</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Gall</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice</article-title>
          <source>Circulation</source>
          <volume>105</volume>
          <year>2002</year>
          <fpage>293</fpage>
          <lpage>296</lpage>
          <pub-id pub-id-type="pmid">11804982</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0300">
        <label>60</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heymes</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Bendall</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Ratajczak</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Cave</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Samuel</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Hasenfuss</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>Increased myocardial NADPH oxidase activity in human heart failure</article-title>
          <source>J. Am. Coll. Cardiol.</source>
          <volume>41</volume>
          <year>2003</year>
          <fpage>2164</fpage>
          <lpage>2171</lpage>
          <pub-id pub-id-type="pmid">12821241</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0305">
        <label>61</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hingtgen</surname>
              <given-names>S.D.</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Dunlay</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Peek</surname>
              <given-names>A.S.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>R.V.</given-names>
            </name>
            <name>
              <surname>Engelhardt</surname>
              <given-names>J.F.</given-names>
            </name>
            <name>
              <surname>Davisson</surname>
              <given-names>R.L.</given-names>
            </name>
          </person-group>
          <article-title>Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy</article-title>
          <source>Physiol. Genomics</source>
          <volume>26</volume>
          <year>2006</year>
          <fpage>180</fpage>
          <lpage>191</lpage>
          <pub-id pub-id-type="pmid">16670255</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0310">
        <label>62</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Byrne</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Grieve</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Bendall</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Gove</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Lambeth</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Cave</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy</article-title>
          <source>Circ. Res.</source>
          <volume>93</volume>
          <year>2003</year>
          <fpage>802</fpage>
          <lpage>805</lpage>
          <pub-id pub-id-type="pmid">14551238</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0315">
        <label>63</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Stouffs</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Serrander</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Banfi</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Bettiol</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Charnay</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Steger</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Krause</surname>
              <given-names>K.H.</given-names>
            </name>
            <name>
              <surname>Jaconi</surname>
              <given-names>M.E.</given-names>
            </name>
          </person-group>
          <article-title>The NADPH oxidase NOX4 drives cardiac differentiation: role in regulating cardiac transcription factors and MAP kinase activation</article-title>
          <source>Mol. Biol. Cell</source>
          <volume>17</volume>
          <year>2006</year>
          <fpage>3978</fpage>
          <lpage>3988</lpage>
          <pub-id pub-id-type="pmid">16775014</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0320">
        <label>64</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ago</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kuroda</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Pain</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Fu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Sadoshima</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes</article-title>
          <source>Circ. Res.</source>
          <volume>106</volume>
          <year>2010</year>
          <fpage>1253</fpage>
          <lpage>1264</lpage>
          <pub-id pub-id-type="pmid">20185797</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0325">
        <label>65</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Brewer</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Schröder</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>C.X.</given-names>
            </name>
            <name>
              <surname>Grieve</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Anilkumar</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Dong</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Brandes</surname>
              <given-names>R.P.</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <volume>107</volume>
          <year>2010</year>
          <fpage>18121</fpage>
          <lpage>18126</lpage>
          <pub-id pub-id-type="pmid">20921387</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0330">
        <label>66</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martyn</surname>
              <given-names>K.D.</given-names>
            </name>
            <name>
              <surname>Frederick</surname>
              <given-names>L.M.</given-names>
            </name>
            <name>
              <surname>von Loehneysen</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Dinauer</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Knaus</surname>
              <given-names>U.G.</given-names>
            </name>
          </person-group>
          <article-title>Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases</article-title>
          <source>Cell. Signal.</source>
          <volume>18</volume>
          <year>2006</year>
          <fpage>69</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="pmid">15927447</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0335">
        <label>67</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Serrander</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Cartier</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Bedard</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Banfi</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Lardy</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Plastre</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Sienkiewicz</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Fórró</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Schlegel</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Krause</surname>
              <given-names>K.H.</given-names>
            </name>
          </person-group>
          <article-title>NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation</article-title>
          <source>Biochem. J.</source>
          <volume>406</volume>
          <year>2007</year>
          <fpage>105</fpage>
          <lpage>114</lpage>
          <pub-id pub-id-type="pmid">17501721</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0340">
        <label>68</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dikalov</surname>
              <given-names>S.I.</given-names>
            </name>
            <name>
              <surname>Dikalova</surname>
              <given-names>A.E.</given-names>
            </name>
            <name>
              <surname>Bikineyeva</surname>
              <given-names>A.T.</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>D.G.</given-names>
            </name>
            <name>
              <surname>Griendling</surname>
              <given-names>K.K.</given-names>
            </name>
          </person-group>
          <article-title>Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production</article-title>
          <source>Free Radic. Biol. Med.</source>
          <volume>45</volume>
          <year>2008</year>
          <fpage>1340</fpage>
          <lpage>1351</lpage>
          <pub-id pub-id-type="pmid">18760347</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0345">
        <label>69</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nisimoto</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>H.M.</given-names>
            </name>
            <name>
              <surname>Ogawa</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kawahara</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Lambeth</surname>
              <given-names>J.D.</given-names>
            </name>
          </person-group>
          <article-title>Constitutive NADPH-dependent electron transferase activity of the Nox4 dehydrogenase domain</article-title>
          <source>Biochemistry</source>
          <volume>49</volume>
          <year>2010</year>
          <fpage>2433</fpage>
          <lpage>2442</lpage>
          <pub-id pub-id-type="pmid">20163138</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0350">
        <label>70</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuroda</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ago</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Matsushima</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Zhai</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>M.D.</given-names>
            </name>
            <name>
              <surname>Sadoshima</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <volume>107</volume>
          <year>2010</year>
          <fpage>15565</fpage>
          <lpage>15570</lpage>
          <pub-id pub-id-type="pmid">20713697</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0355">
        <label>71</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Looi</surname>
              <given-names>Y.H.</given-names>
            </name>
            <name>
              <surname>Grieve</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Siva</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Anilkumar</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Cave</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Marber</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Monaghan</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction</article-title>
          <source>Hypertension</source>
          <volume>51</volume>
          <year>2008</year>
          <fpage>319</fpage>
          <lpage>325</lpage>
          <pub-id pub-id-type="pmid">18180403</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0360">
        <label>72</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmelter</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ateghang</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Helmig</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wartenberg</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sauer</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Embryonic stem cells utilize reactive oxygen species as transducers of mechanical strain-induced cardiovascular differentiation</article-title>
          <source>FASEB J.</source>
          <volume>20</volume>
          <year>2006</year>
          <fpage>1182</fpage>
          <lpage>1184</lpage>
          <pub-id pub-id-type="pmid">16636108</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0365">
        <label>73</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tabar</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Malec</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Eul</surname>
              <given-names>B.G.</given-names>
            </name>
            <name>
              <surname>Klepetko</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Weissmann</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Grimminger</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Seeger</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Rose</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Hänze</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>NOX4 regulates ROS levels under normoxic and hypoxic conditions, triggers proliferation, and inhibits apoptosis in pulmonary artery adventitial fibroblasts</article-title>
          <source>Antioxid. Redox Signaling</source>
          <volume>10</volume>
          <year>2008</year>
          <fpage>1687</fpage>
          <lpage>1698</lpage>
        </element-citation>
      </ref>
      <ref id="bb0370">
        <label>74</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Santos</surname>
              <given-names>C.X.</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>L.Y.</given-names>
            </name>
            <name>
              <surname>Wosniak</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Laurindo</surname>
              <given-names>F.R.</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase</article-title>
          <source>Antioxid. Redox Signaling</source>
          <volume>11</volume>
          <year>2009</year>
          <fpage>2409</fpage>
          <lpage>2427</lpage>
        </element-citation>
      </ref>
      <ref id="bb0375">
        <label>75</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pedruzzi</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Guichard</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Ollivier</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Driss</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Fay</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Prunet</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Marie</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Pouzet</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Samadi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Elbim</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>O'dowd</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Bens</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Vandewalle</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Gougerot-Pocidalo</surname>
              <given-names>M.A.</given-names>
            </name>
          </person-group>
          <article-title>Lizard, G; Ogier-Denis, E. NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells</article-title>
          <source>Mol. Cell. Biol.</source>
          <volume>24</volume>
          <year>2004</year>
          <fpage>10703</fpage>
          <lpage>10717</lpage>
          <pub-id pub-id-type="pmid">15572675</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0380">
        <label>76</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wosniak</surname>
              <given-names>J.</given-names>
              <suffix>Jr.</suffix>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>C.X.</given-names>
            </name>
            <name>
              <surname>Kowaltowski</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Laurindo</surname>
              <given-names>F.R.</given-names>
            </name>
          </person-group>
          <article-title>Cross-talk between mitochondria and NADPH oxidase: effects of mild mitochondrial dysfunction on angiotensin II-mediated increase in Nox isoform expression and activity in vascular smooth muscle cells</article-title>
          <source>Antioxid. Redox Signaling</source>
          <volume>11</volume>
          <year>2009</year>
          <fpage>1265</fpage>
          <lpage>1278</lpage>
        </element-citation>
      </ref>
      <ref id="bb0385">
        <label>77</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Govindarajan</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Sligh</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Vincent</surname>
              <given-names>B.J.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Canter</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Nickoloff</surname>
              <given-names>B.J.</given-names>
            </name>
            <name>
              <surname>Rodenburg</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Smeitink</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Oberley</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Slingerland</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Arnold</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Lambeth</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Hilenski</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Griendling</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Martínez-Diez</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cuezva</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Arbiser</surname>
              <given-names>J.L.</given-names>
            </name>
          </person-group>
          <article-title>Overexpression of Akt converts radial growth melanoma to vertical growth melanoma</article-title>
          <source>J. Clin. Invest.</source>
          <volume>117</volume>
          <year>2007</year>
          <fpage>719</fpage>
          <lpage>729</lpage>
          <pub-id pub-id-type="pmid">17318262</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0390">
        <label>78</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lima</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Forrester</surname>
              <given-names>M.T.</given-names>
            </name>
            <name>
              <surname>Hess</surname>
              <given-names>D.T.</given-names>
            </name>
            <name>
              <surname>Stamler</surname>
              <given-names>J.S.</given-names>
            </name>
          </person-group>
          <article-title>S-nitrosylation in cardiovascular signaling</article-title>
          <source>Circ. Res.</source>
          <volume>106</volume>
          <year>2010</year>
          <fpage>633</fpage>
          <lpage>646</lpage>
          <pub-id pub-id-type="pmid">20203313</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0395">
        <label>79</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vásquez-Vivar</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Tetrahydrobiopterin, superoxide, and vascular dysfunction</article-title>
          <source>Free Radic. Biol. Med.</source>
          <volume>47</volume>
          <year>2009</year>
          <fpage>1108</fpage>
          <lpage>1119</lpage>
          <pub-id pub-id-type="pmid">19628033</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0400">
        <label>80</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Landmesser</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Dikalov</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Price</surname>
              <given-names>S.R.</given-names>
            </name>
            <name>
              <surname>McCann</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Fukai</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Holland</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Mitch</surname>
              <given-names>W.E.</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>D.G.</given-names>
            </name>
          </person-group>
          <article-title>Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension</article-title>
          <source>J. Clin. Invest.</source>
          <volume>111</volume>
          <year>2003</year>
          <fpage>1201</fpage>
          <lpage>1209</lpage>
          <pub-id pub-id-type="pmid">12697739</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0405">
        <label>81</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beckmann</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>Y.Z.</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>P.G.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Accavitti</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Tarpey</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>C.R.</given-names>
            </name>
          </person-group>
          <article-title>Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry</article-title>
          <source>Biol. Chem. Hoppe Seyler</source>
          <volume>375</volume>
          <year>1994</year>
          <fpage>81</fpage>
          <lpage>88</lpage>
          <pub-id pub-id-type="pmid">8192861</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0410">
        <label>82</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nishino</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Okamoto</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Eger</surname>
              <given-names>B.T.</given-names>
            </name>
            <name>
              <surname>Pai</surname>
              <given-names>E.F.</given-names>
            </name>
            <name>
              <surname>Nishino</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Mammalian xanthine oxidoreductase—mechanism of transition from xanthine dehydrogenase to xanthine oxidase</article-title>
          <source>FEBS J.</source>
          <volume>275</volume>
          <year>2008</year>
          <fpage>3278</fpage>
          <lpage>3289</lpage>
          <pub-id pub-id-type="pmid">18513323</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0415">
        <label>83</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kelley</surname>
              <given-names>E.E.</given-names>
            </name>
            <name>
              <surname>Khoo</surname>
              <given-names>N.K.</given-names>
            </name>
            <name>
              <surname>Hundley</surname>
              <given-names>N.J.</given-names>
            </name>
            <name>
              <surname>Malik</surname>
              <given-names>U.Z.</given-names>
            </name>
            <name>
              <surname>Freeman</surname>
              <given-names>B.A.</given-names>
            </name>
            <name>
              <surname>Tarpey</surname>
              <given-names>M.M.</given-names>
            </name>
          </person-group>
          <article-title>Hydrogen peroxide is the major oxidant product of xanthine oxidase</article-title>
          <source>Free Radic. Biol. Med.</source>
          <volume>48</volume>
          <year>2010</year>
          <fpage>493</fpage>
          <lpage>498</lpage>
          <pub-id pub-id-type="pmid">19941951</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0420">
        <label>84</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Minhas</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Saraiva</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Schuleri</surname>
              <given-names>K.H.</given-names>
            </name>
            <name>
              <surname>Lehrke</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Saliaris</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Berry</surname>
              <given-names>C.E.</given-names>
            </name>
            <name>
              <surname>Barouch</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Vandegaer</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Hare</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy</article-title>
          <source>Circ. Res.</source>
          <volume>98</volume>
          <year>2006</year>
          <fpage>271</fpage>
          <lpage>279</lpage>
          <pub-id pub-id-type="pmid">16357304</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0425">
        <label>85</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saavedra</surname>
              <given-names>W.F.</given-names>
            </name>
            <name>
              <surname>Paolocci</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>St John</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Skaf</surname>
              <given-names>M.W.</given-names>
            </name>
            <name>
              <surname>Stewart</surname>
              <given-names>G.C.</given-names>
            </name>
            <name>
              <surname>Xie</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>R.W.</given-names>
            </name>
            <name>
              <surname>Zeichner</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Mudrick</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Marbán</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Kass</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Hare</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart</article-title>
          <source>Circ. Res.</source>
          <volume>90</volume>
          <year>2002</year>
          <fpage>297</fpage>
          <lpage>304</lpage>
          <pub-id pub-id-type="pmid">11861418</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0430">
        <label>86</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kinugawa</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Kaminski</surname>
              <given-names>P.M.</given-names>
            </name>
            <name>
              <surname>Wolin</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Hintze</surname>
              <given-names>T.H.</given-names>
            </name>
          </person-group>
          <article-title>A defect of neuronal nitric oxide synthase increases xanthine oxidase-derived superoxide anion and attenuates the control of myocardial oxygen consumption by nitric oxide derived from endothelial nitric oxide synthase</article-title>
          <source>Circ. Res.</source>
          <volume>96</volume>
          <year>2005</year>
          <fpage>355</fpage>
          <lpage>362</lpage>
          <pub-id pub-id-type="pmid">15637297</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0435">
        <label>87</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>St-Pierre</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Buckingham</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Roebuck</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Brand</surname>
              <given-names>M.D.</given-names>
            </name>
          </person-group>
          <article-title>Topology of superoxide production from different sites in the mitochondrial electron transport chain</article-title>
          <source>J. Biol. Chem.</source>
          <volume>277</volume>
          <year>2002</year>
          <fpage>44784</fpage>
          <lpage>44790</lpage>
          <pub-id pub-id-type="pmid">12237311</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0440">
        <label>88</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaludercic</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Takimoto</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Nagayama</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>E.W.</given-names>
            </name>
            <name>
              <surname>Bedja</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Gabrielson</surname>
              <given-names>K.L.</given-names>
            </name>
            <name>
              <surname>Blakely</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Shih</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Pacak</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kass</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Di Lisa</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Paolocci</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload</article-title>
          <source>Circ. Res.</source>
          <volume>106</volume>
          <year>2010</year>
          <fpage>193</fpage>
          <lpage>202</lpage>
          <pub-id pub-id-type="pmid">19910579</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0445">
        <label>89</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Go</surname>
              <given-names>Y.M.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>D.P.</given-names>
            </name>
          </person-group>
          <article-title>Redox compartmentalization in eukaryotic cells</article-title>
          <source>Biochim. Biophys. Acta</source>
          <volume>1780</volume>
          <year>2008</year>
          <fpage>1273</fpage>
          <lpage>1290</lpage>
          <pub-id pub-id-type="pmid">18267127</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0450">
        <label>90</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yanes</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Patti</surname>
              <given-names>G.J.</given-names>
            </name>
            <name>
              <surname>Sánchez-Ruiz</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Benton</surname>
              <given-names>H.P.</given-names>
            </name>
            <name>
              <surname>Trauger</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Desponts</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Siuzdak</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Metabolic oxidation regulates embryonic stem cell differentiation</article-title>
          <source>Nat. Chem. Biol.</source>
          <volume>6</volume>
          <year>2010</year>
          <fpage>411</fpage>
          <lpage>417</lpage>
          <pub-id pub-id-type="pmid">20436487</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0455">
        <label>91</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sauer</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Rahimi</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Hescheler</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wartenberg</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Role of reactive oxygen species and phosphatidylinositol 3-kinase in cardiomyocyte differentiation of embryonic stem cells</article-title>
          <source>FEBS Lett.</source>
          <volume>476</volume>
          <year>2000</year>
          <fpage>218</fpage>
          <lpage>223</lpage>
          <pub-id pub-id-type="pmid">10913617</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0460">
        <label>92</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buggisch</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ateghang</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Ruhe</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Strobel</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Lange</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wartenberg</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sauer</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Stimulation of ES-cell-derived cardiomyogenesis and neonatal cardiac cell proliferation by reactive oxygen species and NADPH oxidase</article-title>
          <source>J. Cell Sci.</source>
          <volume>120</volume>
          <year>2007</year>
          <fpage>885</fpage>
          <lpage>894</lpage>
          <pub-id pub-id-type="pmid">17298980</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0465">
        <label>93</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gurusamy</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Mukherjee</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Lekli</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Bearzi</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Bardelli</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Das</surname>
              <given-names>D.K.</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of ref-1 stimulates the production of reactive oxygen species and induces differentiation in adult cardiac stem cells</article-title>
          <source>Antioxid. Redox Signaling</source>
          <volume>11</volume>
          <year>2009</year>
          <fpage>589</fpage>
          <lpage>600</lpage>
        </element-citation>
      </ref>
      <ref id="bb0470">
        <label>94</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sauer</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Rahimi</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Hescheler</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wartenberg</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Effects of electrical fields on cardiomyocyte differentiation of embryonic stem cells</article-title>
          <source>J. Cell. Biochem.</source>
          <volume>75</volume>
          <year>1999</year>
          <fpage>710</fpage>
          <lpage>723</lpage>
          <pub-id pub-id-type="pmid">10572253</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0475">
        <label>95</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Serena</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Figallo</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Tandon</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Cannizzaro</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Gerecht</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Elvassore</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Vunjak-Novakovic</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Electrical stimulation of human embryonic stem cells: cardiac differentiation and the generation of reactive oxygen species</article-title>
          <source>Exp. Cell Res.</source>
          <volume>315</volume>
          <year>2009</year>
          <fpage>3611</fpage>
          <lpage>3619</lpage>
          <pub-id pub-id-type="pmid">19720058</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0480">
        <label>96</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pucéat</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Travo</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Quinn</surname>
              <given-names>M.T.</given-names>
            </name>
            <name>
              <surname>Fort</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>A dual role of the GTPase Rac in cardiac differentiation of stem cells</article-title>
          <source>Mol. Biol. Cell</source>
          <volume>14</volume>
          <year>2003</year>
          <fpage>2781</fpage>
          <lpage>2792</lpage>
          <pub-id pub-id-type="pmid">12857864</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0485">
        <label>97</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sauer</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Neukirchen</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Rahimi</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Grünheck</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Hescheler</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wartenberg</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Involvement of reactive oxygen species in cardiotrophin-1-induced proliferation of cardiomyocytes differentiated from murine embryonic stem cells</article-title>
          <source>Exp. Cell Res.</source>
          <volume>294</volume>
          <year>2004</year>
          <fpage>313</fpage>
          <lpage>324</lpage>
          <pub-id pub-id-type="pmid">15023522</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0490">
        <label>98</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sharifpanah</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Wartenberg</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hannig</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Piper</surname>
              <given-names>H.M.</given-names>
            </name>
            <name>
              <surname>Sauer</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Peroxisome proliferator-activated receptor alpha agonists enhance cardiomyogenesis of mouse ES cells by utilization of a reactive oxygen species-dependent mechanism</article-title>
          <source>Stem Cells</source>
          <volume>26</volume>
          <year>2008</year>
          <fpage>64</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="pmid">17951219</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0495">
        <label>99</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yuen</surname>
              <given-names>W.H.</given-names>
            </name>
            <name>
              <surname>Fu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Melendez</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Ibrahim</surname>
              <given-names>F.B.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>X.</given-names>
            </name>
          </person-group>
          <article-title>The mitochondrial respiratory chain controls intracellular calcium signaling and NFAT activity essential for heart formation in Xenopus laevis</article-title>
          <source>Mol. Cell. Biol.</source>
          <volume>27</volume>
          <year>2007</year>
          <fpage>6420</fpage>
          <lpage>6432</lpage>
          <pub-id pub-id-type="pmid">17636012</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0500">
        <label>100</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spitkovsky</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Sasse</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Kolossov</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Böttinger</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Fleischmann</surname>
              <given-names>B.K.</given-names>
            </name>
            <name>
              <surname>Hescheler</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wiesner</surname>
              <given-names>R.J.</given-names>
            </name>
          </person-group>
          <article-title>Activity of complex III of the mitochondrial electron transport chain is essential for early heart muscle cell differentiation</article-title>
          <source>FASEB J.</source>
          <volume>18</volume>
          <year>2004</year>
          <fpage>1300</fpage>
          <lpage>1302</lpage>
          <pub-id pub-id-type="pmid">15180963</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0505">
        <label>101</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bers</surname>
              <given-names>D.M.</given-names>
            </name>
          </person-group>
          <article-title>Calcium cycling and signaling in cardiac myocytes</article-title>
          <source>Annu. Rev. Physiol.</source>
          <volume>70</volume>
          <year>2008</year>
          <fpage>23</fpage>
          <lpage>49</lpage>
          <pub-id pub-id-type="pmid">17988210</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0510">
        <label>102</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Del Monte</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Hajjar</surname>
              <given-names>R.J.</given-names>
            </name>
          </person-group>
          <article-title>Intracellular devastation in heart failure</article-title>
          <source>Heart Fail. Rev.</source>
          <volume>13</volume>
          <year>2008</year>
          <fpage>151</fpage>
          <lpage>162</lpage>
          <pub-id pub-id-type="pmid">18347978</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0515">
        <label>103</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Molkentin</surname>
              <given-names>J.D.</given-names>
            </name>
          </person-group>
          <article-title>Dichotomy of Ca<sup>2+</sup> in the heart: contraction versus intracellular signaling</article-title>
          <source>J. Clin. Invest.</source>
          <volume>116</volume>
          <year>2006</year>
          <fpage>623</fpage>
          <lpage>626</lpage>
          <pub-id pub-id-type="pmid">16511595</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0520">
        <label>104</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aon</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Cortassa</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>O'Rourke</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial oscillations in physiology and pathophysiology</article-title>
          <source>Adv. Exp. Med. Biol.</source>
          <volume>641</volume>
          <year>2008</year>
          <fpage>98</fpage>
          <lpage>117</lpage>
          <pub-id pub-id-type="pmid">18783175</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0525">
        <label>105</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morad</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>Y.J.</given-names>
            </name>
          </person-group>
          <article-title>Redox regulation of cardiac muscle calcium signaling</article-title>
          <source>Antioxid. Redox Signaling</source>
          <volume>2</volume>
          <year>2000</year>
          <fpage>65</fpage>
          <lpage>71</lpage>
        </element-citation>
      </ref>
      <ref id="bb0530">
        <label>106</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zima</surname>
              <given-names>A.V.</given-names>
            </name>
            <name>
              <surname>Blatter</surname>
              <given-names>L.A.</given-names>
            </name>
          </person-group>
          <article-title>Redox regulation of cardiac calcium channels and transporters</article-title>
          <source>Cardiovasc. Res.</source>
          <volume>71</volume>
          <year>2006</year>
          <fpage>310</fpage>
          <lpage>321</lpage>
          <pub-id pub-id-type="pmid">16581043</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0535">
        <label>107</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hidalgo</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Donoso</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Cross-talk between calcium and redox signalling: from molecular mechanisms to health implications</article-title>
          <source>Antioxid. Redox Signaling</source>
          <volume>10</volume>
          <year>2008</year>
          <fpage>1275</fpage>
          <lpage>1312</lpage>
        </element-citation>
      </ref>
      <ref id="bb0540">
        <label>108</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gonzalez</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Treuer</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>Q.A.</given-names>
            </name>
            <name>
              <surname>Stamler</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Hare</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>S-nitrosylation of cardiac ion channels</article-title>
          <source>J. Cardiovasc. Pharmacol.</source>
          <volume>54</volume>
          <year>2009</year>
          <fpage>188</fpage>
          <lpage>195</lpage>
          <pub-id pub-id-type="pmid">19687749</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0545">
        <label>109</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aracena-Parks</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Goonasekera</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Gilman</surname>
              <given-names>C.P.</given-names>
            </name>
            <name>
              <surname>Dirksen</surname>
              <given-names>R.T.</given-names>
            </name>
            <name>
              <surname>Hidalgo</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Hamilton</surname>
              <given-names>S.L.</given-names>
            </name>
          </person-group>
          <article-title>Identification of cysteines involved in S-nitrosylation, S-glutathionylation, and oxidation to disulfides in ryanodine receptor type 1</article-title>
          <source>J. Biol. Chem.</source>
          <volume>281</volume>
          <year>2006</year>
          <fpage>40354</fpage>
          <lpage>40368</lpage>
          <pub-id pub-id-type="pmid">17071618</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0550">
        <label>110</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abramson</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Salama</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Sulfhydryl oxidation and Ca<sup>2+</sup> release from sarcoplasmic reticulum</article-title>
          <source>Mol. Cell. Biochem.</source>
          <volume>82</volume>
          <year>1998</year>
          <fpage>81</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="pmid">3185520</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0555">
        <label>111</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eager</surname>
              <given-names>K.R.</given-names>
            </name>
            <name>
              <surname>Roden</surname>
              <given-names>L.D.</given-names>
            </name>
            <name>
              <surname>Dulhunty</surname>
              <given-names>A.F.</given-names>
            </name>
          </person-group>
          <article-title>Actions of sulfhydryl reagents on single ryanodine receptor Ca<sup>2+</sup>-release channels from sheep myocardium</article-title>
          <source>Am. J. Physiol.</source>
          <volume>272</volume>
          <year>1997</year>
          <fpage>C1908</fpage>
          <lpage>C1918</lpage>
          <pub-id pub-id-type="pmid">9227420</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0560">
        <label>112</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marengo</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Hidalgo</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Bull</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Sulfhydryl oxidation modifies the calcium dependence of ryanodine-sensitive calcium channels of excitable cells</article-title>
          <source>Biophys. J.</source>
          <volume>74</volume>
          <year>1998</year>
          <fpage>1263</fpage>
          <lpage>1277</lpage>
          <pub-id pub-id-type="pmid">9512024</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0565">
        <label>113</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lim</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Venetucci</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Eisner</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Casadei</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Does nitric oxide modulate cardiac ryanodine receptor function? Implications for excitation–contraction coupling</article-title>
          <source>Cardiovasc. Res.</source>
          <volume>77</volume>
          <year>2008</year>
          <fpage>256</fpage>
          <lpage>264</lpage>
          <pub-id pub-id-type="pmid">18006480</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0570">
        <label>114</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barouch</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>R.W.</given-names>
            </name>
            <name>
              <surname>Skaf</surname>
              <given-names>M.W.</given-names>
            </name>
            <name>
              <surname>Rosas</surname>
              <given-names>G.O.</given-names>
            </name>
            <name>
              <surname>Cappola</surname>
              <given-names>T.P.</given-names>
            </name>
            <name>
              <surname>Kobeissi</surname>
              <given-names>Z.A.</given-names>
            </name>
            <name>
              <surname>Hobai</surname>
              <given-names>I.A.</given-names>
            </name>
            <name>
              <surname>Lemmon</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Burnett</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>O'Rourke</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Rodriguez</surname>
              <given-names>E.R.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>P.L.</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Berkowitz</surname>
              <given-names>D.E.</given-names>
            </name>
            <name>
              <surname>Hare</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms</article-title>
          <source>Nature</source>
          <volume>416</volume>
          <year>2002</year>
          <fpage>337</fpage>
          <lpage>339</lpage>
          <pub-id pub-id-type="pmid">11907582</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0575">
        <label>115</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bendall</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Damy</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ratajczak</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Loyer</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Monceau</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Marty</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Milliez</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Robidel</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Marotte</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Samuel</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Heymes</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat</article-title>
          <source>Circulation</source>
          <volume>110</volume>
          <year>2004</year>
          <fpage>2368</fpage>
          <lpage>2375</lpage>
          <pub-id pub-id-type="pmid">15466641</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0580">
        <label>116</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Damy</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ratajczak</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Camors</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Marty</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Hasenfuss</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Marotte</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Samuel</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Heymes</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Increased neuronal nitric oxide synthase-derived NO production in the failing human heart</article-title>
          <source>Lancet</source>
          <volume>363</volume>
          <year>2004</year>
          <fpage>1365</fpage>
          <lpage>1367</lpage>
          <pub-id pub-id-type="pmid">15110495</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0585">
        <label>117</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khan</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Minhas</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Gonzalez</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Raju</surname>
              <given-names>S.V.</given-names>
            </name>
            <name>
              <surname>Tejani</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Berkowitz</surname>
              <given-names>D.E.</given-names>
            </name>
            <name>
              <surname>Hare</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation–contraction coupling</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <volume>101</volume>
          <year>2004</year>
          <fpage>15944</fpage>
          <lpage>15948</lpage>
          <pub-id pub-id-type="pmid">15486091</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0590">
        <label>118</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cherednichenko</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Zima</surname>
              <given-names>A.V.</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Schaefer</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Blatter</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Pessah</surname>
              <given-names>I.N.</given-names>
            </name>
          </person-group>
          <article-title>NADH oxidase activity of rat cardiac sarcoplasmic reticulum regulates calcium-induced calcium release</article-title>
          <source>Circ. Res.</source>
          <volume>94</volume>
          <year>2004</year>
          <fpage>478</fpage>
          <lpage>486</lpage>
          <pub-id pub-id-type="pmid">14699012</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0595">
        <label>119</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sánchez</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Pedrozo</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Domenech</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Hidalgo</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Donoso</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Tachycardia increases NADPH oxidase activity and RyR2 S-glutathionylation in ventricular muscle</article-title>
          <source>J. Mol. Cell. Cardiol.</source>
          <volume>39</volume>
          <year>2005</year>
          <fpage>982</fpage>
          <lpage>991</lpage>
          <pub-id pub-id-type="pmid">16242147</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0600">
        <label>120</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hidalgo</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Sánchez</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Barrientos</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Aracena-Parks</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>A transverse tubule NADPH oxidase activity stimulates calcium release from isolated triads via ryanodine receptor type 1 S-glutathionylation</article-title>
          <source>J. Biol. Chem.</source>
          <volume>281</volume>
          <year>2006</year>
          <fpage>26473</fpage>
          <lpage>26482</lpage>
          <pub-id pub-id-type="pmid">16762927</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0605">
        <label>121</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trafford</surname>
              <given-names>A.W.</given-names>
            </name>
            <name>
              <surname>Díaz</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Sibbring</surname>
              <given-names>G.C.</given-names>
            </name>
            <name>
              <surname>Eisner</surname>
              <given-names>D.A.</given-names>
            </name>
          </person-group>
          <article-title>Modulation of CICR has no maintained effect on systolic Ca<sup>2+</sup>: simultaneous measurements of sarcoplasmic reticulum and sarcolemmal Ca<sup>2+</sup> fluxes in rat ventricular myocytes</article-title>
          <source>J. Physiol.</source>
          <volume>522</volume>
          <year>2000</year>
          <fpage>259</fpage>
          <lpage>270</lpage>
          <pub-id pub-id-type="pmid">10639102</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0610">
        <label>122</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tocchetti</surname>
              <given-names>C.G.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Froehlich</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Huke</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Aon</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Di Benedetto</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>O'Rourke</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>W.D.</given-names>
            </name>
            <name>
              <surname>Wink</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Toscano</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Zaccolo</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bers</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Valdivia</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kass</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Paolocci</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca<sup>2+</sup> cycling</article-title>
          <source>Circ. Res.</source>
          <volume>100</volume>
          <year>2007</year>
          <fpage>96</fpage>
          <lpage>104</lpage>
          <pub-id pub-id-type="pmid">17138943</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0615">
        <label>123</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marx</surname>
              <given-names>S.O.</given-names>
            </name>
            <name>
              <surname>Reiken</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hisamatsu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Jayaraman</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Burkhoff</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Rosemblit</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Marks</surname>
              <given-names>A.R.</given-names>
            </name>
          </person-group>
          <article-title>PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts</article-title>
          <source>Cell</source>
          <volume>101</volume>
          <year>2000</year>
          <fpage>365</fpage>
          <lpage>376</lpage>
          <pub-id pub-id-type="pmid">10830164</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0620">
        <label>124</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kubalova</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Terentyev</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Viatchenko-Karpinski</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Nishijima</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Györke</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Terentyeva</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>da Cuñha</surname>
              <given-names>D.N.</given-names>
            </name>
            <name>
              <surname>Sridhar</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Feldman</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Hamlin</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Carnes</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Györke</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Abnormal intrastore calcium signaling in chronic heart failure</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <volume>102</volume>
          <year>2005</year>
          <fpage>14104</fpage>
          <lpage>14109</lpage>
          <pub-id pub-id-type="pmid">16172392</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0625">
        <label>125</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>M.E.</given-names>
            </name>
          </person-group>
          <article-title>Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias</article-title>
          <source>Pharmacol. Ther.</source>
          <volume>106</volume>
          <year>2005</year>
          <fpage>39</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="pmid">15781121</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0630">
        <label>126</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zissimopoulos</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>F.A.</given-names>
            </name>
          </person-group>
          <article-title>Redox regulation of the ryanodine receptor/calcium release channel</article-title>
          <source>Biochem. Soc. Trans.</source>
          <volume>34</volume>
          <year>2006</year>
          <fpage>919</fpage>
          <lpage>921</lpage>
          <pub-id pub-id-type="pmid">17052227</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0635">
        <label>127</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Györke</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Carnes</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Dysregulated sarcoplasmic reticulum calcium release: potential pharmacological target in cardiac disease</article-title>
          <source>Pharmacol. Ther.</source>
          <volume>119</volume>
          <year>2008</year>
          <fpage>340</fpage>
          <lpage>354</lpage>
          <pub-id pub-id-type="pmid">18675300</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0640">
        <label>128</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Erickson</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Joiner</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Guan</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Kutschke</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Oddis</surname>
              <given-names>C.V.</given-names>
            </name>
            <name>
              <surname>Bartlett</surname>
              <given-names>R.K.</given-names>
            </name>
            <name>
              <surname>Lowe</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>O'Donnell</surname>
              <given-names>S.E.</given-names>
            </name>
            <name>
              <surname>Aykin-Burns</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Zimmerman</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Zimmerman</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Ham</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Spitz</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Shea</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Colbran</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Mohler</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>M.E.</given-names>
            </name>
          </person-group>
          <article-title>A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation</article-title>
          <source>Cell</source>
          <volume>133</volume>
          <year>2008</year>
          <fpage>462</fpage>
          <lpage>474</lpage>
          <pub-id pub-id-type="pmid">18455987</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0645">
        <label>129</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gonzalez</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Treuer</surname>
              <given-names>A.V.</given-names>
            </name>
            <name>
              <surname>Castellanos</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Dulce</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Hare</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>Impaired S-nitrosylation of the ryanodine receptor caused by xanthine oxidase activity contributes to calcium leak in heart failure</article-title>
          <source>J. Biol. Chem.</source>
          <volume>285</volume>
          <year>2010</year>
          <fpage>28938</fpage>
          <lpage>28945</lpage>
          <pub-id pub-id-type="pmid">20643651</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0650">
        <label>130</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mochizuki</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Yano</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Oda</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Tateishi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ikeda</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Ohkusa</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ikemoto</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Matsuzaki</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Scavenging free radicals by low-dose carvedilol prevents redox-dependent Ca<sup>2+</sup> leak via stabilization of ryanodine receptor in heart failure</article-title>
          <source>J. Am. Coll. Cardiol.</source>
          <volume>49</volume>
          <year>2007</year>
          <fpage>1722</fpage>
          <lpage>1732</lpage>
          <pub-id pub-id-type="pmid">17448375</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0655">
        <label>131</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Terentyev</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Györke</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Belevych</surname>
              <given-names>A.E.</given-names>
            </name>
            <name>
              <surname>Terentyeva</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Sridhar</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Nishijima</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>de Blanco</surname>
              <given-names>E.C.</given-names>
            </name>
            <name>
              <surname>Khanna</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Sen</surname>
              <given-names>C.K.</given-names>
            </name>
            <name>
              <surname>Cardounel</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Carnes</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Györke</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca<sup>2+</sup> leak in chronic heart failure</article-title>
          <source>Circ. Res.</source>
          <volume>103</volume>
          <year>2008</year>
          <fpage>1466</fpage>
          <lpage>1472</lpage>
          <pub-id pub-id-type="pmid">19008475</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0660">
        <label>132</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Belevych</surname>
              <given-names>A.E.</given-names>
            </name>
            <name>
              <surname>Terentyev</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Viatchenko-Karpinski</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Terentyeva</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Sridhar</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Nishijima</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>L.D.</given-names>
            </name>
            <name>
              <surname>Cardounel</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Laurita</surname>
              <given-names>K.R.</given-names>
            </name>
            <name>
              <surname>Carnes</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Billman</surname>
              <given-names>G.E.</given-names>
            </name>
            <name>
              <surname>Gyorke</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Redox modification of ryanodine receptors underlies calcium alternans in a canine model of sudden cardiac death</article-title>
          <source>Cardiovasc. Res.</source>
          <volume>84</volume>
          <year>2009</year>
          <fpage>387</fpage>
          <lpage>395</lpage>
          <pub-id pub-id-type="pmid">19617226</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0665">
        <label>133</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ullrich</surname>
              <given-names>N.D.</given-names>
            </name>
            <name>
              <surname>Fanchaouy</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gusev</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Shirokova</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Niggli</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Hypersensitivity of excitation–contraction coupling in dystrophic cardiomyocytes</article-title>
          <source>Am. J. Physiol.</source>
          <volume>297</volume>
          <year>2009</year>
          <fpage>H1992</fpage>
          <lpage>H2003</lpage>
        </element-citation>
      </ref>
      <ref id="bb0670">
        <label>134</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schöneich</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Sharov</surname>
              <given-names>V.S.</given-names>
            </name>
          </person-group>
          <article-title>Mass spectrometry of protein modifications by reactive oxygen and nitrogen species</article-title>
          <source>Free Radic. Biol. Med.</source>
          <volume>41</volume>
          <year>2006</year>
          <fpage>1507</fpage>
          <lpage>1520</lpage>
          <pub-id pub-id-type="pmid">17045919</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0675">
        <label>135</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adachi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Weisbrod</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Pimentel</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Ying</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sharov</surname>
              <given-names>V.S.</given-names>
            </name>
            <name>
              <surname>Schöneich</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>R.A.</given-names>
            </name>
          </person-group>
          <article-title>S-glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide</article-title>
          <source>Nat. Med.</source>
          <volume>10</volume>
          <year>2004</year>
          <fpage>1200</fpage>
          <lpage>1207</lpage>
          <pub-id pub-id-type="pmid">15489859</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0680">
        <label>136</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ying</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Adachi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Sharov</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Lazar</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Menzoian</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Knyushko</surname>
              <given-names>T.V.</given-names>
            </name>
            <name>
              <surname>Bigelow</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Schöneich</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>R.A.</given-names>
            </name>
          </person-group>
          <article-title>Detection of sequence-specific tyrosine nitration of manganese SOD and SERCA in cardiovascular disease and aging</article-title>
          <source>Am. J. Physiol.</source>
          <volume>290</volume>
          <year>2006</year>
          <fpage>H2220</fpage>
          <lpage>H2227</lpage>
        </element-citation>
      </ref>
      <ref id="bb0685">
        <label>137</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sharov</surname>
              <given-names>V.S.</given-names>
            </name>
            <name>
              <surname>Dremina</surname>
              <given-names>E.S.</given-names>
            </name>
            <name>
              <surname>Galeva</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>T.D.</given-names>
            </name>
            <name>
              <surname>Schöneich</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Quantitative mapping of oxidation-sensitive cysteine residues in SERCA in vivo and in vitro by HPLC-electrospray-tandem MS: selective protein oxidation during biological aging</article-title>
          <source>Biochem. J.</source>
          <volume>394</volume>
          <year>2006</year>
          <fpage>605</fpage>
          <lpage>615</lpage>
          <pub-id pub-id-type="pmid">16307534</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0690">
        <label>138</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Redondo</surname>
              <given-names>P.C.</given-names>
            </name>
            <name>
              <surname>Salido</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Rosado</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Pariente</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>Effect of hydrogen peroxide on Ca<sup>2+</sup> mobilisation in human platelets through sulphydryl oxidation dependent and independent mechanisms</article-title>
          <source>Biochem. Pharmacol.</source>
          <volume>67</volume>
          <year>2004</year>
          <fpage>491</fpage>
          <lpage>502</lpage>
          <pub-id pub-id-type="pmid">15037201</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0695">
        <label>139</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lancel</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Evangelista</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Trucillo</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Tong</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Siwik</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Colucci</surname>
              <given-names>W.S.</given-names>
            </name>
          </person-group>
          <article-title>Nitroxyl activates SERCA in cardiac myocytes via glutathiolation of cysteine 674</article-title>
          <source>Circ. Res.</source>
          <volume>104</volume>
          <year>2009</year>
          <fpage>720</fpage>
          <lpage>723</lpage>
          <pub-id pub-id-type="pmid">19265039</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0700">
        <label>140</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuster</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Lancel</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Communal</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Trucillo</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Pfister</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Weinberg</surname>
              <given-names>E.O.</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Siwik</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Colucci</surname>
              <given-names>W.S.</given-names>
            </name>
          </person-group>
          <article-title>Redox-mediated reciprocal regulation of SERCA and Na<sup>+</sup>–Ca<sup>2+</sup> exchanger contributes to sarcoplasmic reticulum Ca<sup>2+</sup> depletion in cardiac myocytes</article-title>
          <source>Free Radic. Biol. Med.</source>
          <volume>48</volume>
          <year>2010</year>
          <fpage>1182</fpage>
          <lpage>1187</lpage>
          <pub-id pub-id-type="pmid">20132882</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0705">
        <label>141</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>S.Y.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Ceylan-Isik</surname>
              <given-names>A.F.</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sreejayan</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Ren</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca<sup>2+</sup>-ATPase and myosin heavy chain isozyme switch</article-title>
          <source>Diabetologia</source>
          <volume>49</volume>
          <year>2006</year>
          <fpage>1434</fpage>
          <lpage>1446</lpage>
          <pub-id pub-id-type="pmid">16612592</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0710">
        <label>142</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tang</surname>
              <given-names>W.H.</given-names>
            </name>
            <name>
              <surname>Kravtsov</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Sauert</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tong</surname>
              <given-names>X.Y.</given-names>
            </name>
            <name>
              <surname>Hou</surname>
              <given-names>X.Y.</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>T.M.</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>S.K.</given-names>
            </name>
          </person-group>
          <article-title>Man Chung, S. S. Polyol pathway impairs the function of SERCA and RyR in ischemic–reperfused rat hearts by increasing oxidative modifications of these proteins</article-title>
          <source>J. Mol. Cell. Cardiol.</source>
          <volume>49</volume>
          <year>2010</year>
          <fpage>58</fpage>
          <lpage>69</lpage>
          <pub-id pub-id-type="pmid">20025885</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0715">
        <label>143</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tang</surname>
              <given-names>W.H.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>W.T.</given-names>
            </name>
            <name>
              <surname>Kravtsov</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Tong</surname>
              <given-names>X.Y.</given-names>
            </name>
            <name>
              <surname>Hou</surname>
              <given-names>X.Y.</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>S.S.</given-names>
            </name>
          </person-group>
          <article-title>Cardiac contractile dysfunction during acute hyperglycemia due to impairment of SERCA by polyol pathway-mediated oxidative stress</article-title>
          <source>Am. J. Physiol.</source>
          <volume>299</volume>
          <year>2010</year>
          <fpage>C643</fpage>
          <lpage>C653</lpage>
        </element-citation>
      </ref>
      <ref id="bb0720">
        <label>144</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shattock</surname>
              <given-names>M.J.</given-names>
            </name>
          </person-group>
          <article-title>Myocardial stunning: do we know the mechanism?</article-title>
          <source>Basic Res. Cardiol.</source>
          <volume>92</volume>
          <issue>Suppl. 2</issue>
          <year>1997</year>
          <fpage>18</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="pmid">9457363</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0725">
        <label>145</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hertelendi</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Tóth</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Borbély</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Galajda</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>van der Velden</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Stienen</surname>
              <given-names>G.J.</given-names>
            </name>
            <name>
              <surname>Edes</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Papp</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>Oxidation of myofilament protein sulfhydryl groups reduces the contractile force and its Ca<sup>2+</sup> sensitivity in human cardiomyocytes</article-title>
          <source>Antioxid. Redox Signaling</source>
          <volume>10</volume>
          <year>2008</year>
          <fpage>1175</fpage>
          <lpage>1184</lpage>
        </element-citation>
      </ref>
      <ref id="bb0730">
        <label>146</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duncan</surname>
              <given-names>J.G.</given-names>
            </name>
            <name>
              <surname>Ravi</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Stull</surname>
              <given-names>L.B.</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>Chronic xanthine oxidase inhibition prevents myofibrillar protein oxidation and preserves cardiac function in a transgenic mouse model of cardiomyopathy</article-title>
          <source>Am. J. Physiol.</source>
          <volume>289</volume>
          <year>2005</year>
          <fpage>H1512</fpage>
          <lpage>H1518</lpage>
        </element-citation>
      </ref>
      <ref id="bb0735">
        <label>147</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tziomalos</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hare</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>Role of xanthine oxidoreductase in cardiac nitroso-redox imbalance</article-title>
          <source>Front. Biosci.</source>
          <volume>14</volume>
          <year>2009</year>
          <fpage>237</fpage>
          <lpage>262</lpage>
          <pub-id pub-id-type="pmid">19273066</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0740">
        <label>148</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grützner</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Garcia-Manyes</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kötter</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Badilla</surname>
              <given-names>C.L.</given-names>
            </name>
            <name>
              <surname>Fernandez</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Linke</surname>
              <given-names>W.A.</given-names>
            </name>
          </person-group>
          <article-title>Modulation of titin-based stiffness by disulfide bonding in the cardiac titin N2-B unique sequence</article-title>
          <source>Biophys. J.</source>
          <volume>97</volume>
          <year>2009</year>
          <fpage>825</fpage>
          <lpage>834</lpage>
          <pub-id pub-id-type="pmid">19651040</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0745">
        <label>149</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Layland</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes</article-title>
          <source>J. Physiol.</source>
          <volume>540</volume>
          <year>2002</year>
          <fpage>457</fpage>
          <lpage>467</lpage>
          <pub-id pub-id-type="pmid">11956336</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0750">
        <label>150</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Avner</surname>
              <given-names>B.S.</given-names>
            </name>
            <name>
              <surname>Hinken</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Solaro</surname>
              <given-names>R.J.</given-names>
            </name>
          </person-group>
          <article-title>H<sub>2</sub>O<sub>2</sub> alters rat cardiac sarcomere function and protein phosphorylation through redox signaling</article-title>
          <source>Am. J. Physiol.</source>
          <volume>299</volume>
          <year>2010</year>
          <fpage>H723</fpage>
          <lpage>H730</lpage>
        </element-citation>
      </ref>
      <ref id="bb0755">
        <label>151</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hool</surname>
              <given-names>L.C.</given-names>
            </name>
            <name>
              <surname>Corry</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Redox control of calcium channels: from mechanisms to therapeutic opportunities</article-title>
          <source>Antioxid. Redox Signaling</source>
          <volume>9</volume>
          <year>2007</year>
          <fpage>409</fpage>
          <lpage>435</lpage>
        </element-citation>
      </ref>
      <ref id="bb0760">
        <label>152</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zeng</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>O'Rourke</surname>
              <given-names>S.T.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Endothelin-1 regulates cardiac L-type calcium channels via NAD(P)H oxidase-derived superoxide</article-title>
          <source>J. Pharmacol. Exp. Ther.</source>
          <volume>326</volume>
          <year>2008</year>
          <fpage>732</fpage>
          <lpage>738</lpage>
          <pub-id pub-id-type="pmid">18539650</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0765">
        <label>153</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zeng</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Bao</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>O'Rourke</surname>
              <given-names>S.T.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>20-HETE increases NADPH oxidase-derived ROS production and stimulates the L-type Ca<sup>2+</sup> channel via a PKC-dependent mechanism in cardiomyocytes</article-title>
          <source>Am. J. Physiol.</source>
          <volume>299</volume>
          <year>2010</year>
          <fpage>H1109</fpage>
          <lpage>H1117</lpage>
        </element-citation>
      </ref>
      <ref id="bb0770">
        <label>154</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nicoll</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Ottolia</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Philipson</surname>
              <given-names>K.D.</given-names>
            </name>
          </person-group>
          <article-title>A new topological model of the cardiac sarcolemmal Na<sup>+</sup>–Ca<sup>2+</sup> exchanger</article-title>
          <source>J. Biol. Chem.</source>
          <volume>274</volume>
          <year>1999</year>
          <fpage>910</fpage>
          <lpage>917</lpage>
          <pub-id pub-id-type="pmid">9873031</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0775">
        <label>155</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reeves</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Bailey</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Hale</surname>
              <given-names>C.C.</given-names>
            </name>
          </person-group>
          <article-title>Redox modification of sodium–calcium exchange activity in cardiac sarcolemmal vesicles</article-title>
          <source>J. Biol. Chem.</source>
          <volume>261</volume>
          <year>1986</year>
          <fpage>4948</fpage>
          <lpage>4955</lpage>
          <pub-id pub-id-type="pmid">3007482</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0780">
        <label>156</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goldhaber</surname>
              <given-names>J.I.</given-names>
            </name>
          </person-group>
          <article-title>Free radicals enhance Na<sup>+</sup>/Ca<sup>2+</sup> exchange in ventricular myocytes</article-title>
          <source>Am. J. Physiol.</source>
          <volume>271</volume>
          <year>1996</year>
          <fpage>H823</fpage>
          <lpage>H833</lpage>
          <pub-id pub-id-type="pmid">8853314</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0785">
        <label>157</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zeitz</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Maass</surname>
              <given-names>A.E.</given-names>
            </name>
            <name>
              <surname>Van Nguyen</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Hensmann</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Kögler</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Möller</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hasenfuss</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Janssen</surname>
              <given-names>P.M.</given-names>
            </name>
          </person-group>
          <article-title>Hydroxyl radical-induced acute diastolic dysfunction is due to calcium overload via reverse-mode Na<sup>+</sup>–Ca<sup>2+</sup> exchange</article-title>
          <source>Circ. Res.</source>
          <volume>90</volume>
          <year>2002</year>
          <fpage>988</fpage>
          <lpage>995</lpage>
          <pub-id pub-id-type="pmid">12016265</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0790">
        <label>158</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shimoni</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Hunt</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Chuang</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>K.Y.</given-names>
            </name>
            <name>
              <surname>Kargacin</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Severson</surname>
              <given-names>D.L.</given-names>
            </name>
          </person-group>
          <article-title>Modulation of potassium currents by angiotensin and oxidative stress in cardiac cells from the diabetic rat</article-title>
          <source>J. Physiol.</source>
          <volume>567</volume>
          <year>2005</year>
          <fpage>177</fpage>
          <lpage>190</lpage>
          <pub-id pub-id-type="pmid">15946965</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0795">
        <label>159</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ren</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Raucci</surname>
              <given-names>F.J.</given-names>
              <suffix>Jr.</suffix>
            </name>
            <name>
              <surname>Browe</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Baumgarten</surname>
              <given-names>C.M.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of swelling-activated Cl<sup>−</sup> current by angiotensin II signalling and NADPH oxidase in rabbit ventricle</article-title>
          <source>Cardiovasc. Res.</source>
          <volume>77</volume>
          <year>2008</year>
          <fpage>73</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">18006461</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0800">
        <label>160</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsai</surname>
              <given-names>C.T.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>W.P.</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Hsieh</surname>
              <given-names>C.S.</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>K.L.</given-names>
            </name>
            <name>
              <surname>Tseng</surname>
              <given-names>C.D.</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>L.P.</given-names>
            </name>
            <name>
              <surname>Tseng</surname>
              <given-names>Y.Z.</given-names>
            </name>
            <name>
              <surname>Chiang</surname>
              <given-names>F.T.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>J.L.</given-names>
            </name>
          </person-group>
          <article-title>Angiotensin II increases expression of alpha1C subunit of L-type calcium channel through a reactive oxygen species and cAMP response element-binding protein-dependent pathway in HL-1 myocytes</article-title>
          <source>Circ. Res.</source>
          <volume>100</volume>
          <year>2007</year>
          <fpage>1476</fpage>
          <lpage>1485</lpage>
          <pub-id pub-id-type="pmid">17463319</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0805">
        <label>161</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shang</surname>
              <given-names>L.L.</given-names>
            </name>
            <name>
              <surname>Sanyal</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Pfahnl</surname>
              <given-names>A.E.</given-names>
            </name>
            <name>
              <surname>Jiao</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Dudley</surname>
              <given-names>S.C.</given-names>
              <suffix>Jr.</suffix>
            </name>
          </person-group>
          <article-title>NF-kappaB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II</article-title>
          <source>Am. J. Physiol.</source>
          <volume>294</volume>
          <year>2008</year>
          <fpage>C372</fpage>
          <lpage>C379</lpage>
        </element-citation>
      </ref>
      <ref id="bb0810">
        <label>162</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Ziegler</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Birder</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Stewart</surname>
              <given-names>A.F.</given-names>
            </name>
            <name>
              <surname>Levitan</surname>
              <given-names>E.S.</given-names>
            </name>
          </person-group>
          <article-title>Angiotensin II and stretch activate NADPH oxidase to destabilize cardiac Kv4.3 channel mRNA</article-title>
          <source>Circ. Res.</source>
          <volume>98</volume>
          <year>2006</year>
          <fpage>1040</fpage>
          <lpage>1047</lpage>
          <pub-id pub-id-type="pmid">16556864</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0815">
        <label>163</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zweier</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Talukder</surname>
              <given-names>M.A.</given-names>
            </name>
          </person-group>
          <article-title>The role of oxidants and free radicals in reperfusion injury</article-title>
          <source>Cardiovasc. Res.</source>
          <volume>70</volume>
          <year>2006</year>
          <fpage>181</fpage>
          <lpage>190</lpage>
          <pub-id pub-id-type="pmid">16580655</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0820">
        <label>164</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Halestrap</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Clarke</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Khaliulin</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>The role of mitochondria in protection of the heart by preconditioning</article-title>
          <source>Biochim. Biophys. Acta</source>
          <volume>1767</volume>
          <year>2007</year>
          <fpage>1007</fpage>
          <lpage>1031</lpage>
          <pub-id pub-id-type="pmid">17631856</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0825">
        <label>165</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malhotra</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Brosius</surname>
              <given-names>F.C.</given-names>
            </name>
          </person-group>
          <article-title>Glucose uptake and glycolysis reduce hypoxia-induced apoptosis in cultured neonatal rat cardiac myocytes</article-title>
          <source>J. Biol. Chem.</source>
          <volume>274</volume>
          <year>1999</year>
          <fpage>12567</fpage>
          <lpage>12575</lpage>
          <pub-id pub-id-type="pmid">10212235</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0830">
        <label>166</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rey</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Semenza</surname>
              <given-names>G.L.</given-names>
            </name>
          </person-group>
          <article-title>Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling</article-title>
          <source>Cardiovasc. Res.</source>
          <volume>86</volume>
          <year>2010</year>
          <fpage>236</fpage>
          <lpage>242</lpage>
          <pub-id pub-id-type="pmid">20164116</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0835">
        <label>167</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Loor</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Schumacker</surname>
              <given-names>P.T.</given-names>
            </name>
          </person-group>
          <article-title>Role of hypoxia-inducible factor in cell survival during myocardial ischemia–reperfusion</article-title>
          <source>Cell Death Differ.</source>
          <volume>15</volume>
          <year>2008</year>
          <fpage>686</fpage>
          <lpage>690</lpage>
          <pub-id pub-id-type="pmid">18259200</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0840">
        <label>168</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schofield</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Ratcliffe</surname>
              <given-names>P.J.</given-names>
            </name>
          </person-group>
          <article-title>Oxygen sensing by HIF hydroxylases</article-title>
          <source>Nat. Rev. Mol. Cell Biol.</source>
          <volume>5</volume>
          <year>2004</year>
          <fpage>343</fpage>
          <lpage>354</lpage>
          <pub-id pub-id-type="pmid">15122348</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0845">
        <label>169</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aragonés</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Fraisl</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Baes</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Carmeliet</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Oxygen sensors at the crossroad of metabolism</article-title>
          <source>Cell Metab.</source>
          <volume>9</volume>
          <year>2009</year>
          <fpage>11</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="pmid">19117543</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0850">
        <label>170</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mole</surname>
              <given-names>D.R.</given-names>
            </name>
          </person-group>
          <article-title>Iron homeostasis and its interaction with prolyl hydroxylases</article-title>
          <source>Antioxid. Redox Signaling</source>
          <volume>12</volume>
          <year>2010</year>
          <fpage>445</fpage>
          <lpage>458</lpage>
        </element-citation>
      </ref>
      <ref id="bb0855">
        <label>171</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ginouvès</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ilc</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Macías</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Pouysségur</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Berra</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>PHDs overactivation during chronic hypoxia "desensitizes" HIFalpha and protects cells from necrosis</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <volume>105</volume>
          <year>2008</year>
          <fpage>4745</fpage>
          <lpage>4750</lpage>
          <pub-id pub-id-type="pmid">18347341</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0860">
        <label>172</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yuan</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Nanduri</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Semenza</surname>
              <given-names>G.L.</given-names>
            </name>
            <name>
              <surname>Prabhakar</surname>
              <given-names>N.R.</given-names>
            </name>
          </person-group>
          <article-title>Induction of HIF-1alpha expression by intermittent hypoxia: involvement of NADPH oxidase, Ca<sup>2+</sup> signaling, prolyl hydroxylases, and mTOR</article-title>
          <source>Cell Physiol.</source>
          <volume>217</volume>
          <year>2008</year>
          <fpage>674</fpage>
          <lpage>685</lpage>
        </element-citation>
      </ref>
      <ref id="bb0865">
        <label>173</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gerald</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Berra</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Frapart</surname>
              <given-names>Y.M.</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Giaccia</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Mansuy</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Pouysségur</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Yaniv</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mechta-Grigoriou</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>JunD reduces tumor angiogenesis by protecting cells from oxidative stress</article-title>
          <source>Cell</source>
          <volume>118</volume>
          <year>2004</year>
          <fpage>781</fpage>
          <lpage>794</lpage>
          <pub-id pub-id-type="pmid">15369676</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0870">
        <label>174</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berchner-Pfannschmidt</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Yamac</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Trinidad</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Fandrey</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Nitric oxide modulates oxygen sensing by hypoxia-inducible factor 1-dependent induction of prolyl hydroxylase2</article-title>
          <source>J. Biol. Chem.</source>
          <volume>282</volume>
          <year>2007</year>
          <fpage>1788</fpage>
          <lpage>1796</lpage>
          <pub-id pub-id-type="pmid">17060326</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0875">
        <label>175</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guzy</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Schumacker</surname>
              <given-names>P.T.</given-names>
            </name>
          </person-group>
          <article-title>Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia</article-title>
          <source>Exp. Physiol.</source>
          <volume>91</volume>
          <year>2006</year>
          <fpage>807</fpage>
          <lpage>819</lpage>
          <pub-id pub-id-type="pmid">16857720</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0880">
        <label>176</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chandel</surname>
              <given-names>N.S.</given-names>
            </name>
            <name>
              <surname>Maltepe</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Goldwasser</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Mathieu</surname>
              <given-names>C.E.</given-names>
            </name>
            <name>
              <surname>Simon</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Schumacker</surname>
              <given-names>P.T.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial reactive oxygen species trigger hypoxia-induced transcription</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <volume>95</volume>
          <year>1998</year>
          <fpage>11715</fpage>
          <lpage>11720</lpage>
          <pub-id pub-id-type="pmid">9751731</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0885">
        <label>177</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Diebold</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Petry</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hess</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Görlach</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1</article-title>
          <source>Mol. Biol. Cell</source>
          <volume>21</volume>
          <year>2010</year>
          <fpage>2087</fpage>
          <lpage>2096</lpage>
          <pub-id pub-id-type="pmid">20427574</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0890">
        <label>178</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jürgensen</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Rosenberger</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Wiesener</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Warnecke</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Hörstrup</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Gräfe</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Philipp</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Griethe</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Maxwell</surname>
              <given-names>P.H.</given-names>
            </name>
            <name>
              <surname>Frei</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Bachmann</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Willenbrock</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Eckardt</surname>
              <given-names>K.U.</given-names>
            </name>
          </person-group>
          <article-title>Persistent induction of HIF-1alpha and -2alpha in cardiomyocytes and stromal cells of ischemic myocardium</article-title>
          <source>FASEB J.</source>
          <volume>18</volume>
          <year>2004</year>
          <fpage>1415</fpage>
          <lpage>1417</lpage>
          <pub-id pub-id-type="pmid">15247145</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0895">
        <label>179</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>P.L.</given-names>
            </name>
            <name>
              <surname>Escudero</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Deutsch</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Jamieson</surname>
              <given-names>S.W.</given-names>
            </name>
            <name>
              <surname>Thistlethwaite</surname>
              <given-names>P.A.</given-names>
            </name>
          </person-group>
          <article-title>Early expression of angiogenesis factors in acute myocardial ischemia and infarction</article-title>
          <source>N. Engl. J. Med.</source>
          <volume>342</volume>
          <year>2000</year>
          <fpage>626</fpage>
          <lpage>633</lpage>
          <pub-id pub-id-type="pmid">10699162</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0900">
        <label>180</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Hickey</surname>
              <given-names>R.P.</given-names>
            </name>
            <name>
              <surname>Yeh</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Dadak</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>L.H.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Giordano</surname>
              <given-names>F.J.</given-names>
            </name>
          </person-group>
          <article-title>Cardiac myocyte-specific HIF-1alpha deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart</article-title>
          <source>FASEB J.</source>
          <volume>18</volume>
          <year>2004</year>
          <fpage>1138</fpage>
          <lpage>1140</lpage>
          <pub-id pub-id-type="pmid">15132980</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0905">
        <label>181</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kido</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Sullivan</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Deutsch</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Jamieson</surname>
              <given-names>S.W.</given-names>
            </name>
            <name>
              <surname>Thistlethwaite</surname>
              <given-names>P.A.</given-names>
            </name>
          </person-group>
          <article-title>Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse</article-title>
          <source>J. Am. Coll. Cardiol.</source>
          <volume>46</volume>
          <year>2005</year>
          <fpage>2116</fpage>
          <lpage>2124</lpage>
          <pub-id pub-id-type="pmid">16325051</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0910">
        <label>182</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Natarajan</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Salloum</surname>
              <given-names>F.N.</given-names>
            </name>
            <name>
              <surname>Fisher</surname>
              <given-names>B.J.</given-names>
            </name>
            <name>
              <surname>Kukreja</surname>
              <given-names>R.C.</given-names>
            </name>
            <name>
              <surname>Fowler</surname>
              <given-names>A.A.</given-names>
            </name>
          </person-group>
          <article-title>Hypoxia inducible factor 1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury</article-title>
          <source>Circ. Res.</source>
          <volume>98</volume>
          <year>2006</year>
          <fpage>133</fpage>
          <lpage>140</lpage>
          <pub-id pub-id-type="pmid">16306444</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0915">
        <label>183</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>S.P.</given-names>
            </name>
            <name>
              <surname>Bolli</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>The ubiquitous role of nitric oxide in cardioprotection</article-title>
          <source>J. Mol. Cell. Cardiol.</source>
          <volume>40</volume>
          <year>2006</year>
          <fpage>16</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="pmid">16288777</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0920">
        <label>184</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pachori</surname>
              <given-names>A.S.</given-names>
            </name>
            <name>
              <surname>Melo</surname>
              <given-names>L.G.</given-names>
            </name>
            <name>
              <surname>Hart</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Noiseux</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Morello</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Solomon</surname>
              <given-names>S.D.</given-names>
            </name>
            <name>
              <surname>Stahl</surname>
              <given-names>G.L.</given-names>
            </name>
            <name>
              <surname>Pratt</surname>
              <given-names>R.E.</given-names>
            </name>
            <name>
              <surname>Dzau</surname>
              <given-names>V.J.</given-names>
            </name>
          </person-group>
          <article-title>Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <volume>101</volume>
          <year>2004</year>
          <fpage>12282</fpage>
          <lpage>12287</lpage>
          <pub-id pub-id-type="pmid">15302924</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0925">
        <label>185</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lei</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Mason</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Marks</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Hickey</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Jovin</surname>
              <given-names>I.S.</given-names>
            </name>
            <name>
              <surname>Pypaert</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Giordano</surname>
              <given-names>F.J.</given-names>
            </name>
          </person-group>
          <article-title>Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein</article-title>
          <source>Mol. Cell. Biol.</source>
          <volume>28</volume>
          <year>2008</year>
          <fpage>3790</fpage>
          <lpage>3803</lpage>
          <pub-id pub-id-type="pmid">18285456</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0930">
        <label>186</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Minamishima</surname>
              <given-names>Y.A.</given-names>
            </name>
            <name>
              <surname>Moslehi</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Padera</surname>
              <given-names>R.F.</given-names>
            </name>
            <name>
              <surname>Bronson</surname>
              <given-names>R.T.</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Kaelin</surname>
              <given-names>W.G.</given-names>
              <suffix>Jr.</suffix>
            </name>
          </person-group>
          <article-title>A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo</article-title>
          <source>Mol. Cell. Biol.</source>
          <volume>29</volume>
          <year>2009</year>
          <fpage>5729</fpage>
          <lpage>5741</lpage>
          <pub-id pub-id-type="pmid">19720742</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0935">
        <label>187</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moslehi</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Minamishima</surname>
              <given-names>Y.A.</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Neuberg</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Charytan</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Padera</surname>
              <given-names>R.F.</given-names>
            </name>
            <name>
              <surname>Signoretti</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Kaelin</surname>
              <given-names>W.G.</given-names>
              <suffix>Jr.</suffix>
            </name>
          </person-group>
          <article-title>Loss of hypoxia-inducible factor prolyl hydroxylase activity in cardiomyocytes phenocopies ischemic cardiomyopathy</article-title>
          <source>Circulation</source>
          <volume>122</volume>
          <year>2010</year>
          <fpage>1004</fpage>
          <lpage>1016</lpage>
          <pub-id pub-id-type="pmid">20733101</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0940">
        <label>188</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bekeredjian</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Walton</surname>
              <given-names>C.B.</given-names>
            </name>
            <name>
              <surname>MacCannell</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Ecker</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kruse</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Outten</surname>
              <given-names>J.T.</given-names>
            </name>
            <name>
              <surname>Sutcliffe</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Gerard</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Bruick</surname>
              <given-names>R.K.</given-names>
            </name>
            <name>
              <surname>Shohet</surname>
              <given-names>R.V.</given-names>
            </name>
          </person-group>
          <article-title>Conditional HIF-1alpha expression produces a reversible cardiomyopathy</article-title>
          <source>PLoS ONE</source>
          <volume>5</volume>
          <year>2010</year>
          <fpage>e11693</fpage>
          <pub-id pub-id-type="pmid">20657781</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0945">
        <label>189</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Downey</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>M.V.</given-names>
            </name>
          </person-group>
          <article-title>Signaling pathways in ischemic preconditioning</article-title>
          <source>Heart Fail. Rev.</source>
          <volume>12</volume>
          <year>2007</year>
          <fpage>181</fpage>
          <lpage>188</lpage>
          <pub-id pub-id-type="pmid">17516169</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0950">
        <label>190</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Granfeldt</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lefer</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Vinten-Johansen</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Protective ischaemia in patients: preconditioning and postconditioning</article-title>
          <source>Cardiovasc. Res.</source>
          <volume>83</volume>
          <year>2009</year>
          <fpage>234</fpage>
          <lpage>246</lpage>
          <pub-id pub-id-type="pmid">19398470</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0955">
        <label>191</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Forbes</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Steenbergen</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism</article-title>
          <source>Circ. Res.</source>
          <volume>88</volume>
          <year>2001</year>
          <fpage>802</fpage>
          <lpage>809</lpage>
          <pub-id pub-id-type="pmid">11325872</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0960">
        <label>192</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pain</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>X.M.</given-names>
            </name>
            <name>
              <surname>Critz</surname>
              <given-names>S.D.</given-names>
            </name>
            <name>
              <surname>Yue</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Nakano</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>G.S.</given-names>
            </name>
            <name>
              <surname>Heusch</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>M.V.</given-names>
            </name>
            <name>
              <surname>Downey</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals</article-title>
          <source>Circ. Res.</source>
          <volume>87</volume>
          <year>2000</year>
          <fpage>460</fpage>
          <lpage>466</lpage>
          <pub-id pub-id-type="pmid">10988237</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0965">
        <label>193</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Juhaszova</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Zorov</surname>
              <given-names>D.B.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Pepe</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Fu</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Fishbein</surname>
              <given-names>K.W.</given-names>
            </name>
            <name>
              <surname>Ziman</surname>
              <given-names>B.D.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ytrehus</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Antos</surname>
              <given-names>C.L.</given-names>
            </name>
            <name>
              <surname>Olson</surname>
              <given-names>E.N.</given-names>
            </name>
            <name>
              <surname>Sollott</surname>
              <given-names>S.J.</given-names>
            </name>
          </person-group>
          <article-title>Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore</article-title>
          <source>J. Clin. Invest.</source>
          <volume>113</volume>
          <year>2004</year>
          <fpage>1535</fpage>
          <lpage>1549</lpage>
          <pub-id pub-id-type="pmid">15173880</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0970">
        <label>194</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robin</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Guzy</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Loor</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Iwase</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Waypa</surname>
              <given-names>G.B.</given-names>
            </name>
            <name>
              <surname>Marks</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Hoek</surname>
              <given-names>T.L.</given-names>
            </name>
            <name>
              <surname>Schumacker</surname>
              <given-names>P.T.</given-names>
            </name>
          </person-group>
          <article-title>Oxidant stress during simulated ischemia primes cardiomyocytes for cell death during reperfusion</article-title>
          <source>J. Biol. Chem.</source>
          <volume>282</volume>
          <year>2007</year>
          <fpage>19133</fpage>
          <lpage>19143</lpage>
          <pub-id pub-id-type="pmid">17488710</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0975">
        <label>195</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bell</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Cave</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Johar</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hearse</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Shattock</surname>
              <given-names>M.J.</given-names>
            </name>
          </person-group>
          <article-title>Pivotal role of NOX-2-containing NADPH oxidase in early ischemic preconditioning</article-title>
          <source>FASEB J.</source>
          <volume>14</volume>
          <year>2005</year>
          <fpage>2037</fpage>
          <lpage>2039</lpage>
          <pub-id pub-id-type="pmid">16236999</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0980">
        <label>196</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kimura</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>G.X.</given-names>
            </name>
            <name>
              <surname>Nishiyama</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Shokoji</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>Y.Y.</given-names>
            </name>
            <name>
              <surname>Rahman</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Maeta</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Abe</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II</article-title>
          <source>Hypertension</source>
          <volume>45</volume>
          <year>2005</year>
          <fpage>860</fpage>
          <lpage>866</lpage>
          <pub-id pub-id-type="pmid">15824196</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0985">
        <label>197</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tong</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Imahashi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Steenbergen</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective</article-title>
          <source>Circ. Res.</source>
          <volume>90</volume>
          <year>2007</year>
          <fpage>377</fpage>
          <lpage>379</lpage>
          <pub-id pub-id-type="pmid">11884365</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0990">
        <label>198</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clarke</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Khaliulin</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Das</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Heesom</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Halestrap</surname>
              <given-names>A.P.</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation</article-title>
          <source>Circ. Res.</source>
          <volume>102</volume>
          <year>2008</year>
          <fpage>1082</fpage>
          <lpage>1090</lpage>
          <pub-id pub-id-type="pmid">18356542</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0995">
        <label>199</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Skyschally</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>van Caster</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Boengler</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Gres</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Musiolik</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Schilawa</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Heusch</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Ischemic postconditioning in pigs: no causal role for RISK activation</article-title>
          <source>Circ. Res.</source>
          <volume>104</volume>
          <year>2009</year>
          <fpage>15</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="pmid">19038864</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1000">
        <label>200</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nishino</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Webb</surname>
              <given-names>I.G.</given-names>
            </name>
            <name>
              <surname>Davidson</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Ahmed</surname>
              <given-names>A.I.</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Jacquet</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Miura</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Yellon</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Avkiran</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Marber</surname>
              <given-names>M.S.</given-names>
            </name>
          </person-group>
          <article-title>Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse</article-title>
          <source>Circ. Res.</source>
          <volume>103</volume>
          <year>2008</year>
          <fpage>307</fpage>
          <lpage>314</lpage>
          <pub-id pub-id-type="pmid">18583716</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1005">
        <label>201</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guo</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>W.K.</given-names>
            </name>
            <name>
              <surname>Xuan</surname>
              <given-names>Y.T.</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>X.L.</given-names>
            </name>
            <name>
              <surname>Bao</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>W.J.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Laubach</surname>
              <given-names>V.E.</given-names>
            </name>
            <name>
              <surname>Ping</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Qiu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Bolli</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <volume>96</volume>
          <year>1999</year>
          <fpage>11507</fpage>
          <lpage>11512</lpage>
          <pub-id pub-id-type="pmid">10500207</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1010">
        <label>202</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kodani</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>S.X.</given-names>
            </name>
            <name>
              <surname>Takano</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>X.L.</given-names>
            </name>
            <name>
              <surname>Bolli</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Cardioprotection during the final stage of the late phase of ischemic preconditioning is mediated by neuronal NO synthase in concert with cyclooxygenase2</article-title>
          <source>Circ. Res.</source>
          <volume>95</volume>
          <year>2004</year>
          <fpage>84</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">15166094</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1015">
        <label>203</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yoshida</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Maulik</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>Y.S.</given-names>
            </name>
            <name>
              <surname>Alam</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Das</surname>
              <given-names>D.K.</given-names>
            </name>
          </person-group>
          <article-title>H(mox-1) constitutes an adaptive response to effect antioxidant cardioprotection: a study with transgenic mice heterozygous for targeted disruption of the heme oxygenase-1 gene</article-title>
          <source>Circulation</source>
          <volume>103</volume>
          <year>2001</year>
          <fpage>1695</fpage>
          <lpage>1701</lpage>
          <pub-id pub-id-type="pmid">11273999</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1020">
        <label>204</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heineke</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Molkentin</surname>
              <given-names>J.D.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of cardiac hypertrophy by intracellular signalling pathways</article-title>
          <source>Nat. Rev. Mol. Cell Biol.</source>
          <volume>7</volume>
          <year>2006</year>
          <fpage>589</fpage>
          <lpage>600</lpage>
          <pub-id pub-id-type="pmid">16936699</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1025">
        <label>205</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Catalucci</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Latronico</surname>
              <given-names>M.V.</given-names>
            </name>
            <name>
              <surname>Ellingsen</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Condorelli</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Physiological myocardial hypertrophy: how and why?</article-title>
          <source>Front. Biosci.</source>
          <volume>13</volume>
          <year>2008</year>
          <fpage>312</fpage>
          <lpage>324</lpage>
          <pub-id pub-id-type="pmid">17981549</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1030">
        <label>206</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hill</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Olson</surname>
              <given-names>E.N.</given-names>
            </name>
          </person-group>
          <article-title>Cardiac plasticity</article-title>
          <source>N. Engl. J. Med.</source>
          <volume>358</volume>
          <year>2008</year>
          <fpage>1370</fpage>
          <lpage>1380</lpage>
          <pub-id pub-id-type="pmid">18367740</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1035">
        <label>207</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sugden</surname>
              <given-names>P.H.</given-names>
            </name>
            <name>
              <surname>Clerk</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Oxidative stress and growth-regulating intracellular signaling pathways in cardiac myocytes</article-title>
          <source>Antioxid. Redox Signaling</source>
          <volume>8</volume>
          <year>2006</year>
          <fpage>2111</fpage>
          <lpage>2124</lpage>
        </element-citation>
      </ref>
      <ref id="bb1040">
        <label>208</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xiao</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Pimentel</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Colucci</surname>
              <given-names>W.S.</given-names>
            </name>
            <name>
              <surname>Sawyer</surname>
              <given-names>D.B.</given-names>
            </name>
          </person-group>
          <article-title>Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes</article-title>
          <source>Am. J. Physiol.</source>
          <volume>282</volume>
          <year>2002</year>
          <fpage>C926</fpage>
          <lpage>C934</lpage>
        </element-citation>
      </ref>
      <ref id="bb1045">
        <label>209</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xiao</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Pimental</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Amin</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Sawyer</surname>
              <given-names>D.B.</given-names>
            </name>
            <name>
              <surname>Colucci</surname>
              <given-names>W.S.</given-names>
            </name>
          </person-group>
          <article-title>MEK1/2-ERK1/2 mediates alpha1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes</article-title>
          <source>J. Mol. Cell. Cardiol.</source>
          <volume>33</volume>
          <year>2001</year>
          <fpage>779</fpage>
          <lpage>787</lpage>
          <pub-id pub-id-type="pmid">11273730</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1050">
        <label>210</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirotani</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Otsu</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Nishida</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Higuchi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Morita</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Nakayama</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Yamaguchi</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Mano</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Matsumura</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Ueno</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Tada</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hori</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy</article-title>
          <source>Circulation</source>
          <volume>105</volume>
          <year>2002</year>
          <fpage>509</fpage>
          <lpage>515</lpage>
          <pub-id pub-id-type="pmid">11815436</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1055">
        <label>211</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuster</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Pimentel</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Adachi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ido</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Brenner</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Siwik</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Colucci</surname>
              <given-names>W.S.</given-names>
            </name>
          </person-group>
          <article-title>Alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes is mediated via thioredoxin-1-sensitive oxidative modification of thiols on Ras</article-title>
          <source>Circulation</source>
          <volume>111</volume>
          <year>2005</year>
          <fpage>1192</fpage>
          <lpage>1198</lpage>
          <pub-id pub-id-type="pmid">15723974</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1060">
        <label>212</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Higuchi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Otsu</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Nishida</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hirotani</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Nakayama</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Yamaguchi</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Matsumura</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Ueno</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Tada</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hori</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy</article-title>
          <source>J. Mol. Cell. Cardiol.</source>
          <volume>34</volume>
          <year>2002</year>
          <fpage>233</fpage>
          <lpage>240</lpage>
          <pub-id pub-id-type="pmid">11851362</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1065">
        <label>213</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirotani</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Higuchi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Nishida</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Nakayama</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Yamaguchi</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Hikoso</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Takeda</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kashiwase</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Asahi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Taniike</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tsujimoto</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Matsumura</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Sasaki</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hori</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Otsu</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Ca<sup>2+</sup>-sensitive tyrosine kinase Pyk2/CAK beta-dependent signaling is essential for G-protein-coupled receptor agonist-induced hypertrophy</article-title>
          <source>J. Mol. Cell. Cardiol.</source>
          <volume>36</volume>
          <year>2004</year>
          <fpage>799</fpage>
          <lpage>807</lpage>
          <pub-id pub-id-type="pmid">15158121</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1070">
        <label>214</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Higuchi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Otsu</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Nishida</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hirotani</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Nakayama</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Yamaguchi</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Hikoso</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kashiwase</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Takeda</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Mano</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Matsumura</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Ueno</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hori</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>The small GTP-binding protein Rac1 induces cardiac myocyte hypertrophy through the activation of apoptosis signal-regulating kinase 1 and nuclear factor-kappa B</article-title>
          <source>J. Biol. Chem.</source>
          <volume>278</volume>
          <year>2003</year>
          <fpage>20770</fpage>
          <lpage>20777</lpage>
          <pub-id pub-id-type="pmid">12672819</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1075">
        <label>215</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakagami</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Takemoto</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>J.K.</given-names>
            </name>
          </person-group>
          <article-title>NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy</article-title>
          <source>J. Mol. Cell. Cardiol.</source>
          <volume>35</volume>
          <year>2003</year>
          <fpage>851</fpage>
          <lpage>859</lpage>
          <pub-id pub-id-type="pmid">12818576</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1080">
        <label>216</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hingtgen</surname>
              <given-names>S.D.</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Dunlay</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Peek</surname>
              <given-names>A.S.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>R.V.</given-names>
            </name>
            <name>
              <surname>Engelhardt</surname>
              <given-names>J.F.</given-names>
            </name>
            <name>
              <surname>Davisson</surname>
              <given-names>R.L.</given-names>
            </name>
          </person-group>
          <article-title>Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy</article-title>
          <source>Physiol. Genomics</source>
          <volume>26</volume>
          <year>2006</year>
          <fpage>180</fpage>
          <lpage>191</lpage>
          <pub-id pub-id-type="pmid">16670255</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1085">
        <label>217</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tanaka</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Takabatake</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte</article-title>
          <source>J. Am. Coll. Cardiol.</source>
          <volume>37</volume>
          <year>2001</year>
          <fpage>676</fpage>
          <lpage>685</lpage>
          <pub-id pub-id-type="pmid">11216996</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1090">
        <label>218</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Satoh</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ogita</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Takeshita</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Mukai</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kwiatkowski</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>J.K.</given-names>
            </name>
          </person-group>
          <article-title>Requirement of Rac1 in the development of cardiac hypertrophy</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <volume>103</volume>
          <year>2006</year>
          <fpage>7432</fpage>
          <lpage>7437</lpage>
          <pub-id pub-id-type="pmid">16651530</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1095">
        <label>219</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Izumiya</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Izumi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Yoshiyama</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Matsuzawa</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ichijo</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Iwao</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling</article-title>
          <source>Circ. Res.</source>
          <volume>93</volume>
          <year>2003</year>
          <fpage>874</fpage>
          <lpage>883</lpage>
          <pub-id pub-id-type="pmid">14551246</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1100">
        <label>220</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Date</surname>
              <given-names>M.O.</given-names>
            </name>
            <name>
              <surname>Morita</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Yamashita</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Nishida</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Yamaguchi</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Higuchi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Hirotani</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Matsumura</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Hori</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tada</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Otsu</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model</article-title>
          <source>J. Am. Coll. Cardiol.</source>
          <volume>39</volume>
          <year>2002</year>
          <fpage>907</fpage>
          <lpage>912</lpage>
          <pub-id pub-id-type="pmid">11869860</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1105">
        <label>221</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pimentel</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Amin</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Xiao</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Viereck</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Oliver-Krasinski</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Baliga</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Siwik</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Pagano</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Colucci</surname>
              <given-names>W.S.</given-names>
            </name>
            <name>
              <surname>Sawyer</surname>
              <given-names>D.B.</given-names>
            </name>
          </person-group>
          <article-title>Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes</article-title>
          <source>Circ. Res.</source>
          <volume>89</volume>
          <year>2001</year>
          <fpage>453</fpage>
          <lpage>460</lpage>
          <pub-id pub-id-type="pmid">11532907</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1110">
        <label>222</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aikawa</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Nagai</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Zou</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Ishihara</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Takano</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hasegawa</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Akazawa</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Mizukami</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Nagai</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Komuro</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Reactive oxygen species in mechanical stress-induced cardiac hypertrophy</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <volume>289</volume>
          <year>2001</year>
          <fpage>901</fpage>
          <lpage>907</lpage>
          <pub-id pub-id-type="pmid">11735132</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1115">
        <label>223</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pimentel</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Adachi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ido</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Heibeck</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Melendez</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Colucci</surname>
              <given-names>W.S.</given-names>
            </name>
          </person-group>
          <article-title>Strain-stimulated hypertrophy in cardiac myocytes is mediated by reactive oxygen species-dependent Ras S-glutathiolation</article-title>
          <source>J. Mol. Cell. Cardiol.</source>
          <volume>41</volume>
          <year>2006</year>
          <fpage>613</fpage>
          <lpage>622</lpage>
          <pub-id pub-id-type="pmid">16806262</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1120">
        <label>224</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nadruz</surname>
              <given-names>W.</given-names>
              <suffix>Jr.</suffix>
            </name>
            <name>
              <surname>Lagosta</surname>
              <given-names>V.J.</given-names>
            </name>
            <name>
              <surname>Moreno</surname>
              <given-names>H.</given-names>
              <suffix>Jr.</suffix>
            </name>
            <name>
              <surname>Coelho</surname>
              <given-names>O.R.</given-names>
            </name>
            <name>
              <surname>Franchini</surname>
              <given-names>K.G.</given-names>
            </name>
          </person-group>
          <article-title>Simvastatin prevents load-induced protein tyrosine nitration in overloaded hearts</article-title>
          <source>Hypertension</source>
          <volume>43</volume>
          <year>2004</year>
          <fpage>1060</fpage>
          <lpage>1066</lpage>
          <pub-id pub-id-type="pmid">15023931</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1125">
        <label>225</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H.L.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>C.N.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>Y.S.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>A.B.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y.Q.</given-names>
            </name>
            <name>
              <surname>Hui</surname>
              <given-names>R.T.</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>D.P.</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>C.C.</given-names>
            </name>
          </person-group>
          <article-title>Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways</article-title>
          <source>Free Radic. Biol. Med.</source>
          <volume>40</volume>
          <year>2006</year>
          <fpage>1756</fpage>
          <lpage>1775</lpage>
          <pub-id pub-id-type="pmid">16767845</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1130">
        <label>226</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maack</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Böhm</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Vlaskin</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Dabew</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Lorenz</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Schäfers</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Lohse</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Engelhardt</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor</article-title>
          <source>Circulation</source>
          <volume>108</volume>
          <year>2003</year>
          <fpage>348</fpage>
          <lpage>353</lpage>
          <pub-id pub-id-type="pmid">12847069</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1135">
        <label>227</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nediani</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Borchi</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Giordano</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Baruzzo</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ponziani</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Sebastiani</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Nassi</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Mugelli</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>d'Amati, G.; Cerbai, E. NADPH oxidase-dependent redox signaling in human heart failure: relationship between the left and right ventricle</article-title>
          <source>J. Mol. Cell. Cardiol.</source>
          <volume>42</volume>
          <year>2007</year>
          <fpage>826</fpage>
          <lpage>834</lpage>
          <pub-id pub-id-type="pmid">17346742</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1140">
        <label>228</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grieve</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Byrne</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Siva</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Layland</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Johar</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cave</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload</article-title>
          <source>J. Am. Coll. Cardiol.</source>
          <volume>47</volume>
          <year>2006</year>
          <fpage>817</fpage>
          <lpage>826</lpage>
          <pub-id pub-id-type="pmid">16487851</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1145">
        <label>229</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Johar</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cave</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Narayanapanicker</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Grieve</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase</article-title>
          <source>FASEB J.</source>
          <volume>20</volume>
          <year>2006</year>
          <fpage>1546</fpage>
          <lpage>1548</lpage>
          <pub-id pub-id-type="pmid">16720735</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1150">
        <label>230</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maytin</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Siwik</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Xiao</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Sawyer</surname>
              <given-names>D.B.</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Colucci</surname>
              <given-names>W.S.</given-names>
            </name>
          </person-group>
          <article-title>Pressure overload-induced myocardial hypertrophy in mice does not require gp91phox</article-title>
          <source>Circulation</source>
          <volume>109</volume>
          <year>2004</year>
          <fpage>1168</fpage>
          <lpage>1171</lpage>
          <pub-id pub-id-type="pmid">14981002</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1155">
        <label>231</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shiojima</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Izumiya</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Schiekofer</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Colucci</surname>
              <given-names>W.S.</given-names>
            </name>
            <name>
              <surname>Walsh</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure</article-title>
          <source>J. Clin. Invest.</source>
          <volume>115</volume>
          <year>2005</year>
          <fpage>2108</fpage>
          <lpage>2118</lpage>
          <pub-id pub-id-type="pmid">16075055</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1160">
        <label>232</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heineke</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Auger-Messier</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Oka</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Sargent</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>York</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Klevitsky</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Vaikunth</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Duncan</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Aronow</surname>
              <given-names>B.J.</given-names>
            </name>
            <name>
              <surname>Robbins</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Crombleholme</surname>
              <given-names>T.M.</given-names>
            </name>
            <name>
              <surname>Molkentin</surname>
              <given-names>J.D.</given-names>
            </name>
          </person-group>
          <article-title>Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart</article-title>
          <source>J. Clin. Invest.</source>
          <volume>117</volume>
          <year>2007</year>
          <fpage>3198</fpage>
          <lpage>3210</lpage>
          <pub-id pub-id-type="pmid">17975667</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1165">
        <label>233</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sano</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Minamino</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Toko</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Miyauchi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Orimo</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Qin</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Akazawa</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Tateno</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kayama</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Harada</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Shimizu</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Asahara</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hamada</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Tomita</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Molkentin</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Zou</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Komuro</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload</article-title>
          <source>Nature</source>
          <volume>446</volume>
          <year>2007</year>
          <fpage>444</fpage>
          <lpage>448</lpage>
          <pub-id pub-id-type="pmid">17334357</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1170">
        <label>234</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Helmcke</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Heumüller</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tikkanen</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Schröder</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Brandes</surname>
              <given-names>R.P.</given-names>
            </name>
          </person-group>
          <article-title>Identification of structural elements in Nox1 and Nox4 controlling localization and activity</article-title>
          <source>Antioxid. Redox Signaling</source>
          <volume>11</volume>
          <year>2009</year>
          <fpage>1279</fpage>
          <lpage>1287</lpage>
        </element-citation>
      </ref>
      <ref id="bb1175">
        <label>235</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>von Löhneysen</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Noack</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>M.R.</given-names>
            </name>
            <name>
              <surname>Friedman</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Knaus</surname>
              <given-names>U.G.</given-names>
            </name>
          </person-group>
          <article-title>Structural insights into Nox4 and Nox2: motifs involved in function and cellular localization</article-title>
          <source>Mol. Cell. Biol.</source>
          <volume>30</volume>
          <year>2010</year>
          <fpage>961</fpage>
          <lpage>975</lpage>
          <pub-id pub-id-type="pmid">19995913</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1180">
        <label>236</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krishnan</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Suter</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Windak</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Krebs</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Felley</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Montessuit</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Tokarska-Schlattner</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Aasum</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Bogdanova</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Perriard</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Perriard</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Larsen</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Pedrazzini</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Krek</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy</article-title>
          <source>Cell Metab.</source>
          <volume>9</volume>
          <year>2009</year>
          <fpage>512</fpage>
          <lpage>524</lpage>
          <pub-id pub-id-type="pmid">19490906</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1185">
        <label>237</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Empel</surname>
              <given-names>V.P.</given-names>
            </name>
            <name>
              <surname>Bertrand</surname>
              <given-names>A.T.</given-names>
            </name>
            <name>
              <surname>Hofstra</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Crijns</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Doevendans</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>De Windt</surname>
              <given-names>L.J.</given-names>
            </name>
          </person-group>
          <article-title>Myocyte apoptosis in heart failure</article-title>
          <source>Cardiovasc. Res.</source>
          <volume>67</volume>
          <year>2005</year>
          <fpage>21</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="pmid">15896727</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1190">
        <label>238</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Foo</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Mani</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kitsis</surname>
              <given-names>R.N.</given-names>
            </name>
          </person-group>
          <article-title>Death begets failure in the heart</article-title>
          <source>J. Clin. Invest.</source>
          <volume>115</volume>
          <year>2005</year>
          <fpage>565</fpage>
          <lpage>571</lpage>
          <pub-id pub-id-type="pmid">15765138</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1195">
        <label>239</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kang</surname>
              <given-names>Y.J.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>X.</given-names>
            </name>
          </person-group>
          <article-title>Antiapoptotic effect and inhibition of ischemia/reperfusion-induced myocardial injury in metallothionein-overexpressing transgenic mice</article-title>
          <source>Am. J. Pathol.</source>
          <volume>163</volume>
          <year>2003</year>
          <fpage>1579</fpage>
          <lpage>1586</lpage>
          <pub-id pub-id-type="pmid">14507664</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1200">
        <label>240</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nagy</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Malik</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Tosaki</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>Y.S.</given-names>
            </name>
            <name>
              <surname>Maulik</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Das</surname>
              <given-names>D.K.</given-names>
            </name>
          </person-group>
          <article-title>Overexpression of glutaredoxin-2 reduces myocardial cell death by preventing both apoptosis and necrosis</article-title>
          <source>J. Mol. Cell. Cardiol.</source>
          <volume>44</volume>
          <year>2008</year>
          <fpage>252</fpage>
          <lpage>260</lpage>
          <pub-id pub-id-type="pmid">18076901</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1205">
        <label>241</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhao</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>G.C.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Z.G.</given-names>
            </name>
            <name>
              <surname>Bandyopadhyay</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Kranias</surname>
              <given-names>E.G.</given-names>
            </name>
          </person-group>
          <article-title>Protection of peroxiredoxin II on oxidative stress-induced cardiomyocyte death and apoptosis</article-title>
          <source>Basic Res. Cardiol.</source>
          <volume>104</volume>
          <year>2009</year>
          <fpage>377</fpage>
          <lpage>389</lpage>
          <pub-id pub-id-type="pmid">19030911</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1210">
        <label>242</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>von Harsdorf</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>P.F.</given-names>
            </name>
            <name>
              <surname>Dietz</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis</article-title>
          <source>Circulation</source>
          <volume>99</volume>
          <year>1999</year>
          <fpage>2934</fpage>
          <lpage>2941</lpage>
          <pub-id pub-id-type="pmid">10359739</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1215">
        <label>243</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Foo</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>L.K.</given-names>
            </name>
            <name>
              <surname>Kitsis</surname>
              <given-names>R.N.</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>M.R.</given-names>
            </name>
          </person-group>
          <article-title>Ubiquitination and degradation of the anti-apoptotic protein ARC by MDM2</article-title>
          <source>J. Biol. Chem.</source>
          <volume>282</volume>
          <year>2007</year>
          <fpage>5529</fpage>
          <lpage>5535</lpage>
          <pub-id pub-id-type="pmid">17142834</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1220">
        <label>244</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Neuss</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Monticone</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Lundberg</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Chesley</surname>
              <given-names>A.T.</given-names>
            </name>
            <name>
              <surname>Fleck</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Crow</surname>
              <given-names>M.T.</given-names>
            </name>
          </person-group>
          <article-title>The apoptotic regulatory protein ARC (apoptosis repressor with caspase recruitment domain) prevents oxidant stress-mediated cell death by preserving mitochondrial function</article-title>
          <source>J. Biol. Chem.</source>
          <volume>276</volume>
          <year>2001</year>
          <fpage>33915</fpage>
          <lpage>33922</lpage>
          <pub-id pub-id-type="pmid">11438535</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1225">
        <label>245</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Donath</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Willenbockel</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Al-Saadi</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Gross</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Willnow</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Bader</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Bauersachs</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wollert</surname>
              <given-names>K.C.</given-names>
            </name>
            <name>
              <surname>Dietz</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>von Harsdorf</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress</article-title>
          <source>Circulation</source>
          <volume>113</volume>
          <year>2006</year>
          <fpage>1203</fpage>
          <lpage>1212</lpage>
          <pub-id pub-id-type="pmid">16505176</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1230">
        <label>246</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Toth</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Nickson</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Qin</surname>
              <given-names>L.L.</given-names>
            </name>
            <name>
              <surname>Erhardt</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Differential regulation of cardiomyocyte survival and hypertrophy by MDM2, an E3 ubiquitin ligase</article-title>
          <source>J. Biol. Chem.</source>
          <volume>281</volume>
          <year>2006</year>
          <fpage>3679</fpage>
          <lpage>3689</lpage>
          <pub-id pub-id-type="pmid">16339144</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1235">
        <label>247</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Empel</surname>
              <given-names>V.P.</given-names>
            </name>
            <name>
              <surname>Bertrand</surname>
              <given-names>A.T.</given-names>
            </name>
            <name>
              <surname>van der Nagel</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Kostin</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Doevendans</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Crijns</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>de Wit</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Sluiter</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Ackerman</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>De Windt</surname>
              <given-names>L.I.</given-names>
            </name>
          </person-group>
          <article-title>Downregulation of apoptosis-inducing factor in harlequin mutant mice sensitizes the myocardium to oxidative stress-related cell death and pressure overload-induced decompensation</article-title>
          <source>Circ. Res.</source>
          <volume>96</volume>
          <year>2005</year>
          <fpage>e92</fpage>
          <lpage>e101</lpage>
          <pub-id pub-id-type="pmid">15933268</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1240">
        <label>248</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yussman</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Toyokawa</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Odley</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lynch</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Colbert</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Aronow</surname>
              <given-names>B.J.</given-names>
            </name>
            <name>
              <surname>Lorenz</surname>
              <given-names>J.N.</given-names>
            </name>
            <name>
              <surname>Dorn</surname>
              <given-names>G.W.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy</article-title>
          <source>Nat. Med.</source>
          <volume>8</volume>
          <year>2002</year>
          <fpage>725</fpage>
          <lpage>730</lpage>
          <pub-id pub-id-type="pmid">12053174</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1245">
        <label>249</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bianchi</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Kunduzova</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Masini</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Cambon</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Bani</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Raimondi</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Seguelas</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Nistri</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Colucci</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Leducq</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Parini</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury</article-title>
          <source>Circulation</source>
          <volume>112</volume>
          <year>2005</year>
          <fpage>3297</fpage>
          <lpage>3305</lpage>
          <pub-id pub-id-type="pmid">16286591</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1250">
        <label>250</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsuzawa</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ichijo</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Stress-responsive protein kinases in redox-regulated apoptosis signaling</article-title>
          <source>Antioxid. Redox Signaling</source>
          <volume>7</volume>
          <year>2005</year>
          <fpage>472</fpage>
          <lpage>481</lpage>
        </element-citation>
      </ref>
      <ref id="bb1255">
        <label>251</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Remondino</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kwon</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Communal</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Pimentel</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Sawyer</surname>
              <given-names>D.B.</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Colucci</surname>
              <given-names>W.S.</given-names>
            </name>
          </person-group>
          <article-title>Beta-adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH<sub>2</sub>-terminal kinase-dependent activation of the mitochondrial pathway</article-title>
          <source>Circ. Res.</source>
          <volume>92</volume>
          <year>2003</year>
          <fpage>136</fpage>
          <lpage>138</lpage>
          <pub-id pub-id-type="pmid">12574140</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1260">
        <label>252</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nishida</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Otsu</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>The role of apoptosis signal-regulating kinase 1 in cardiomyocyte apoptosis</article-title>
          <source>Antioxid. Redox Signaling</source>
          <volume>8</volume>
          <year>2006</year>
          <fpage>1729</fpage>
          <lpage>1736</lpage>
        </element-citation>
      </ref>
      <ref id="bb1265">
        <label>253</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Palomeque</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Rueda</surname>
              <given-names>O.V.</given-names>
            </name>
            <name>
              <surname>Sapia</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Valverde</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Salas</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Petroff</surname>
              <given-names>M.V.</given-names>
            </name>
            <name>
              <surname>Mattiazzi</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Angiotensin II-induced oxidative stress resets the Ca<sup>2+</sup> dependence of Ca<sup>2+</sup>-calmodulin protein kinase II and promotes a death pathway conserved across different species</article-title>
          <source>Circ. Res.</source>
          <volume>105</volume>
          <year>2009</year>
          <fpage>1204</fpage>
          <lpage>1212</lpage>
          <pub-id pub-id-type="pmid">19850941</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1270">
        <label>254</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shono</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Yokoyama</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Uesaka</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kuroda</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Takeya</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Yamasaki</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Amano</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Mizoguchi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>S.O.</given-names>
            </name>
            <name>
              <surname>Niiro</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Miyamoto</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Akashi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Iwaki</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Sumimoto</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Sasaki</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Enhanced expression of NADPH oxidase Nox4 in human gliomas and its roles in cell proliferation and survival</article-title>
          <source>Int. J. Cancer</source>
          <volume>123</volume>
          <year>2008</year>
          <fpage>787</fpage>
          <lpage>792</lpage>
          <pub-id pub-id-type="pmid">18508317</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1275">
        <label>255</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vaquero</surname>
              <given-names>E.C.</given-names>
            </name>
            <name>
              <surname>Edderkaoui</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Pandol</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Gukovsky</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Gukovskaya</surname>
              <given-names>A.S.</given-names>
            </name>
          </person-group>
          <article-title>Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells</article-title>
          <source>J. Biol. Chem.</source>
          <volume>279</volume>
          <year>2004</year>
          <fpage>34643</fpage>
          <lpage>34654</lpage>
          <pub-id pub-id-type="pmid">15155719</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1280">
        <label>256</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edderkaoui</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Vaquero</surname>
              <given-names>E.C.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Friess</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Buchler</surname>
              <given-names>M.W.</given-names>
            </name>
            <name>
              <surname>Lerch</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Pandol</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Gukovskaya</surname>
              <given-names>A.S.</given-names>
            </name>
          </person-group>
          <article-title>Extracellular matrix stimulates reactive oxygen species production and increases pancreatic cancer cell survival through 5-lipoxygenase and NADPH oxidase</article-title>
          <source>Am. J. Physiol.</source>
          <volume>289</volume>
          <year>2005</year>
          <fpage>G1137</fpage>
          <lpage>G1147</lpage>
        </element-citation>
      </ref>
      <ref id="bb1285">
        <label>257</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mochizuki</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Furuta</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mitsushita</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Shang</surname>
              <given-names>W.H.</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Yokoo</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yamaura</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ishizone</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Nakayama</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Konagai</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hirose</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kiyosawa</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kamata</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells</article-title>
          <source>Oncogene</source>
          <volume>25</volume>
          <year>2006</year>
          <fpage>3699</fpage>
          <lpage>3707</lpage>
          <pub-id pub-id-type="pmid">16532036</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1290">
        <label>258</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murillo</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Carmona-Cuenca</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Del Castillo</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Ortiz</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Roncero</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Sánchez</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Fernández</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Fabregat</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Activation of NADPH oxidase by transforming growth factor-beta in hepatocytes mediates up-regulation of epidermal growth factor receptor ligands through a nuclear factor-kappaB-dependent mechanism</article-title>
          <source>Biochem. J.</source>
          <volume>405</volume>
          <year>2007</year>
          <fpage>251</fpage>
          <lpage>259</lpage>
          <pub-id pub-id-type="pmid">17407446</pub-id>
        </element-citation>
      </ref>
      <ref id="bb1295">
        <label>259</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Edderkaoui</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Truong</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Ohno</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Jang</surname>
              <given-names>K.T.</given-names>
            </name>
            <name>
              <surname>Berti</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Pandol</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Gukovskaya</surname>
              <given-names>A.S.</given-names>
            </name>
          </person-group>
          <article-title>NADPH oxidase promotes pancreatic cancer cell survival via inhibiting JAK2 dephosphorylation by tyrosine phosphatases</article-title>
          <source>Gastroenterology</source>
          <volume>133</volume>
          <year>2007</year>
          <fpage>1637</fpage>
          <lpage>1648</lpage>
          <pub-id pub-id-type="pmid">17983808</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <ack>
      <title>Acknowledgments</title>
      <p>The authors’ research is supported by the British Heart Foundation (RG/08/011/25922; CH/99001; RE/08/003), a Leducq Foundation Transatlantic Network of Excellence award, EU FP6 Grant LSHM-CT-2005-018833 (EUGeneHeart), and a National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's &amp; St Thomas’ NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust.</p>
    </ack>
  </back>
  <floats-group>
    <fig id="f0005">
      <label>Fig. 1</label>
      <caption>
        <p>Main ROS sources and effects in cardiac myocytes. A diverse range of signals can initiate redox signaling, e.g., GPCR agonists, growth factors, and stresses such as hypoxia. These may result in the induction of and/or changes in ROS generation by sources that include NO synthases (NOS), NADPH oxidases (Nox), and mitochondria. Emerging data support cross talk among the ROS-generating systems. The main species that are generated in the first instance are NO, O<sub>2</sub><sup>•−</sup>, or H<sub>2</sub>O<sub>2</sub>, with recent data suggesting that Nox4 may generate predominantly H<sub>2</sub>O<sub>2</sub> rather than O<sub>2</sub><sup>•−</sup>. O<sub>2</sub>-dependent metabolism also influences redox signaling significantly, notably through changes in the generation of NADPH, which is critical for the maintenance of major antioxidant pools. ROS often act at a molecular level by mediating protein posttranslational modifications within diverse signaling pathways. In general, low-level production of ROS may be involved in potentially adaptive processes—such as adaptation to hypoxia and modulation of excitation–contraction coupling (ECC). On the other hand, the generation of higher levels of ROS and/or more potent oxidants such as <sup>•</sup>OH may result in significant pathology as a result of macromolecular damage as well as detrimental signaling.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="f0010">
      <label>Fig. 2</label>
      <caption>
        <p>Regulation and downstream effects of Nox2 and Nox4 in cardiac myocytes. Nox2 is normally quiescent and is activated through the binding of cytosolic regulatory components to generate O<sub>2</sub><sup>•−</sup>, which may react with NO or be converted to H<sub>2</sub>O<sub>2</sub>. Nox4 on the other hand is constitutively active but its expression level is increased by stresses such as hypoxia or during development. Recent studies suggest that Nox4 generates predominantly H<sub>2</sub>O<sub>2</sub>. The downstream effects of the two Nox isoforms are divergent, with Nox2 generally driving detrimental effects, whereas Nox4 may facilitate adaptive processes such as angiogenesis. Abbreviations as in the text.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="f0015">
      <label>Fig. 3</label>
      <caption>
        <p>Components of the excitation–contraction coupling machinery in cardiomyocytes and the main redox-sensitive targets<italic>.</italic> The table indicates the main redox-sensitive targets and types of protein modification, i.e., RSSR, disulfide bond; RSNO, thiol nitrosylation; RSSG, thiol glutathiolation; RSO<sub>3</sub>, sulfonic acid; PTyrNO<sub>2</sub>, tyrosine nitration. In the case of redox-activated protein kinases, the modification is protein phosphorylation.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
  </floats-group>
</article>